AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR
142.4|148.5|145.4|8582|All ICCC Groups Combined|59151007|0-14|All Races|Male and Female|1999
43.5|46.9|45.1|2667|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59151007|0-14|All Races|Male and Female|1999
14.4|16.4|15.4|907|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59151007|0-14|All Races|Male and Female|1999
30.2|33.1|31.7|1873|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59151007|0-14|All Races|Male and Female|1999
2.6|3.5|3.0|177|IIIa Ependymomas and choroid plexus tumor|59151007|0-14|All Races|Male and Female|1999
13.4|15.4|14.4|851|IIIb Astrocytomas|59151007|0-14|All Races|Male and Female|1999
7.1|8.6|7.8|464|IIIc Intracranial and intraspinal embryonal tumors|59151007|0-14|All Races|Male and Female|1999
4.7|5.9|5.2|311|IIId Other gliomas|59151007|0-14|All Races|Male and Female|1999
0.3|0.7|0.5|30|IIIe Other specified intracranial and intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999
0.5|0.9|0.7|40|IIIf Unspecified intracranial and intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999
4.9|6.1|5.5|324|IIa Hodgkin lymphomas|59151007|0-14|All Races|Male and Female|1999
5.4|6.6|6.0|353|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59151007|0-14|All Races|Male and Female|1999
2.1|2.9|2.5|149|IIc Burkitt lymphoma|59151007|0-14|All Races|Male and Female|1999
0.7|1.2|0.9|54|IId Miscellaneous lymphoreticular neoplasms|59151007|0-14|All Races|Male and Female|1999
0.3|0.7|0.5|27|IIe Unspecified lymphomas|59151007|0-14|All Races|Male and Female|1999
9.9|11.6|10.7|627|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59151007|0-14|All Races|Male and Female|1999
9.7|11.4|10.5|617|IVa Neuroblastoma and ganglioneuroblastoma|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|IVb Other peripheral nervous cell tumors|59151007|0-14|All Races|Male and Female|1999
8.6|10.2|9.4|555|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59151007|0-14|All Races|Male and Female|1999
4.2|5.4|4.8|283|IXa Rhabdomyosarcomas|59151007|0-14|All Races|Male and Female|1999
0.7|1.2|0.9|55|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|IXc Kaposi sarcoma|59151007|0-14|All Races|Male and Female|1999
2.3|3.2|2.7|161|IXd Other specified soft tissue sarcomas|59151007|0-14|All Races|Male and Female|1999
0.7|1.2|0.9|55|IXe Unspecified soft tissue sarcomas|59151007|0-14|All Races|Male and Female|1999
34.0|37.0|35.5|2096|Ia Lymphoid leukemias|59151007|0-14|All Races|Male and Female|1999
6.9|8.4|7.6|450|Ib Acute myeloid leukemias|59151007|0-14|All Races|Male and Female|1999
0.4|0.9|0.6|37|Ic Chronic myeloproliferative diseases|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|59151007|0-14|All Races|Male and Female|1999
1.0|1.6|1.3|74|Ie Unspecified and other specified leukemias|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.3|18|Not classified by ICCC|59151007|0-14|All Races|Male and Female|1999
3.7|4.8|4.2|246|V RETINOBLASTOMA|59151007|0-14|All Races|Male and Female|1999
7.3|8.8|8.0|473|VI RENAL TUMORS|59151007|0-14|All Races|Male and Female|1999
1.8|2.6|2.2|130|VII HEPATIC TUMORS|59151007|0-14|All Races|Male and Female|1999
6.5|7.8|7.1|421|VIII MALIGNANT BONE TUMORS|59151007|0-14|All Races|Male and Female|1999
3.7|4.7|4.2|246|VIIIa Osteosarcomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIIIb Chondrosarcomas|59151007|0-14|All Races|Male and Female|1999
2.0|2.8|2.3|138|VIIIc Ewing tumor and related sarcomas of bone|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.3|19|VIIId Other specified malignant bone tumors|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIIIe Unspecified malignant bone tumors|59151007|0-14|All Races|Male and Female|1999
1.5|2.2|1.9|109|VIIa Hepatoblastoma and mesenchymal tumors of liver|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.4|21|VIIb Hepatic carcinomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59151007|0-14|All Races|Male and Female|1999
6.9|8.3|7.6|447|VIa Nephroblastoma and other non-epithelial renal tumors|59151007|0-14|All Races|Male and Female|1999
0.2|0.6|0.4|23|VIb Renal carcinomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIc Unspecified malignant renal tumors|59151007|0-14|All Races|Male and Female|1999
4.4|5.6|5.0|292|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59151007|0-14|All Races|Male and Female|1999
5.2|6.4|5.8|341|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59151007|0-14|All Races|Male and Female|1999
0.4|0.8|0.5|32|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|XIIa Other specified malignant tumors|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.3|20|XIIb Other unspecified malignant tumors|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|XIa Adrenocortical carcinomas|59151007|0-14|All Races|Male and Female|1999
1.5|2.3|1.9|111|XIb Thyroid carcinomas|59151007|0-14|All Races|Male and Female|1999
0.2|0.6|0.4|23|XIc Nasopharyngeal carcinomas|59151007|0-14|All Races|Male and Female|1999
1.4|2.1|1.8|104|XId Malignant melanomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|XIe Skin carcinomas|59151007|0-14|All Races|Male and Female|1999
1.1|1.8|1.4|84|XIf Other and unspecified carcinomas|59151007|0-14|All Races|Male and Female|1999
1.0|1.6|1.3|76|Xa Intracranial and intraspinal germ cell tumors|59151007|0-14|All Races|Male and Female|1999
1.1|1.7|1.4|79|Xb Malignant extracranial and extragonadal germ cell tumors|59151007|0-14|All Races|Male and Female|1999
1.8|2.5|2.1|125|Xc Malignant gonadal germ cell tumors|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|Xd Gonadal carcinomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59151007|0-14|All Races|Male and Female|1999
146.0|152.3|149.1|8849|All ICCC Groups Combined|59476204|0-14|All Races|Male and Female|2000
44.2|47.6|45.9|2718|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59476204|0-14|All Races|Male and Female|2000
15.6|17.7|16.6|989|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59476204|0-14|All Races|Male and Female|2000
31.2|34.1|32.6|1937|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59476204|0-14|All Races|Male and Female|2000
2.3|3.1|2.7|157|IIIa Ependymomas and choroid plexus tumor|59476204|0-14|All Races|Male and Female|2000
15.7|17.8|16.7|992|IIIb Astrocytomas|59476204|0-14|All Races|Male and Female|2000
6.8|8.2|7.4|442|IIIc Intracranial and intraspinal embryonal tumors|59476204|0-14|All Races|Male and Female|2000
4.1|5.2|4.7|277|IIId Other gliomas|59476204|0-14|All Races|Male and Female|2000
0.3|0.7|0.5|29|IIIe Other specified intracranial and intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000
0.5|0.9|0.7|40|IIIf Unspecified intracranial and intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000
5.3|6.5|5.9|350|IIa Hodgkin lymphomas|59476204|0-14|All Races|Male and Female|2000
5.4|6.6|6.0|357|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59476204|0-14|All Races|Male and Female|2000
2.4|3.3|2.8|168|IIc Burkitt lymphoma|59476204|0-14|All Races|Male and Female|2000
1.0|1.6|1.3|78|IId Miscellaneous lymphoreticular neoplasms|59476204|0-14|All Races|Male and Female|2000
0.4|0.8|0.6|36|IIe Unspecified lymphomas|59476204|0-14|All Races|Male and Female|2000
9.3|10.9|10.1|596|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59476204|0-14|All Races|Male and Female|2000
9.2|10.8|10.0|588|IVa Neuroblastoma and ganglioneuroblastoma|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|IVb Other peripheral nervous cell tumors|59476204|0-14|All Races|Male and Female|2000
9.5|11.2|10.3|614|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59476204|0-14|All Races|Male and Female|2000
4.5|5.7|5.1|301|IXa Rhabdomyosarcomas|59476204|0-14|All Races|Male and Female|2000
0.7|1.2|1.0|57|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|IXc Kaposi sarcoma|59476204|0-14|All Races|Male and Female|2000
2.8|3.7|3.2|193|IXd Other specified soft tissue sarcomas|59476204|0-14|All Races|Male and Female|2000
0.8|1.3|1.0|61|IXe Unspecified soft tissue sarcomas|59476204|0-14|All Races|Male and Female|2000
35.5|38.6|37.0|2192|Ia Lymphoid leukemias|59476204|0-14|All Races|Male and Female|2000
6.1|7.5|6.8|402|Ib Acute myeloid leukemias|59476204|0-14|All Races|Male and Female|2000
0.5|1.0|0.7|44|Ic Chronic myeloproliferative diseases|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|59476204|0-14|All Races|Male and Female|2000
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Not classified by ICCC|59476204|0-14|All Races|Male and Female|2000
3.8|4.9|4.4|257|V RETINOBLASTOMA|59476204|0-14|All Races|Male and Female|2000
8.0|9.6|8.8|518|VI RENAL TUMORS|59476204|0-14|All Races|Male and Female|2000
2.0|2.8|2.4|139|VII HEPATIC TUMORS|59476204|0-14|All Races|Male and Female|2000
5.9|7.2|6.5|390|VIII MALIGNANT BONE TUMORS|59476204|0-14|All Races|Male and Female|2000
3.1|4.1|3.6|213|VIIIa Osteosarcomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIIb Chondrosarcomas|59476204|0-14|All Races|Male and Female|2000
2.2|3.1|2.6|156|VIIIc Ewing tumor and related sarcomas of bone|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIId Other specified malignant bone tumors|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIIe Unspecified malignant bone tumors|59476204|0-14|All Races|Male and Female|2000
1.7|2.5|2.1|123|VIIa Hepatoblastoma and mesenchymal tumors of liver|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIb Hepatic carcinomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59476204|0-14|All Races|Male and Female|2000
7.6|9.1|8.4|494|VIa Nephroblastoma and other non-epithelial renal tumors|59476204|0-14|All Races|Male and Female|2000
0.2|0.6|0.4|23|VIb Renal carcinomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIc Unspecified malignant renal tumors|59476204|0-14|All Races|Male and Female|2000
4.4|5.5|4.9|294|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59476204|0-14|All Races|Male and Female|2000
5.1|6.3|5.7|340|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59476204|0-14|All Races|Male and Female|2000
0.5|1.0|0.7|44|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|XIIa Other specified malignant tumors|59476204|0-14|All Races|Male and Female|2000
0.4|0.7|0.5|31|XIIb Other unspecified malignant tumors|59476204|0-14|All Races|Male and Female|2000
0.2|0.5|0.3|18|XIa Adrenocortical carcinomas|59476204|0-14|All Races|Male and Female|2000
1.6|2.3|1.9|113|XIb Thyroid carcinomas|59476204|0-14|All Races|Male and Female|2000
0.2|0.5|0.3|20|XIc Nasopharyngeal carcinomas|59476204|0-14|All Races|Male and Female|2000
1.4|2.1|1.8|105|XId Malignant melanomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|XIe Skin carcinomas|59476204|0-14|All Races|Male and Female|2000
1.1|1.7|1.4|81|XIf Other and unspecified carcinomas|59476204|0-14|All Races|Male and Female|2000
1.2|1.8|1.5|87|Xa Intracranial and intraspinal germ cell tumors|59476204|0-14|All Races|Male and Female|2000
0.8|1.4|1.1|65|Xb Malignant extracranial and extragonadal germ cell tumors|59476204|0-14|All Races|Male and Female|2000
1.9|2.6|2.2|133|Xc Malignant gonadal germ cell tumors|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Xd Gonadal carcinomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59476204|0-14|All Races|Male and Female|2000
152.9|159.3|156.1|9330|All ICCC Groups Combined|59815030|0-14|All Races|Male and Female|2001
48.6|52.3|50.4|2999|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59815030|0-14|All Races|Male and Female|2001
15.0|17.0|16.0|962|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59815030|0-14|All Races|Male and Female|2001
31.5|34.4|33.0|1966|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59815030|0-14|All Races|Male and Female|2001
2.3|3.2|2.7|164|IIIa Ependymomas and choroid plexus tumor|59815030|0-14|All Races|Male and Female|2001
15.4|17.5|16.4|979|IIIb Astrocytomas|59815030|0-14|All Races|Male and Female|2001
6.7|8.1|7.4|438|IIIc Intracranial and intraspinal embryonal tumors|59815030|0-14|All Races|Male and Female|2001
4.8|6.0|5.4|320|IIId Other gliomas|59815030|0-14|All Races|Male and Female|2001
0.5|0.9|0.7|42|IIIe Other specified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001
0.2|0.6|0.4|23|IIIf Unspecified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001
5.3|6.6|5.9|357|IIa Hodgkin lymphomas|59815030|0-14|All Races|Male and Female|2001
5.8|7.1|6.4|387|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|0-14|All Races|Male and Female|2001
1.9|2.7|2.3|135|IIc Burkitt lymphoma|59815030|0-14|All Races|Male and Female|2001
0.8|1.3|1.0|60|IId Miscellaneous lymphoreticular neoplasms|59815030|0-14|All Races|Male and Female|2001
0.2|0.6|0.4|23|IIe Unspecified lymphomas|59815030|0-14|All Races|Male and Female|2001
10.8|12.5|11.6|695|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59815030|0-14|All Races|Male and Female|2001
10.6|12.3|11.4|685|IVa Neuroblastoma and ganglioneuroblastoma|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|IVb Other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001
9.6|11.2|10.4|621|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59815030|0-14|All Races|Male and Female|2001
4.5|5.6|5.0|299|IXa Rhabdomyosarcomas|59815030|0-14|All Races|Male and Female|2001
1.0|1.6|1.3|76|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|IXc Kaposi sarcoma|59815030|0-14|All Races|Male and Female|2001
2.7|3.6|3.1|187|IXd Other specified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001
0.7|1.3|1.0|59|IXe Unspecified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001
37.0|40.2|38.6|2289|Ia Lymphoid leukemias|59815030|0-14|All Races|Male and Female|2001
6.7|8.1|7.3|440|Ib Acute myeloid leukemias|59815030|0-14|All Races|Male and Female|2001
1.4|2.1|1.7|102|Ic Chronic myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001
1.3|2.0|1.6|96|Id Myelodysplastic syndrome and other myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|Not classified by ICCC|59815030|0-14|All Races|Male and Female|2001
3.9|5.0|4.4|263|V RETINOBLASTOMA|59815030|0-14|All Races|Male and Female|2001
7.9|9.4|8.6|511|VI RENAL TUMORS|59815030|0-14|All Races|Male and Female|2001
1.9|2.6|2.2|134|VII HEPATIC TUMORS|59815030|0-14|All Races|Male and Female|2001
6.4|7.7|7.0|424|VIII MALIGNANT BONE TUMORS|59815030|0-14|All Races|Male and Female|2001
3.4|4.4|3.8|232|VIIIa Osteosarcomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIIb Chondrosarcomas|59815030|0-14|All Races|Male and Female|2001
2.3|3.1|2.7|160|VIIIc Ewing tumor and related sarcomas of bone|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIId Other specified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIIe Unspecified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001
1.5|2.2|1.8|108|VIIa Hepatoblastoma and mesenchymal tumors of liver|59815030|0-14|All Races|Male and Female|2001
0.3|0.6|0.4|25|VIIb Hepatic carcinomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59815030|0-14|All Races|Male and Female|2001
7.5|9.0|8.2|489|VIa Nephroblastoma and other non-epithelial renal tumors|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|20|VIb Renal carcinomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIc Unspecified malignant renal tumors|59815030|0-14|All Races|Male and Female|2001
4.5|5.6|5.0|304|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59815030|0-14|All Races|Male and Female|2001
6.0|7.3|6.6|400|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59815030|0-14|All Races|Male and Female|2001
0.5|1.0|0.7|43|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59815030|0-14|All Races|Male and Female|2001
0.2|0.6|0.4|23|XIIa Other specified malignant tumors|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|20|XIIb Other unspecified malignant tumors|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|17|XIa Adrenocortical carcinomas|59815030|0-14|All Races|Male and Female|2001
2.0|2.8|2.3|142|XIb Thyroid carcinomas|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|19|XIc Nasopharyngeal carcinomas|59815030|0-14|All Races|Male and Female|2001
1.7|2.4|2.0|122|XId Malignant melanomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|XIe Skin carcinomas|59815030|0-14|All Races|Male and Female|2001
1.3|2.0|1.6|97|XIf Other and unspecified carcinomas|59815030|0-14|All Races|Male and Female|2001
1.0|1.6|1.3|79|Xa Intracranial and intraspinal germ cell tumors|59815030|0-14|All Races|Male and Female|2001
1.1|1.7|1.4|85|Xb Malignant extracranial and extragonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001
1.7|2.4|2.0|121|Xc Malignant gonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|Xd Gonadal carcinomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59815030|0-14|All Races|Male and Female|2001
151.9|158.2|155.0|9288|All ICCC Groups Combined|59931314|0-14|All Races|Male and Female|2002
47.5|51.1|49.3|2940|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59931314|0-14|All Races|Male and Female|2002
14.7|16.7|15.7|946|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59931314|0-14|All Races|Male and Female|2002
33.2|36.2|34.7|2071|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59931314|0-14|All Races|Male and Female|2002
3.1|4.1|3.6|216|IIIa Ependymomas and choroid plexus tumor|59931314|0-14|All Races|Male and Female|2002
15.5|17.6|16.5|989|IIIb Astrocytomas|59931314|0-14|All Races|Male and Female|2002
6.8|8.2|7.4|443|IIIc Intracranial and intraspinal embryonal tumors|59931314|0-14|All Races|Male and Female|2002
5.4|6.6|6.0|355|IIId Other gliomas|59931314|0-14|All Races|Male and Female|2002
0.5|1.0|0.7|43|IIIe Other specified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002
0.3|0.6|0.4|25|IIIf Unspecified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002
4.9|6.1|5.5|335|IIa Hodgkin lymphomas|59931314|0-14|All Races|Male and Female|2002
5.5|6.7|6.1|365|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59931314|0-14|All Races|Male and Female|2002
2.3|3.2|2.7|164|IIc Burkitt lymphoma|59931314|0-14|All Races|Male and Female|2002
0.9|1.5|1.2|71|IId Miscellaneous lymphoreticular neoplasms|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|IIe Unspecified lymphomas|59931314|0-14|All Races|Male and Female|2002
10.3|12.0|11.1|663|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59931314|0-14|All Races|Male and Female|2002
10.1|11.8|11.0|656|IVa Neuroblastoma and ganglioneuroblastoma|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|IVb Other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002
9.9|11.6|10.7|644|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59931314|0-14|All Races|Male and Female|2002
4.6|5.8|5.2|310|IXa Rhabdomyosarcomas|59931314|0-14|All Races|Male and Female|2002
0.9|1.4|1.1|69|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|IXc Kaposi sarcoma|59931314|0-14|All Races|Male and Female|2002
3.0|4.0|3.5|210|IXd Other specified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002
0.7|1.2|0.9|55|IXe Unspecified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002
35.3|38.4|36.8|2193|Ia Lymphoid leukemias|59931314|0-14|All Races|Male and Female|2002
7.3|8.8|8.0|482|Ib Acute myeloid leukemias|59931314|0-14|All Races|Male and Female|2002
1.3|1.9|1.6|96|Ic Chronic myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002
1.3|2.0|1.6|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|59931314|0-14|All Races|Male and Female|2002
0.2|0.4|0.3|16|Not classified by ICCC|59931314|0-14|All Races|Male and Female|2002
3.3|4.3|3.8|225|V RETINOBLASTOMA|59931314|0-14|All Races|Male and Female|2002
7.6|9.0|8.3|492|VI RENAL TUMORS|59931314|0-14|All Races|Male and Female|2002
1.8|2.5|2.1|126|VII HEPATIC TUMORS|59931314|0-14|All Races|Male and Female|2002
6.2|7.6|6.9|417|VIII MALIGNANT BONE TUMORS|59931314|0-14|All Races|Male and Female|2002
3.2|4.1|3.6|221|VIIIa Osteosarcomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIIIb Chondrosarcomas|59931314|0-14|All Races|Male and Female|2002
2.2|3.0|2.6|157|VIIIc Ewing tumor and related sarcomas of bone|59931314|0-14|All Races|Male and Female|2002
0.2|0.6|0.4|22|VIIId Other specified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIIIe Unspecified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002
1.4|2.1|1.7|104|VIIa Hepatoblastoma and mesenchymal tumors of liver|59931314|0-14|All Races|Male and Female|2002
0.2|0.5|0.3|21|VIIb Hepatic carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59931314|0-14|All Races|Male and Female|2002
7.3|8.8|8.0|478|VIa Nephroblastoma and other non-epithelial renal tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIb Renal carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIc Unspecified malignant renal tumors|59931314|0-14|All Races|Male and Female|2002
4.7|5.9|5.3|319|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59931314|0-14|All Races|Male and Female|2002
5.8|7.1|6.5|393|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59931314|0-14|All Races|Male and Female|2002
0.4|0.8|0.6|36|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59931314|0-14|All Races|Male and Female|2002
0.2|0.6|0.4|22|XIIa Other specified malignant tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIIb Other unspecified malignant tumors|59931314|0-14|All Races|Male and Female|2002
0.2|0.4|0.3|16|XIa Adrenocortical carcinomas|59931314|0-14|All Races|Male and Female|2002
1.7|2.4|2.0|124|XIb Thyroid carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIc Nasopharyngeal carcinomas|59931314|0-14|All Races|Male and Female|2002
1.9|2.7|2.3|138|XId Malignant melanomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIe Skin carcinomas|59931314|0-14|All Races|Male and Female|2002
1.3|1.9|1.6|96|XIf Other and unspecified carcinomas|59931314|0-14|All Races|Male and Female|2002
1.1|1.7|1.4|85|Xa Intracranial and intraspinal germ cell tumors|59931314|0-14|All Races|Male and Female|2002
1.2|1.8|1.5|90|Xb Malignant extracranial and extragonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002
1.9|2.6|2.2|134|Xc Malignant gonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|Xd Gonadal carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59931314|0-14|All Races|Male and Female|2002
148.9|155.1|152.0|9233|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003
45.8|49.3|47.5|2871|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60628650|0-14|All Races|Male and Female|2003
15.1|17.2|16.1|984|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60628650|0-14|All Races|Male and Female|2003
31.5|34.4|32.9|1989|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60628650|0-14|All Races|Male and Female|2003
2.1|2.9|2.4|148|IIIa Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003
15.5|17.5|16.5|998|IIIb Astrocytomas|60628650|0-14|All Races|Male and Female|2003
6.5|7.9|7.2|433|IIIc Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003
5.0|6.2|5.6|337|IIId Other gliomas|60628650|0-14|All Races|Male and Female|2003
0.6|1.1|0.9|52|IIIe Other specified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003
0.2|0.5|0.3|21|IIIf Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003
5.3|6.5|5.8|360|IIa Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003
5.7|6.9|6.3|382|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003
2.3|3.2|2.7|163|IIc Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003
0.9|1.5|1.2|73|IId Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|IIe Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003
9.9|11.6|10.7|652|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60628650|0-14|All Races|Male and Female|2003
9.7|11.4|10.5|642|IVa Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|IVb Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003
9.7|11.3|10.5|640|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60628650|0-14|All Races|Male and Female|2003
4.3|5.5|4.9|295|IXa Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003
0.8|1.4|1.1|65|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|IXc Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003
3.1|4.1|3.6|219|IXd Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003
0.7|1.2|1.0|59|IXe Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003
34.3|37.4|35.8|2159|Ia Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003
6.9|8.3|7.6|462|Ib Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003
1.2|1.8|1.5|91|Ic Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003
1.5|2.2|1.8|110|Id Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003
0.6|1.1|0.8|49|Ie Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003
3.6|4.6|4.1|249|V RETINOBLASTOMA|60628650|0-14|All Races|Male and Female|2003
7.8|9.3|8.5|514|VI RENAL TUMORS|60628650|0-14|All Races|Male and Female|2003
2.3|3.1|2.7|163|VII HEPATIC TUMORS|60628650|0-14|All Races|Male and Female|2003
6.0|7.3|6.6|407|VIII MALIGNANT BONE TUMORS|60628650|0-14|All Races|Male and Female|2003
3.2|4.2|3.7|227|VIIIa Osteosarcomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIIIb Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003
1.9|2.6|2.2|136|VIIIc Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003
0.2|0.4|0.3|17|VIIId Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIIIe Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003
1.9|2.6|2.2|136|VIIa Hepatoblastoma and mesenchymal tumors of liver|60628650|0-14|All Races|Male and Female|2003
0.3|0.6|0.4|27|VIIb Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003
7.4|8.9|8.1|490|VIa Nephroblastoma and other non-epithelial renal tumors|60628650|0-14|All Races|Male and Female|2003
0.2|0.5|0.3|20|VIb Renal carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIc Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003
4.5|5.6|5.0|311|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60628650|0-14|All Races|Male and Female|2003
5.7|6.9|6.3|390|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60628650|0-14|All Races|Male and Female|2003
0.6|1.1|0.8|52|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60628650|0-14|All Races|Male and Female|2003
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003
0.3|0.6|0.4|27|XIIb Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|XIa Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003
1.9|2.6|2.2|138|XIb Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|XIc Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003
1.6|2.3|1.9|118|XId Malignant melanomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|XIe Skin carcinomas|60628650|0-14|All Races|Male and Female|2003
1.4|2.1|1.7|108|XIf Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003
0.9|1.5|1.2|72|Xa Intracranial and intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003
1.2|1.8|1.4|88|Xb Malignant extracranial and extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003
1.8|2.6|2.2|136|Xc Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|Xd Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003
156.7|163.1|159.9|9737|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004
49.2|52.8|51.0|3093|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60651802|0-14|All Races|Male and Female|2004
15.1|17.1|16.1|984|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60651802|0-14|All Races|Male and Female|2004
33.7|36.8|35.2|2131|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60651802|0-14|All Races|Male and Female|2004
2.6|3.5|3.0|182|IIIa Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004
16.5|18.6|17.5|1062|IIIb Astrocytomas|60651802|0-14|All Races|Male and Female|2004
7.1|8.6|7.8|473|IIIc Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004
4.9|6.1|5.5|330|IIId Other gliomas|60651802|0-14|All Races|Male and Female|2004
0.6|1.1|0.8|50|IIIe Other specified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004
0.4|0.8|0.6|34|IIIf Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004
4.7|5.9|5.3|324|IIa Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004
6.2|7.6|6.9|420|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004
2.1|2.9|2.4|147|IIc Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004
1.1|1.6|1.3|81|IId Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|IIe Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004
10.3|12.0|11.1|681|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60651802|0-14|All Races|Male and Female|2004
10.1|11.7|10.9|666|IVa Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|IVb Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004
9.7|11.3|10.5|641|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60651802|0-14|All Races|Male and Female|2004
4.0|5.1|4.5|276|IXa Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004
1.0|1.6|1.2|77|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|IXc Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004
3.2|4.2|3.6|224|IXd Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004
0.8|1.3|1.0|62|IXe Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004
37.1|40.2|38.6|2337|Ia Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004
7.3|8.7|8.0|489|Ib Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004
1.3|1.9|1.6|97|Ic Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004
1.2|1.9|1.5|92|Id Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004
1.0|1.6|1.3|78|Ie Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004
3.8|4.8|4.3|265|V RETINOBLASTOMA|60651802|0-14|All Races|Male and Female|2004
7.4|8.9|8.1|493|VI RENAL TUMORS|60651802|0-14|All Races|Male and Female|2004
2.4|3.3|2.8|174|VII HEPATIC TUMORS|60651802|0-14|All Races|Male and Female|2004
6.4|7.8|7.1|436|VIII MALIGNANT BONE TUMORS|60651802|0-14|All Races|Male and Female|2004
3.6|4.7|4.1|253|VIIIa Osteosarcomas|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.3|18|VIIIb Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004
1.9|2.7|2.3|142|VIIIc Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.3|18|VIIId Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIIIe Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004
2.1|3.0|2.5|155|VIIa Hepatoblastoma and mesenchymal tumors of liver|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIIb Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004
7.1|8.5|7.7|470|VIa Nephroblastoma and other non-epithelial renal tumors|60651802|0-14|All Races|Male and Female|2004
0.2|0.6|0.4|23|VIb Renal carcinomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIc Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004
5.1|6.3|5.6|349|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60651802|0-14|All Races|Male and Female|2004
6.4|7.8|7.1|435|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60651802|0-14|All Races|Male and Female|2004
0.5|1.0|0.7|44|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.4|22|XIIa Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.4|22|XIIb Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004
0.2|0.4|0.3|16|XIa Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004
2.2|3.1|2.6|162|XIb Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004
0.2|0.6|0.4|24|XIc Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004
2.0|2.8|2.4|148|XId Malignant melanomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|XIe Skin carcinomas|60651802|0-14|All Races|Male and Female|2004
1.0|1.6|1.3|80|XIf Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004
1.3|1.9|1.6|97|Xa Intracranial and intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004
1.1|1.6|1.3|82|Xb Malignant extracranial and extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004
2.1|2.9|2.5|152|Xc Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|Xd Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004
152.8|159.1|155.9|9489|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005
47.3|50.9|49.1|2982|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60519046|0-14|All Races|Male and Female|2005
15.6|17.6|16.6|1009|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60519046|0-14|All Races|Male and Female|2005
31.8|34.7|33.2|2008|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60519046|0-14|All Races|Male and Female|2005
2.9|3.8|3.3|202|IIIa Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005
15.8|17.8|16.8|1016|IIIb Astrocytomas|60519046|0-14|All Races|Male and Female|2005
6.3|7.7|7.0|421|IIIc Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005
4.5|5.7|5.1|306|IIId Other gliomas|60519046|0-14|All Races|Male and Female|2005
0.4|0.8|0.6|35|IIIe Other specified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005
0.3|0.7|0.5|28|IIIf Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005
5.3|6.5|5.9|360|IIa Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005
5.7|7.0|6.4|386|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005
2.2|3.0|2.6|155|IIc Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005
1.2|1.9|1.5|94|IId Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|IIe Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005
11.0|12.8|11.9|731|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60519046|0-14|All Races|Male and Female|2005
10.9|12.6|11.7|722|IVa Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|IVb Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005
9.7|11.3|10.5|637|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60519046|0-14|All Races|Male and Female|2005
4.6|5.7|5.1|310|IXa Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005
0.9|1.4|1.1|70|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|IXc Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005
2.9|3.8|3.3|205|IXd Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005
0.6|1.1|0.8|50|IXe Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005
35.8|38.9|37.4|2265|Ia Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005
6.7|8.1|7.3|449|Ib Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005
1.2|1.8|1.4|88|Ic Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005
1.3|2.0|1.6|100|Id Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005
1.0|1.6|1.3|80|Ie Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005
3.5|4.5|4.0|245|V RETINOBLASTOMA|60519046|0-14|All Races|Male and Female|2005
7.5|8.9|8.2|499|VI RENAL TUMORS|60519046|0-14|All Races|Male and Female|2005
2.1|2.9|2.5|155|VII HEPATIC TUMORS|60519046|0-14|All Races|Male and Female|2005
6.1|7.5|6.8|413|VIII MALIGNANT BONE TUMORS|60519046|0-14|All Races|Male and Female|2005
3.2|4.2|3.7|226|VIIIa Osteosarcomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIIIb Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005
2.0|2.8|2.4|146|VIIIc Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005
0.2|0.5|0.3|20|VIIId Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIIIe Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005
1.7|2.4|2.0|126|VIIa Hepatoblastoma and mesenchymal tumors of liver|60519046|0-14|All Races|Male and Female|2005
0.3|0.6|0.4|27|VIIb Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005
7.1|8.6|7.8|477|VIa Nephroblastoma and other non-epithelial renal tumors|60519046|0-14|All Races|Male and Female|2005
0.2|0.5|0.3|19|VIb Renal carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIc Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005
4.9|6.1|5.5|339|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60519046|0-14|All Races|Male and Female|2005
6.1|7.5|6.8|415|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60519046|0-14|All Races|Male and Female|2005
0.5|1.0|0.7|43|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60519046|0-14|All Races|Male and Female|2005
0.3|0.6|0.4|26|XIIa Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005
0.2|0.5|0.3|17|XIIb Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|XIa Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005
1.9|2.7|2.3|139|XIb Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|XIc Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005
2.0|2.8|2.4|144|XId Malignant melanomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|XIe Skin carcinomas|60519046|0-14|All Races|Male and Female|2005
1.5|2.1|1.8|108|XIf Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005
1.1|1.7|1.4|83|Xa Intracranial and intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005
1.3|2.0|1.6|101|Xb Malignant extracranial and extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005
1.9|2.6|2.2|138|Xc Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|Xd Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005
156.1|162.4|159.2|9691|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006
49.7|53.3|51.5|3131|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60516709|0-14|All Races|Male and Female|2006
15.7|17.8|16.7|1015|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60516709|0-14|All Races|Male and Female|2006
32.9|35.9|34.4|2080|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60516709|0-14|All Races|Male and Female|2006
2.7|3.6|3.1|188|IIIa Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006
15.5|17.5|16.5|998|IIIb Astrocytomas|60516709|0-14|All Races|Male and Female|2006
7.1|8.5|7.8|470|IIIc Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006
5.2|6.5|5.8|351|IIId Other gliomas|60516709|0-14|All Races|Male and Female|2006
0.3|0.7|0.5|31|IIIe Other specified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006
0.5|0.9|0.7|42|IIIf Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006
5.5|6.8|6.1|373|IIa Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006
5.8|7.1|6.4|389|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006
2.1|2.9|2.5|150|IIc Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006
1.2|1.8|1.5|90|IId Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|IIe Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006
9.6|11.2|10.4|638|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60516709|0-14|All Races|Male and Female|2006
9.4|11.1|10.2|630|IVa Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|IVb Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006
9.6|11.2|10.4|633|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60516709|0-14|All Races|Male and Female|2006
4.1|5.2|4.7|283|IXa Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006
0.9|1.4|1.1|69|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|IXc Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006
3.0|4.0|3.5|213|IXd Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006
0.8|1.4|1.1|65|IXe Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006
37.2|40.4|38.8|2352|Ia Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006
7.3|8.8|8.0|490|Ib Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006
1.5|2.1|1.8|108|Ic Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006
1.5|2.2|1.8|110|Id Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006
0.9|1.5|1.2|71|Ie Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006
3.6|4.6|4.1|253|V RETINOBLASTOMA|60516709|0-14|All Races|Male and Female|2006
7.5|9.0|8.2|503|VI RENAL TUMORS|60516709|0-14|All Races|Male and Female|2006
2.5|3.4|2.9|181|VII HEPATIC TUMORS|60516709|0-14|All Races|Male and Female|2006
6.4|7.7|7.0|425|VIII MALIGNANT BONE TUMORS|60516709|0-14|All Races|Male and Female|2006
3.5|4.5|4.0|243|VIIIa Osteosarcomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIIIb Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006
2.0|2.9|2.4|146|VIIIc Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006
0.2|0.5|0.3|18|VIIId Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIIIe Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006
2.1|2.9|2.5|153|VIIa Hepatoblastoma and mesenchymal tumors of liver|60516709|0-14|All Races|Male and Female|2006
0.3|0.6|0.4|24|VIIb Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006
7.1|8.6|7.8|477|VIa Nephroblastoma and other non-epithelial renal tumors|60516709|0-14|All Races|Male and Female|2006
0.2|0.5|0.3|21|VIb Renal carcinomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIc Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006
4.6|5.8|5.2|318|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60516709|0-14|All Races|Male and Female|2006
6.8|8.2|7.5|455|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60516709|0-14|All Races|Male and Female|2006
0.6|1.0|0.8|46|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60516709|0-14|All Races|Male and Female|2006
0.3|0.7|0.5|29|XIIa Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006
0.2|0.4|0.3|17|XIIb Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|XIa Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006
2.3|3.1|2.7|164|XIb Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006
0.2|0.5|0.3|18|XIc Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006
2.0|2.8|2.4|146|XId Malignant melanomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|XIe Skin carcinomas|60516709|0-14|All Races|Male and Female|2006
1.5|2.1|1.8|108|XIf Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006
1.0|1.6|1.3|78|Xa Intracranial and intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006
1.3|1.9|1.5|96|Xb Malignant extracranial and extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006
1.7|2.5|2.1|128|Xc Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|Xd Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006
159.3|165.7|162.5|9929|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007
50.2|53.8|52.0|3171|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60681615|0-14|All Races|Male and Female|2007
15.7|17.7|16.7|1011|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60681615|0-14|All Races|Male and Female|2007
34.1|37.1|35.6|2162|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60681615|0-14|All Races|Male and Female|2007
2.5|3.4|2.9|179|IIIa Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007
16.2|18.3|17.2|1047|IIIb Astrocytomas|60681615|0-14|All Races|Male and Female|2007
7.0|8.4|7.6|465|IIIc Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007
5.9|7.2|6.5|395|IIId Other gliomas|60681615|0-14|All Races|Male and Female|2007
0.5|1.0|0.7|45|IIIe Other specified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007
0.3|0.7|0.5|31|IIIf Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007
4.9|6.1|5.5|333|IIa Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007
6.4|7.8|7.1|427|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007
2.2|3.1|2.6|159|IIc Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007
1.0|1.6|1.3|80|IId Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|IIe Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007
11.0|12.7|11.9|740|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60681615|0-14|All Races|Male and Female|2007
10.8|12.5|11.7|728|IVa Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|IVb Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007
10.1|11.8|10.9|665|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60681615|0-14|All Races|Male and Female|2007
4.9|6.1|5.5|336|IXa Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007
0.9|1.5|1.2|73|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|IXc Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007
2.9|3.8|3.3|204|IXd Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007
0.6|1.1|0.9|52|IXe Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007
38.2|41.4|39.8|2422|Ia Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007
7.1|8.5|7.8|476|Ib Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007
1.4|2.1|1.7|106|Ic Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007
1.3|1.9|1.6|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007
0.9|1.4|1.1|70|Ie Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007
3.9|4.9|4.4|274|V RETINOBLASTOMA|60681615|0-14|All Races|Male and Female|2007
7.9|9.4|8.6|529|VI RENAL TUMORS|60681615|0-14|All Races|Male and Female|2007
2.3|3.2|2.7|169|VII HEPATIC TUMORS|60681615|0-14|All Races|Male and Female|2007
6.2|7.5|6.9|415|VIII MALIGNANT BONE TUMORS|60681615|0-14|All Races|Male and Female|2007
3.2|4.2|3.7|223|VIIIa Osteosarcomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIIIb Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007
2.1|2.9|2.5|151|VIIIc Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007
0.2|0.5|0.3|18|VIIId Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIIIe Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007
2.1|2.8|2.4|151|VIIa Hepatoblastoma and mesenchymal tumors of liver|60681615|0-14|All Races|Male and Female|2007
0.2|0.5|0.3|18|VIIb Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007
7.5|8.9|8.2|502|VIa Nephroblastoma and other non-epithelial renal tumors|60681615|0-14|All Races|Male and Female|2007
0.3|0.6|0.4|26|VIb Renal carcinomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIc Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007
4.9|6.1|5.5|338|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60681615|0-14|All Races|Male and Female|2007
6.0|7.3|6.6|402|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60681615|0-14|All Races|Male and Female|2007
0.5|0.9|0.7|41|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60681615|0-14|All Races|Male and Female|2007
0.3|0.6|0.4|24|XIIa Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007
0.2|0.4|0.3|17|XIIb Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|XIa Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007
2.0|2.8|2.3|143|XIb Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007
0.2|0.4|0.3|17|XIc Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007
1.8|2.5|2.1|129|XId Malignant melanomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|XIe Skin carcinomas|60681615|0-14|All Races|Male and Female|2007
1.3|1.9|1.6|97|XIf Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007
1.1|1.7|1.4|84|Xa Intracranial and intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007
1.0|1.6|1.3|82|Xb Malignant extracranial and extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007
2.2|3.0|2.6|157|Xc Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|Xd Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007
161.8|168.2|165.0|10120|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008
52.0|55.7|53.8|3305|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60907384|0-14|All Races|Male and Female|2008
16.2|18.3|17.2|1045|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60907384|0-14|All Races|Male and Female|2008
34.2|37.2|35.7|2180|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60907384|0-14|All Races|Male and Female|2008
2.2|3.1|2.6|162|IIIa Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008
16.8|18.9|17.8|1085|IIIb Astrocytomas|60907384|0-14|All Races|Male and Female|2008
7.5|8.9|8.2|501|IIIc Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008
5.5|6.7|6.1|368|IIId Other gliomas|60907384|0-14|All Races|Male and Female|2008
0.5|0.9|0.7|43|IIIe Other specified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008
0.2|0.5|0.3|21|IIIf Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008
5.7|7.0|6.3|384|IIa Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008
6.1|7.4|6.7|409|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008
2.3|3.2|2.7|164|IIc Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008
0.9|1.5|1.2|74|IId Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|IIe Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008
10.2|11.8|11.0|688|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60907384|0-14|All Races|Male and Female|2008
9.9|11.5|10.7|670|IVa Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008
0.2|0.5|0.3|18|IVb Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008
10.2|11.9|11.0|673|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60907384|0-14|All Races|Male and Female|2008
4.6|5.7|5.1|315|IXa Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008
0.8|1.3|1.1|65|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|IXc Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008
3.1|4.0|3.5|215|IXd Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008
1.0|1.6|1.3|77|IXe Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008
39.2|42.4|40.8|2502|Ia Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008
7.4|8.8|8.0|496|Ib Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008
1.9|2.6|2.2|137|Ic Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008
1.4|2.1|1.7|106|Id Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008
0.8|1.3|1.0|64|Ie Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008
0.1|0.4|0.3|16|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008
3.7|4.8|4.2|268|V RETINOBLASTOMA|60907384|0-14|All Races|Male and Female|2008
8.2|9.8|9.0|556|VI RENAL TUMORS|60907384|0-14|All Races|Male and Female|2008
2.4|3.3|2.8|175|VII HEPATIC TUMORS|60907384|0-14|All Races|Male and Female|2008
6.2|7.6|6.9|415|VIII MALIGNANT BONE TUMORS|60907384|0-14|All Races|Male and Female|2008
3.4|4.4|3.9|233|VIIIa Osteosarcomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIIb Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008
2.1|2.9|2.4|148|VIIIc Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIId Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIIe Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008
2.0|2.8|2.4|151|VIIa Hepatoblastoma and mesenchymal tumors of liver|60907384|0-14|All Races|Male and Female|2008
0.3|0.6|0.4|24|VIIb Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008
7.8|9.3|8.6|531|VIa Nephroblastoma and other non-epithelial renal tumors|60907384|0-14|All Races|Male and Female|2008
0.3|0.6|0.4|24|VIb Renal carcinomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIc Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008
4.7|5.9|5.3|326|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60907384|0-14|All Races|Male and Female|2008
6.5|7.8|7.1|434|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60907384|0-14|All Races|Male and Female|2008
0.4|0.9|0.6|39|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60907384|0-14|All Races|Male and Female|2008
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|XIIb Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008
0.1|0.4|0.3|16|XIa Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008
2.2|3.1|2.6|159|XIb Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008
0.2|0.4|0.3|17|XIc Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008
1.8|2.6|2.2|134|XId Malignant melanomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|XIe Skin carcinomas|60907384|0-14|All Races|Male and Female|2008
1.4|2.1|1.7|105|XIf Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008
1.1|1.7|1.4|82|Xa Intracranial and intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008
1.1|1.7|1.4|90|Xb Malignant extracranial and extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008
1.9|2.7|2.3|141|Xc Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|Xd Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008
160.5|166.9|163.7|10058|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009
50.8|54.4|52.6|3241|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61087581|0-14|All Races|Male and Female|2009
15.9|18.0|16.9|1031|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61087581|0-14|All Races|Male and Female|2009
34.4|37.4|35.9|2196|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61087581|0-14|All Races|Male and Female|2009
2.1|3.0|2.5|156|IIIa Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009
16.9|19.0|17.9|1096|IIIb Astrocytomas|61087581|0-14|All Races|Male and Female|2009
7.0|8.4|7.6|469|IIIc Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009
6.1|7.4|6.7|411|IIId Other gliomas|61087581|0-14|All Races|Male and Female|2009
0.4|0.8|0.6|35|IIIe Other specified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009
0.3|0.7|0.5|29|IIIf Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009
5.2|6.4|5.8|350|IIa Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009
6.3|7.6|6.9|421|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009
2.0|2.8|2.4|143|IIc Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009
1.4|2.0|1.7|105|IId Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|IIe Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009
10.0|11.7|10.8|675|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61087581|0-14|All Races|Male and Female|2009
9.9|11.5|10.7|664|IVa Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|IVb Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009
9.8|11.4|10.6|648|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61087581|0-14|All Races|Male and Female|2009
3.9|5.0|4.4|271|IXa Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009
1.0|1.6|1.3|79|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|IXc Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009
3.2|4.2|3.7|224|IXd Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009
1.0|1.5|1.2|74|IXe Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009
39.4|42.7|41.0|2528|Ia Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009
6.7|8.0|7.3|451|Ib Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009
1.3|2.0|1.6|100|Ic Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009
1.3|1.9|1.6|98|Id Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009
0.8|1.3|1.0|64|Ie Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009
0.2|0.5|0.3|18|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009
4.0|5.1|4.5|284|V RETINOBLASTOMA|61087581|0-14|All Races|Male and Female|2009
8.5|10.0|9.2|574|VI RENAL TUMORS|61087581|0-14|All Races|Male and Female|2009
2.0|2.8|2.4|150|VII HEPATIC TUMORS|61087581|0-14|All Races|Male and Female|2009
6.4|7.7|7.0|426|VIII MALIGNANT BONE TUMORS|61087581|0-14|All Races|Male and Female|2009
3.5|4.5|4.0|240|VIIIa Osteosarcomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIIIb Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009
2.0|2.8|2.4|144|VIIIc Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009
0.2|0.6|0.4|23|VIIId Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIIIe Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009
1.7|2.5|2.1|129|VIIa Hepatoblastoma and mesenchymal tumors of liver|61087581|0-14|All Races|Male and Female|2009
0.2|0.5|0.3|19|VIIb Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009
7.9|9.4|8.7|538|VIa Nephroblastoma and other non-epithelial renal tumors|61087581|0-14|All Races|Male and Female|2009
0.4|0.8|0.6|35|VIb Renal carcinomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIc Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009
4.9|6.0|5.4|332|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61087581|0-14|All Races|Male and Female|2009
6.4|7.7|7.0|428|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61087581|0-14|All Races|Male and Female|2009
0.7|1.2|0.9|55|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61087581|0-14|All Races|Male and Female|2009
0.3|0.7|0.5|28|XIIa Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009
0.3|0.6|0.4|27|XIIb Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009
0.2|0.4|0.3|17|XIa Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009
2.5|3.4|2.9|177|XIb Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009
0.3|0.6|0.4|25|XIc Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009
1.3|1.9|1.6|95|XId Malignant melanomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|XIe Skin carcinomas|61087581|0-14|All Races|Male and Female|2009
1.5|2.2|1.8|108|XIf Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009
1.1|1.7|1.4|85|Xa Intracranial and intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009
0.9|1.5|1.2|74|Xb Malignant extracranial and extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009
2.2|3.1|2.6|160|Xc Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|Xd Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009
167.7|174.2|170.9|10513|All ICCC Groups Combined|61228956|0-14|All Races|Male and Female|2010
52.0|55.7|53.8|3320|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61228956|0-14|All Races|Male and Female|2010
19.5|21.8|20.6|1260|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61228956|0-14|All Races|Male and Female|2010
35.4|38.4|36.9|2264|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61228956|0-14|All Races|Male and Female|2010
2.9|3.8|3.3|206|IIIa Ependymomas and choroid plexus tumor|61228956|0-14|All Races|Male and Female|2010
17.9|20.1|19.0|1165|IIIb Astrocytomas|61228956|0-14|All Races|Male and Female|2010
6.7|8.1|7.4|455|IIIc Intracranial and intraspinal embryonal tumors|61228956|0-14|All Races|Male and Female|2010
5.6|6.8|6.2|377|IIId Other gliomas|61228956|0-14|All Races|Male and Female|2010
0.5|0.9|0.6|39|IIIe Other specified intracranial and intraspinal neoplasms|61228956|0-14|All Races|Male and Female|2010
0.2|0.5|0.4|22|IIIf Unspecified intracranial and intraspinal neoplasms|61228956|0-14|All Races|Male and Female|2010
4.7|5.9|5.3|323|IIa Hodgkin lymphomas|61228956|0-14|All Races|Male and Female|2010
7.0|8.4|7.6|466|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61228956|0-14|All Races|Male and Female|2010
2.1|2.9|2.4|149|IIc Burkitt lymphoma|61228956|0-14|All Races|Male and Female|2010
4.5|5.7|5.1|312|IId Miscellaneous lymphoreticular neoplasms|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|IIe Unspecified lymphomas|61228956|0-14|All Races|Male and Female|2010
10.5|12.1|11.3|700|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61228956|0-14|All Races|Male and Female|2010
10.3|11.9|11.1|688|IVa Neuroblastoma and ganglioneuroblastoma|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|IVb Other peripheral nervous cell tumors|61228956|0-14|All Races|Male and Female|2010
10.4|12.1|11.2|686|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61228956|0-14|All Races|Male and Female|2010
4.8|5.9|5.3|327|IXa Rhabdomyosarcomas|61228956|0-14|All Races|Male and Female|2010
0.6|1.1|0.8|50|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|IXc Kaposi sarcoma|61228956|0-14|All Races|Male and Female|2010
3.3|4.3|3.7|229|IXd Other specified soft tissue sarcomas|61228956|0-14|All Races|Male and Female|2010
1.0|1.6|1.3|80|IXe Unspecified soft tissue sarcomas|61228956|0-14|All Races|Male and Female|2010
39.4|42.6|41.0|2530|Ia Lymphoid leukemias|61228956|0-14|All Races|Male and Female|2010
7.2|8.6|7.9|487|Ib Acute myeloid leukemias|61228956|0-14|All Races|Male and Female|2010
1.6|2.4|2.0|121|Ic Chronic myeloproliferative diseases|61228956|0-14|All Races|Male and Female|2010
1.6|2.3|1.9|119|Id Myelodysplastic syndrome and other myeloproliferative diseases|61228956|0-14|All Races|Male and Female|2010
0.8|1.3|1.0|63|Ie Unspecified and other specified leukemias|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|Not classified by ICCC|61228956|0-14|All Races|Male and Female|2010
4.0|5.1|4.5|282|V RETINOBLASTOMA|61228956|0-14|All Races|Male and Female|2010
7.7|9.2|8.4|523|VI RENAL TUMORS|61228956|0-14|All Races|Male and Female|2010
3.0|3.9|3.4|211|VII HEPATIC TUMORS|61228956|0-14|All Races|Male and Female|2010
6.2|7.5|6.8|413|VIII MALIGNANT BONE TUMORS|61228956|0-14|All Races|Male and Female|2010
3.3|4.2|3.7|226|VIIIa Osteosarcomas|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|VIIIb Chondrosarcomas|61228956|0-14|All Races|Male and Female|2010
2.0|2.8|2.4|145|VIIIc Ewing tumor and related sarcomas of bone|61228956|0-14|All Races|Male and Female|2010
0.2|0.5|0.3|21|VIIId Other specified malignant bone tumors|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|VIIIe Unspecified malignant bone tumors|61228956|0-14|All Races|Male and Female|2010
2.5|3.4|2.9|181|VIIa Hepatoblastoma and mesenchymal tumors of liver|61228956|0-14|All Races|Male and Female|2010
0.3|0.7|0.5|29|VIIb Hepatic carcinomas|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61228956|0-14|All Races|Male and Female|2010
7.4|8.8|8.1|503|VIa Nephroblastoma and other non-epithelial renal tumors|61228956|0-14|All Races|Male and Female|2010
0.2|0.5|0.3|19|VIb Renal carcinomas|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|VIc Unspecified malignant renal tumors|61228956|0-14|All Races|Male and Female|2010
5.5|6.8|6.1|376|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61228956|0-14|All Races|Male and Female|2010
6.3|7.6|6.9|420|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61228956|0-14|All Races|Male and Female|2010
0.5|0.9|0.7|43|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61228956|0-14|All Races|Male and Female|2010
0.3|0.7|0.5|30|XIIa Other specified malignant tumors|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|XIIb Other unspecified malignant tumors|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|XIa Adrenocortical carcinomas|61228956|0-14|All Races|Male and Female|2010
2.5|3.3|2.9|174|XIb Thyroid carcinomas|61228956|0-14|All Races|Male and Female|2010
0.2|0.4|0.3|17|XIc Nasopharyngeal carcinomas|61228956|0-14|All Races|Male and Female|2010
1.4|2.1|1.7|106|XId Malignant melanomas|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|XIe Skin carcinomas|61228956|0-14|All Races|Male and Female|2010
1.4|2.1|1.7|104|XIf Other and unspecified carcinomas|61228956|0-14|All Races|Male and Female|2010
1.5|2.2|1.8|111|Xa Intracranial and intraspinal germ cell tumors|61228956|0-14|All Races|Male and Female|2010
1.1|1.7|1.4|84|Xb Malignant extracranial and extragonadal germ cell tumors|61228956|0-14|All Races|Male and Female|2010
2.2|3.0|2.6|158|Xc Malignant gonadal germ cell tumors|61228956|0-14|All Races|Male and Female|2010
~|~|~|~|Xd Gonadal carcinomas|61228956|0-14|All Races|Male and Female|2010
0.1|0.4|0.3|16|Xe Other and unspecified malignant gonadal tumors|61228956|0-14|All Races|Male and Female|2010
167.4|174.0|170.7|10503|All ICCC Groups Combined|61310580|0-14|All Races|Male and Female|2011
52.0|55.7|53.8|3317|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61310580|0-14|All Races|Male and Female|2011
19.8|22.1|20.9|1279|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61310580|0-14|All Races|Male and Female|2011
34.8|37.9|36.3|2232|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61310580|0-14|All Races|Male and Female|2011
2.9|3.9|3.4|208|IIIa Ependymomas and choroid plexus tumor|61310580|0-14|All Races|Male and Female|2011
17.5|19.7|18.6|1140|IIIb Astrocytomas|61310580|0-14|All Races|Male and Female|2011
6.4|7.8|7.1|436|IIIc Intracranial and intraspinal embryonal tumors|61310580|0-14|All Races|Male and Female|2011
5.7|7.0|6.3|386|IIId Other gliomas|61310580|0-14|All Races|Male and Female|2011
0.4|0.8|0.6|35|IIIe Other specified intracranial and intraspinal neoplasms|61310580|0-14|All Races|Male and Female|2011
0.3|0.6|0.4|27|IIIf Unspecified intracranial and intraspinal neoplasms|61310580|0-14|All Races|Male and Female|2011
4.7|5.8|5.2|319|IIa Hodgkin lymphomas|61310580|0-14|All Races|Male and Female|2011
6.2|7.6|6.9|420|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61310580|0-14|All Races|Male and Female|2011
2.3|3.1|2.7|162|IIc Burkitt lymphoma|61310580|0-14|All Races|Male and Female|2011
5.3|6.6|5.9|365|IId Miscellaneous lymphoreticular neoplasms|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|IIe Unspecified lymphomas|61310580|0-14|All Races|Male and Female|2011
10.5|12.2|11.3|703|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61310580|0-14|All Races|Male and Female|2011
10.3|12.0|11.1|689|IVa Neuroblastoma and ganglioneuroblastoma|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|IVb Other peripheral nervous cell tumors|61310580|0-14|All Races|Male and Female|2011
9.9|11.5|10.7|657|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61310580|0-14|All Races|Male and Female|2011
4.4|5.5|4.9|304|IXa Rhabdomyosarcomas|61310580|0-14|All Races|Male and Female|2011
0.8|1.3|1.1|65|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|IXc Kaposi sarcoma|61310580|0-14|All Races|Male and Female|2011
3.1|4.1|3.6|220|IXd Other specified soft tissue sarcomas|61310580|0-14|All Races|Male and Female|2011
0.8|1.4|1.1|66|IXe Unspecified soft tissue sarcomas|61310580|0-14|All Races|Male and Female|2011
40.3|43.5|41.9|2583|Ia Lymphoid leukemias|61310580|0-14|All Races|Male and Female|2011
7.1|8.5|7.8|481|Ib Acute myeloid leukemias|61310580|0-14|All Races|Male and Female|2011
1.6|2.3|1.9|118|Ic Chronic myeloproliferative diseases|61310580|0-14|All Races|Male and Female|2011
1.1|1.7|1.3|83|Id Myelodysplastic syndrome and other myeloproliferative diseases|61310580|0-14|All Races|Male and Female|2011
0.6|1.1|0.8|52|Ie Unspecified and other specified leukemias|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|Not classified by ICCC|61310580|0-14|All Races|Male and Female|2011
3.7|4.7|4.2|260|V RETINOBLASTOMA|61310580|0-14|All Races|Male and Female|2011
8.2|9.7|9.0|556|VI RENAL TUMORS|61310580|0-14|All Races|Male and Female|2011
3.0|4.0|3.5|215|VII HEPATIC TUMORS|61310580|0-14|All Races|Male and Female|2011
6.7|8.1|7.4|451|VIII MALIGNANT BONE TUMORS|61310580|0-14|All Races|Male and Female|2011
3.6|4.6|4.1|249|VIIIa Osteosarcomas|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|VIIIb Chondrosarcomas|61310580|0-14|All Races|Male and Female|2011
2.4|3.2|2.8|170|VIIIc Ewing tumor and related sarcomas of bone|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|VIIId Other specified malignant bone tumors|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|VIIIe Unspecified malignant bone tumors|61310580|0-14|All Races|Male and Female|2011
2.6|3.5|3.0|187|VIIa Hepatoblastoma and mesenchymal tumors of liver|61310580|0-14|All Races|Male and Female|2011
0.3|0.6|0.4|25|VIIb Hepatic carcinomas|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61310580|0-14|All Races|Male and Female|2011
7.9|9.4|8.6|533|VIa Nephroblastoma and other non-epithelial renal tumors|61310580|0-14|All Races|Male and Female|2011
0.2|0.5|0.4|22|VIb Renal carcinomas|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|VIc Unspecified malignant renal tumors|61310580|0-14|All Races|Male and Female|2011
4.6|5.7|5.1|314|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61310580|0-14|All Races|Male and Female|2011
7.0|8.4|7.7|471|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61310580|0-14|All Races|Male and Female|2011
0.5|0.9|0.6|40|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61310580|0-14|All Races|Male and Female|2011
0.2|0.5|0.3|20|XIIa Other specified malignant tumors|61310580|0-14|All Races|Male and Female|2011
0.2|0.5|0.3|20|XIIb Other unspecified malignant tumors|61310580|0-14|All Races|Male and Female|2011
0.2|0.4|0.3|17|XIa Adrenocortical carcinomas|61310580|0-14|All Races|Male and Female|2011
2.9|3.8|3.4|205|XIb Thyroid carcinomas|61310580|0-14|All Races|Male and Female|2011
0.2|0.5|0.3|19|XIc Nasopharyngeal carcinomas|61310580|0-14|All Races|Male and Female|2011
1.7|2.4|2.0|123|XId Malignant melanomas|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|XIe Skin carcinomas|61310580|0-14|All Races|Male and Female|2011
1.4|2.1|1.7|105|XIf Other and unspecified carcinomas|61310580|0-14|All Races|Male and Female|2011
1.2|1.9|1.5|94|Xa Intracranial and intraspinal germ cell tumors|61310580|0-14|All Races|Male and Female|2011
1.0|1.5|1.2|75|Xb Malignant extracranial and extragonadal germ cell tumors|61310580|0-14|All Races|Male and Female|2011
1.8|2.6|2.2|133|Xc Malignant gonadal germ cell tumors|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|Xd Gonadal carcinomas|61310580|0-14|All Races|Male and Female|2011
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61310580|0-14|All Races|Male and Female|2011
166.5|173.0|169.7|10439|All ICCC Groups Combined|61369720|0-14|All Races|Male and Female|2012
50.1|53.7|51.8|3194|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61369720|0-14|All Races|Male and Female|2012
21.1|23.4|22.2|1363|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61369720|0-14|All Races|Male and Female|2012
34.3|37.3|35.8|2201|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61369720|0-14|All Races|Male and Female|2012
2.6|3.4|3.0|183|IIIa Ependymomas and choroid plexus tumor|61369720|0-14|All Races|Male and Female|2012
18.0|20.2|19.1|1172|IIIb Astrocytomas|61369720|0-14|All Races|Male and Female|2012
6.5|7.8|7.1|438|IIIc Intracranial and intraspinal embryonal tumors|61369720|0-14|All Races|Male and Female|2012
4.8|6.0|5.4|329|IIId Other gliomas|61369720|0-14|All Races|Male and Female|2012
0.4|0.8|0.6|37|IIIe Other specified intracranial and intraspinal neoplasms|61369720|0-14|All Races|Male and Female|2012
0.5|0.9|0.7|42|IIIf Unspecified intracranial and intraspinal neoplasms|61369720|0-14|All Races|Male and Female|2012
5.1|6.3|5.7|350|IIa Hodgkin lymphomas|61369720|0-14|All Races|Male and Female|2012
7.3|8.7|8.0|490|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61369720|0-14|All Races|Male and Female|2012
2.0|2.7|2.3|143|IIc Burkitt lymphoma|61369720|0-14|All Races|Male and Female|2012
5.2|6.4|5.8|357|IId Miscellaneous lymphoreticular neoplasms|61369720|0-14|All Races|Male and Female|2012
0.2|0.6|0.4|23|IIe Unspecified lymphomas|61369720|0-14|All Races|Male and Female|2012
10.6|12.3|11.4|703|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61369720|0-14|All Races|Male and Female|2012
10.3|12.0|11.2|689|IVa Neuroblastoma and ganglioneuroblastoma|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|IVb Other peripheral nervous cell tumors|61369720|0-14|All Races|Male and Female|2012
10.2|11.9|11.0|676|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61369720|0-14|All Races|Male and Female|2012
4.4|5.5|4.9|304|IXa Rhabdomyosarcomas|61369720|0-14|All Races|Male and Female|2012
0.9|1.5|1.2|71|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|IXc Kaposi sarcoma|61369720|0-14|All Races|Male and Female|2012
3.1|4.1|3.6|221|IXd Other specified soft tissue sarcomas|61369720|0-14|All Races|Male and Female|2012
1.0|1.6|1.3|78|IXe Unspecified soft tissue sarcomas|61369720|0-14|All Races|Male and Female|2012
38.6|41.8|40.2|2479|Ia Lymphoid leukemias|61369720|0-14|All Races|Male and Female|2012
6.5|7.9|7.2|441|Ib Acute myeloid leukemias|61369720|0-14|All Races|Male and Female|2012
1.5|2.1|1.8|109|Ic Chronic myeloproliferative diseases|61369720|0-14|All Races|Male and Female|2012
1.4|2.0|1.7|102|Id Myelodysplastic syndrome and other myeloproliferative diseases|61369720|0-14|All Races|Male and Female|2012
0.8|1.3|1.0|63|Ie Unspecified and other specified leukemias|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|Not classified by ICCC|61369720|0-14|All Races|Male and Female|2012
3.9|4.9|4.4|270|V RETINOBLASTOMA|61369720|0-14|All Races|Male and Female|2012
7.9|9.4|8.6|531|VI RENAL TUMORS|61369720|0-14|All Races|Male and Female|2012
3.1|4.0|3.5|218|VII HEPATIC TUMORS|61369720|0-14|All Races|Male and Female|2012
6.6|8.0|7.3|446|VIII MALIGNANT BONE TUMORS|61369720|0-14|All Races|Male and Female|2012
3.9|4.9|4.4|267|VIIIa Osteosarcomas|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|VIIIb Chondrosarcomas|61369720|0-14|All Races|Male and Female|2012
1.9|2.7|2.3|139|VIIIc Ewing tumor and related sarcomas of bone|61369720|0-14|All Races|Male and Female|2012
0.2|0.5|0.3|21|VIIId Other specified malignant bone tumors|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|VIIIe Unspecified malignant bone tumors|61369720|0-14|All Races|Male and Female|2012
2.6|3.5|3.0|188|VIIa Hepatoblastoma and mesenchymal tumors of liver|61369720|0-14|All Races|Male and Female|2012
0.3|0.7|0.5|28|VIIb Hepatic carcinomas|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61369720|0-14|All Races|Male and Female|2012
7.5|9.0|8.2|507|VIa Nephroblastoma and other non-epithelial renal tumors|61369720|0-14|All Races|Male and Female|2012
0.2|0.5|0.3|19|VIb Renal carcinomas|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|VIc Unspecified malignant renal tumors|61369720|0-14|All Races|Male and Female|2012
4.6|5.8|5.2|318|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61369720|0-14|All Races|Male and Female|2012
6.8|8.2|7.5|459|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61369720|0-14|All Races|Male and Female|2012
0.6|1.1|0.8|49|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61369720|0-14|All Races|Male and Female|2012
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|61369720|0-14|All Races|Male and Female|2012
0.3|0.6|0.4|24|XIIb Other unspecified malignant tumors|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|XIa Adrenocortical carcinomas|61369720|0-14|All Races|Male and Female|2012
2.8|3.7|3.2|199|XIb Thyroid carcinomas|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|XIc Nasopharyngeal carcinomas|61369720|0-14|All Races|Male and Female|2012
1.5|2.2|1.9|114|XId Malignant melanomas|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|XIe Skin carcinomas|61369720|0-14|All Races|Male and Female|2012
1.6|2.3|1.9|115|XIf Other and unspecified carcinomas|61369720|0-14|All Races|Male and Female|2012
1.1|1.7|1.3|82|Xa Intracranial and intraspinal germ cell tumors|61369720|0-14|All Races|Male and Female|2012
1.2|1.9|1.5|94|Xb Malignant extracranial and extragonadal germ cell tumors|61369720|0-14|All Races|Male and Female|2012
1.7|2.5|2.1|127|Xc Malignant gonadal germ cell tumors|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|Xd Gonadal carcinomas|61369720|0-14|All Races|Male and Female|2012
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61369720|0-14|All Races|Male and Female|2012
169.0|175.5|172.2|10589|All ICCC Groups Combined|61438344|0-14|All Races|Male and Female|2013
48.9|52.4|50.6|3114|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61438344|0-14|All Races|Male and Female|2013
21.2|23.6|22.4|1374|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61438344|0-14|All Races|Male and Female|2013
35.5|38.6|37.0|2275|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61438344|0-14|All Races|Male and Female|2013
2.7|3.6|3.1|192|IIIa Ependymomas and choroid plexus tumor|61438344|0-14|All Races|Male and Female|2013
18.4|20.6|19.5|1199|IIIb Astrocytomas|61438344|0-14|All Races|Male and Female|2013
6.3|7.6|6.9|426|IIIc Intracranial and intraspinal embryonal tumors|61438344|0-14|All Races|Male and Female|2013
5.6|6.9|6.2|382|IIId Other gliomas|61438344|0-14|All Races|Male and Female|2013
0.5|1.0|0.7|46|IIIe Other specified intracranial and intraspinal neoplasms|61438344|0-14|All Races|Male and Female|2013
0.3|0.7|0.5|30|IIIf Unspecified intracranial and intraspinal neoplasms|61438344|0-14|All Races|Male and Female|2013
5.0|6.2|5.5|340|IIa Hodgkin lymphomas|61438344|0-14|All Races|Male and Female|2013
7.2|8.6|7.9|486|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61438344|0-14|All Races|Male and Female|2013
1.9|2.7|2.3|142|IIc Burkitt lymphoma|61438344|0-14|All Races|Male and Female|2013
5.8|7.1|6.4|393|IId Miscellaneous lymphoreticular neoplasms|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|IIe Unspecified lymphomas|61438344|0-14|All Races|Male and Female|2013
11.4|13.2|12.3|755|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61438344|0-14|All Races|Male and Female|2013
11.1|12.9|12.0|735|IVa Neuroblastoma and ganglioneuroblastoma|61438344|0-14|All Races|Male and Female|2013
0.2|0.5|0.3|20|IVb Other peripheral nervous cell tumors|61438344|0-14|All Races|Male and Female|2013
10.1|11.8|10.9|671|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61438344|0-14|All Races|Male and Female|2013
4.5|5.7|5.1|313|IXa Rhabdomyosarcomas|61438344|0-14|All Races|Male and Female|2013
0.9|1.5|1.2|74|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|IXc Kaposi sarcoma|61438344|0-14|All Races|Male and Female|2013
3.2|4.1|3.6|222|IXd Other specified soft tissue sarcomas|61438344|0-14|All Races|Male and Female|2013
0.8|1.3|1.0|61|IXe Unspecified soft tissue sarcomas|61438344|0-14|All Races|Male and Female|2013
36.6|39.7|38.1|2347|Ia Lymphoid leukemias|61438344|0-14|All Races|Male and Female|2013
7.3|8.7|8.0|492|Ib Acute myeloid leukemias|61438344|0-14|All Races|Male and Female|2013
1.4|2.0|1.7|102|Ic Chronic myeloproliferative diseases|61438344|0-14|All Races|Male and Female|2013
1.3|1.9|1.6|96|Id Myelodysplastic syndrome and other myeloproliferative diseases|61438344|0-14|All Races|Male and Female|2013
1.0|1.6|1.3|77|Ie Unspecified and other specified leukemias|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|Not classified by ICCC|61438344|0-14|All Races|Male and Female|2013
3.8|4.9|4.3|265|V RETINOBLASTOMA|61438344|0-14|All Races|Male and Female|2013
8.2|9.7|8.9|550|VI RENAL TUMORS|61438344|0-14|All Races|Male and Female|2013
2.6|3.5|3.0|186|VII HEPATIC TUMORS|61438344|0-14|All Races|Male and Female|2013
6.7|8.1|7.4|453|VIII MALIGNANT BONE TUMORS|61438344|0-14|All Races|Male and Female|2013
3.3|4.3|3.8|233|VIIIa Osteosarcomas|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|VIIIb Chondrosarcomas|61438344|0-14|All Races|Male and Female|2013
2.4|3.3|2.8|175|VIIIc Ewing tumor and related sarcomas of bone|61438344|0-14|All Races|Male and Female|2013
0.3|0.6|0.4|27|VIIId Other specified malignant bone tumors|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|VIIIe Unspecified malignant bone tumors|61438344|0-14|All Races|Male and Female|2013
2.2|3.0|2.6|158|VIIa Hepatoblastoma and mesenchymal tumors of liver|61438344|0-14|All Races|Male and Female|2013
0.3|0.6|0.4|26|VIIb Hepatic carcinomas|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61438344|0-14|All Races|Male and Female|2013
7.8|9.3|8.5|523|VIa Nephroblastoma and other non-epithelial renal tumors|61438344|0-14|All Races|Male and Female|2013
0.3|0.6|0.4|24|VIb Renal carcinomas|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|VIc Unspecified malignant renal tumors|61438344|0-14|All Races|Male and Female|2013
5.1|6.4|5.7|352|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61438344|0-14|All Races|Male and Female|2013
8.0|9.5|8.7|534|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61438344|0-14|All Races|Male and Female|2013
0.5|1.0|0.7|46|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61438344|0-14|All Races|Male and Female|2013
0.3|0.7|0.5|30|XIIa Other specified malignant tumors|61438344|0-14|All Races|Male and Female|2013
0.1|0.4|0.3|16|XIIb Other unspecified malignant tumors|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|XIa Adrenocortical carcinomas|61438344|0-14|All Races|Male and Female|2013
3.1|4.1|3.6|221|XIb Thyroid carcinomas|61438344|0-14|All Races|Male and Female|2013
0.2|0.5|0.4|22|XIc Nasopharyngeal carcinomas|61438344|0-14|All Races|Male and Female|2013
1.8|2.5|2.1|132|XId Malignant melanomas|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|XIe Skin carcinomas|61438344|0-14|All Races|Male and Female|2013
2.0|2.8|2.4|146|XIf Other and unspecified carcinomas|61438344|0-14|All Races|Male and Female|2013
1.4|2.0|1.7|103|Xa Intracranial and intraspinal germ cell tumors|61438344|0-14|All Races|Male and Female|2013
1.1|1.6|1.3|81|Xb Malignant extracranial and extragonadal germ cell tumors|61438344|0-14|All Races|Male and Female|2013
2.0|2.8|2.4|147|Xc Malignant gonadal germ cell tumors|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|Xd Gonadal carcinomas|61438344|0-14|All Races|Male and Female|2013
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61438344|0-14|All Races|Male and Female|2013
172.3|179.0|175.6|10817|All ICCC Groups Combined|61538034|0-14|All Races|Male and Female|2014
49.8|53.4|51.5|3173|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61538034|0-14|All Races|Male and Female|2014
22.7|25.1|23.9|1470|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61538034|0-14|All Races|Male and Female|2014
35.5|38.6|37.0|2278|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61538034|0-14|All Races|Male and Female|2014
2.9|3.8|3.3|204|IIIa Ependymomas and choroid plexus tumor|61538034|0-14|All Races|Male and Female|2014
18.0|20.2|19.1|1177|IIIb Astrocytomas|61538034|0-14|All Races|Male and Female|2014
6.8|8.2|7.4|458|IIIc Intracranial and intraspinal embryonal tumors|61538034|0-14|All Races|Male and Female|2014
5.2|6.4|5.8|356|IIId Other gliomas|61538034|0-14|All Races|Male and Female|2014
0.6|1.1|0.8|51|IIIe Other specified intracranial and intraspinal neoplasms|61538034|0-14|All Races|Male and Female|2014
0.4|0.7|0.5|32|IIIf Unspecified intracranial and intraspinal neoplasms|61538034|0-14|All Races|Male and Female|2014
4.9|6.1|5.5|337|IIa Hodgkin lymphomas|61538034|0-14|All Races|Male and Female|2014
8.1|9.6|8.8|542|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61538034|0-14|All Races|Male and Female|2014
2.4|3.2|2.8|171|IIc Burkitt lymphoma|61538034|0-14|All Races|Male and Female|2014
5.9|7.2|6.5|402|IId Miscellaneous lymphoreticular neoplasms|61538034|0-14|All Races|Male and Female|2014
0.2|0.5|0.3|18|IIe Unspecified lymphomas|61538034|0-14|All Races|Male and Female|2014
11.2|12.9|12.0|741|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61538034|0-14|All Races|Male and Female|2014
11.0|12.7|11.8|728|IVa Neuroblastoma and ganglioneuroblastoma|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|IVb Other peripheral nervous cell tumors|61538034|0-14|All Races|Male and Female|2014
10.1|11.7|10.9|670|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61538034|0-14|All Races|Male and Female|2014
4.2|5.3|4.7|291|IXa Rhabdomyosarcomas|61538034|0-14|All Races|Male and Female|2014
1.0|1.5|1.2|76|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|IXc Kaposi sarcoma|61538034|0-14|All Races|Male and Female|2014
3.3|4.2|3.7|230|IXd Other specified soft tissue sarcomas|61538034|0-14|All Races|Male and Female|2014
0.9|1.5|1.2|72|IXe Unspecified soft tissue sarcomas|61538034|0-14|All Races|Male and Female|2014
37.4|40.6|39.0|2401|Ia Lymphoid leukemias|61538034|0-14|All Races|Male and Female|2014
7.3|8.7|8.0|491|Ib Acute myeloid leukemias|61538034|0-14|All Races|Male and Female|2014
1.3|2.0|1.6|101|Ic Chronic myeloproliferative diseases|61538034|0-14|All Races|Male and Female|2014
1.3|2.0|1.6|100|Id Myelodysplastic syndrome and other myeloproliferative diseases|61538034|0-14|All Races|Male and Female|2014
1.0|1.6|1.3|80|Ie Unspecified and other specified leukemias|61538034|0-14|All Races|Male and Female|2014
0.2|0.5|0.3|21|Not classified by ICCC|61538034|0-14|All Races|Male and Female|2014
3.7|4.7|4.2|258|V RETINOBLASTOMA|61538034|0-14|All Races|Male and Female|2014
8.4|9.9|9.1|563|VI RENAL TUMORS|61538034|0-14|All Races|Male and Female|2014
2.9|3.8|3.3|203|VII HEPATIC TUMORS|61538034|0-14|All Races|Male and Female|2014
7.1|8.5|7.8|481|VIII MALIGNANT BONE TUMORS|61538034|0-14|All Races|Male and Female|2014
3.8|4.8|4.3|265|VIIIa Osteosarcomas|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|VIIIb Chondrosarcomas|61538034|0-14|All Races|Male and Female|2014
2.3|3.1|2.7|165|VIIIc Ewing tumor and related sarcomas of bone|61538034|0-14|All Races|Male and Female|2014
0.3|0.7|0.5|29|VIIId Other specified malignant bone tumors|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|VIIIe Unspecified malignant bone tumors|61538034|0-14|All Races|Male and Female|2014
2.5|3.3|2.9|178|VIIa Hepatoblastoma and mesenchymal tumors of liver|61538034|0-14|All Races|Male and Female|2014
0.3|0.6|0.4|25|VIIb Hepatic carcinomas|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61538034|0-14|All Races|Male and Female|2014
8.0|9.5|8.7|535|VIa Nephroblastoma and other non-epithelial renal tumors|61538034|0-14|All Races|Male and Female|2014
0.3|0.6|0.4|26|VIb Renal carcinomas|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|VIc Unspecified malignant renal tumors|61538034|0-14|All Races|Male and Female|2014
5.1|6.3|5.7|350|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61538034|0-14|All Races|Male and Female|2014
8.4|9.9|9.2|565|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61538034|0-14|All Races|Male and Female|2014
0.5|1.0|0.7|44|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61538034|0-14|All Races|Male and Female|2014
0.3|0.7|0.5|30|XIIa Other specified malignant tumors|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|XIIb Other unspecified malignant tumors|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|XIa Adrenocortical carcinomas|61538034|0-14|All Races|Male and Female|2014
3.5|4.5|4.0|246|XIb Thyroid carcinomas|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|XIc Nasopharyngeal carcinomas|61538034|0-14|All Races|Male and Female|2014
1.8|2.6|2.2|134|XId Malignant melanomas|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|XIe Skin carcinomas|61538034|0-14|All Races|Male and Female|2014
2.2|3.0|2.6|159|XIf Other and unspecified carcinomas|61538034|0-14|All Races|Male and Female|2014
1.2|1.8|1.5|90|Xa Intracranial and intraspinal germ cell tumors|61538034|0-14|All Races|Male and Female|2014
1.3|2.0|1.6|101|Xb Malignant extracranial and extragonadal germ cell tumors|61538034|0-14|All Races|Male and Female|2014
1.9|2.6|2.2|138|Xc Malignant gonadal germ cell tumors|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|Xd Gonadal carcinomas|61538034|0-14|All Races|Male and Female|2014
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61538034|0-14|All Races|Male and Female|2014
175.2|181.8|178.5|11007|All ICCC Groups Combined|61598538|0-14|All Races|Male and Female|2015
52.3|56.0|54.1|3335|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61598538|0-14|All Races|Male and Female|2015
22.7|25.1|23.9|1473|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61598538|0-14|All Races|Male and Female|2015
34.4|37.4|35.8|2206|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61598538|0-14|All Races|Male and Female|2015
2.7|3.6|3.1|193|IIIa Ependymomas and choroid plexus tumor|61598538|0-14|All Races|Male and Female|2015
17.2|19.3|18.2|1123|IIIb Astrocytomas|61598538|0-14|All Races|Male and Female|2015
6.7|8.0|7.3|450|IIIc Intracranial and intraspinal embryonal tumors|61598538|0-14|All Races|Male and Female|2015
5.4|6.7|6.0|371|IIId Other gliomas|61598538|0-14|All Races|Male and Female|2015
0.5|0.9|0.7|43|IIIe Other specified intracranial and intraspinal neoplasms|61598538|0-14|All Races|Male and Female|2015
0.3|0.6|0.4|26|IIIf Unspecified intracranial and intraspinal neoplasms|61598538|0-14|All Races|Male and Female|2015
5.2|6.5|5.8|360|IIa Hodgkin lymphomas|61598538|0-14|All Races|Male and Female|2015
7.5|8.9|8.2|504|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61598538|0-14|All Races|Male and Female|2015
2.2|3.0|2.5|156|IIc Burkitt lymphoma|61598538|0-14|All Races|Male and Female|2015
6.4|7.8|7.1|436|IId Miscellaneous lymphoreticular neoplasms|61598538|0-14|All Races|Male and Female|2015
0.2|0.4|0.3|17|IIe Unspecified lymphomas|61598538|0-14|All Races|Male and Female|2015
11.4|13.2|12.3|759|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61598538|0-14|All Races|Male and Female|2015
11.2|13.0|12.1|746|IVa Neuroblastoma and ganglioneuroblastoma|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|IVb Other peripheral nervous cell tumors|61598538|0-14|All Races|Male and Female|2015
10.0|11.6|10.8|666|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61598538|0-14|All Races|Male and Female|2015
4.3|5.5|4.9|301|IXa Rhabdomyosarcomas|61598538|0-14|All Races|Male and Female|2015
0.8|1.4|1.1|67|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|IXc Kaposi sarcoma|61598538|0-14|All Races|Male and Female|2015
3.2|4.1|3.6|223|IXd Other specified soft tissue sarcomas|61598538|0-14|All Races|Male and Female|2015
0.9|1.5|1.2|74|IXe Unspecified soft tissue sarcomas|61598538|0-14|All Races|Male and Female|2015
39.9|43.1|41.5|2555|Ia Lymphoid leukemias|61598538|0-14|All Races|Male and Female|2015
7.3|8.8|8.0|495|Ib Acute myeloid leukemias|61598538|0-14|All Races|Male and Female|2015
1.6|2.3|2.0|121|Ic Chronic myeloproliferative diseases|61598538|0-14|All Races|Male and Female|2015
1.2|1.9|1.5|94|Id Myelodysplastic syndrome and other myeloproliferative diseases|61598538|0-14|All Races|Male and Female|2015
0.9|1.4|1.1|70|Ie Unspecified and other specified leukemias|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|Not classified by ICCC|61598538|0-14|All Races|Male and Female|2015
4.4|5.5|4.9|304|V RETINOBLASTOMA|61598538|0-14|All Races|Male and Female|2015
9.0|10.6|9.8|603|VI RENAL TUMORS|61598538|0-14|All Races|Male and Female|2015
3.2|4.1|3.6|223|VII HEPATIC TUMORS|61598538|0-14|All Races|Male and Female|2015
6.8|8.2|7.5|460|VIII MALIGNANT BONE TUMORS|61598538|0-14|All Races|Male and Female|2015
3.4|4.4|3.9|238|VIIIa Osteosarcomas|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|VIIIb Chondrosarcomas|61598538|0-14|All Races|Male and Female|2015
2.3|3.1|2.7|166|VIIIc Ewing tumor and related sarcomas of bone|61598538|0-14|All Races|Male and Female|2015
0.4|0.7|0.5|32|VIIId Other specified malignant bone tumors|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|VIIIe Unspecified malignant bone tumors|61598538|0-14|All Races|Male and Female|2015
2.7|3.6|3.2|196|VIIa Hepatoblastoma and mesenchymal tumors of liver|61598538|0-14|All Races|Male and Female|2015
0.3|0.6|0.4|26|VIIb Hepatic carcinomas|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61598538|0-14|All Races|Male and Female|2015
8.6|10.2|9.4|577|VIa Nephroblastoma and other non-epithelial renal tumors|61598538|0-14|All Races|Male and Female|2015
0.2|0.6|0.4|24|VIb Renal carcinomas|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|VIc Unspecified malignant renal tumors|61598538|0-14|All Races|Male and Female|2015
4.9|6.1|5.5|337|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61598538|0-14|All Races|Male and Female|2015
8.7|10.2|9.4|584|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61598538|0-14|All Races|Male and Female|2015
0.6|1.0|0.8|47|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61598538|0-14|All Races|Male and Female|2015
0.4|0.8|0.5|34|XIIa Other specified malignant tumors|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|XIIb Other unspecified malignant tumors|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|XIa Adrenocortical carcinomas|61598538|0-14|All Races|Male and Female|2015
3.0|4.0|3.5|214|XIb Thyroid carcinomas|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|XIc Nasopharyngeal carcinomas|61598538|0-14|All Races|Male and Female|2015
1.7|2.5|2.1|129|XId Malignant melanomas|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|XIe Skin carcinomas|61598538|0-14|All Races|Male and Female|2015
3.1|4.1|3.6|220|XIf Other and unspecified carcinomas|61598538|0-14|All Races|Male and Female|2015
1.3|2.0|1.6|99|Xa Intracranial and intraspinal germ cell tumors|61598538|0-14|All Races|Male and Female|2015
1.1|1.7|1.4|85|Xb Malignant extracranial and extragonadal germ cell tumors|61598538|0-14|All Races|Male and Female|2015
1.9|2.6|2.2|138|Xc Malignant gonadal germ cell tumors|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|Xd Gonadal carcinomas|61598538|0-14|All Races|Male and Female|2015
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61598538|0-14|All Races|Male and Female|2015
173.4|180.1|176.7|10916|All ICCC Groups Combined|61701909|0-14|All Races|Male and Female|2016
52.8|56.5|54.6|3374|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61701909|0-14|All Races|Male and Female|2016
21.6|24.0|22.7|1405|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61701909|0-14|All Races|Male and Female|2016
34.4|37.4|35.8|2211|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61701909|0-14|All Races|Male and Female|2016
2.5|3.3|2.9|177|IIIa Ependymomas and choroid plexus tumor|61701909|0-14|All Races|Male and Female|2016
16.7|18.8|17.7|1092|IIIb Astrocytomas|61701909|0-14|All Races|Male and Female|2016
6.1|7.4|6.7|416|IIIc Intracranial and intraspinal embryonal tumors|61701909|0-14|All Races|Male and Female|2016
6.4|7.7|7.0|434|IIId Other gliomas|61701909|0-14|All Races|Male and Female|2016
0.7|1.1|0.9|54|IIIe Other specified intracranial and intraspinal neoplasms|61701909|0-14|All Races|Male and Female|2016
0.4|0.8|0.6|38|IIIf Unspecified intracranial and intraspinal neoplasms|61701909|0-14|All Races|Male and Female|2016
5.1|6.3|5.7|352|IIa Hodgkin lymphomas|61701909|0-14|All Races|Male and Female|2016
8.2|9.7|8.9|550|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61701909|0-14|All Races|Male and Female|2016
2.0|2.8|2.4|147|IIc Burkitt lymphoma|61701909|0-14|All Races|Male and Female|2016
5.0|6.2|5.6|344|IId Miscellaneous lymphoreticular neoplasms|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|IIe Unspecified lymphomas|61701909|0-14|All Races|Male and Female|2016
10.8|12.5|11.6|715|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61701909|0-14|All Races|Male and Female|2016
10.6|12.3|11.4|706|IVa Neuroblastoma and ganglioneuroblastoma|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|IVb Other peripheral nervous cell tumors|61701909|0-14|All Races|Male and Female|2016
10.1|11.7|10.9|673|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61701909|0-14|All Races|Male and Female|2016
4.9|6.1|5.5|338|IXa Rhabdomyosarcomas|61701909|0-14|All Races|Male and Female|2016
0.8|1.3|1.0|61|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|IXc Kaposi sarcoma|61701909|0-14|All Races|Male and Female|2016
2.9|3.9|3.4|209|IXd Other specified soft tissue sarcomas|61701909|0-14|All Races|Male and Female|2016
0.8|1.3|1.0|64|IXe Unspecified soft tissue sarcomas|61701909|0-14|All Races|Male and Female|2016
40.0|43.2|41.6|2568|Ia Lymphoid leukemias|61701909|0-14|All Races|Male and Female|2016
7.5|9.0|8.2|510|Ib Acute myeloid leukemias|61701909|0-14|All Races|Male and Female|2016
1.8|2.5|2.1|131|Ic Chronic myeloproliferative diseases|61701909|0-14|All Races|Male and Female|2016
1.2|1.8|1.5|91|Id Myelodysplastic syndrome and other myeloproliferative diseases|61701909|0-14|All Races|Male and Female|2016
0.9|1.5|1.2|74|Ie Unspecified and other specified leukemias|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|Not classified by ICCC|61701909|0-14|All Races|Male and Female|2016
3.7|4.8|4.2|261|V RETINOBLASTOMA|61701909|0-14|All Races|Male and Female|2016
7.9|9.3|8.6|529|VI RENAL TUMORS|61701909|0-14|All Races|Male and Female|2016
3.0|4.0|3.5|214|VII HEPATIC TUMORS|61701909|0-14|All Races|Male and Female|2016
7.3|8.8|8.0|497|VIII MALIGNANT BONE TUMORS|61701909|0-14|All Races|Male and Female|2016
3.8|4.8|4.3|265|VIIIa Osteosarcomas|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|VIIIb Chondrosarcomas|61701909|0-14|All Races|Male and Female|2016
2.6|3.4|3.0|184|VIIIc Ewing tumor and related sarcomas of bone|61701909|0-14|All Races|Male and Female|2016
0.3|0.7|0.5|30|VIIId Other specified malignant bone tumors|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|VIIIe Unspecified malignant bone tumors|61701909|0-14|All Races|Male and Female|2016
2.8|3.7|3.2|197|VIIa Hepatoblastoma and mesenchymal tumors of liver|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|VIIb Hepatic carcinomas|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61701909|0-14|All Races|Male and Female|2016
7.4|8.8|8.1|498|VIa Nephroblastoma and other non-epithelial renal tumors|61701909|0-14|All Races|Male and Female|2016
0.3|0.7|0.5|29|VIb Renal carcinomas|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|VIc Unspecified malignant renal tumors|61701909|0-14|All Races|Male and Female|2016
5.3|6.5|5.8|362|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61701909|0-14|All Races|Male and Female|2016
8.9|10.5|9.7|601|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61701909|0-14|All Races|Male and Female|2016
0.7|1.2|1.0|59|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61701909|0-14|All Races|Male and Female|2016
0.5|0.9|0.6|40|XIIa Other specified malignant tumors|61701909|0-14|All Races|Male and Female|2016
0.2|0.5|0.3|19|XIIb Other unspecified malignant tumors|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|XIa Adrenocortical carcinomas|61701909|0-14|All Races|Male and Female|2016
3.0|3.9|3.4|212|XIb Thyroid carcinomas|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|XIc Nasopharyngeal carcinomas|61701909|0-14|All Races|Male and Female|2016
1.5|2.2|1.8|112|XId Malignant melanomas|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|XIe Skin carcinomas|61701909|0-14|All Races|Male and Female|2016
3.6|4.6|4.1|252|XIf Other and unspecified carcinomas|61701909|0-14|All Races|Male and Female|2016
1.5|2.2|1.9|115|Xa Intracranial and intraspinal germ cell tumors|61701909|0-14|All Races|Male and Female|2016
1.0|1.6|1.3|80|Xb Malignant extracranial and extragonadal germ cell tumors|61701909|0-14|All Races|Male and Female|2016
2.0|2.8|2.4|150|Xc Malignant gonadal germ cell tumors|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|Xd Gonadal carcinomas|61701909|0-14|All Races|Male and Female|2016
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61701909|0-14|All Races|Male and Female|2016
169.8|176.4|173.0|10702|All ICCC Groups Combined|61805607|0-14|All Races|Male and Female|2017
49.6|53.2|51.4|3177|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61805607|0-14|All Races|Male and Female|2017
22.1|24.5|23.3|1442|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61805607|0-14|All Races|Male and Female|2017
36.0|39.1|37.5|2316|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61805607|0-14|All Races|Male and Female|2017
3.0|3.9|3.4|212|IIIa Ependymomas and choroid plexus tumor|61805607|0-14|All Races|Male and Female|2017
18.1|20.3|19.2|1185|IIIb Astrocytomas|61805607|0-14|All Races|Male and Female|2017
6.2|7.5|6.9|422|IIIc Intracranial and intraspinal embryonal tumors|61805607|0-14|All Races|Male and Female|2017
6.3|7.6|6.9|426|IIId Other gliomas|61805607|0-14|All Races|Male and Female|2017
0.4|0.8|0.6|36|IIIe Other specified intracranial and intraspinal neoplasms|61805607|0-14|All Races|Male and Female|2017
0.4|0.8|0.6|35|IIIf Unspecified intracranial and intraspinal neoplasms|61805607|0-14|All Races|Male and Female|2017
5.1|6.3|5.7|355|IIa Hodgkin lymphomas|61805607|0-14|All Races|Male and Female|2017
7.4|8.8|8.1|500|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61805607|0-14|All Races|Male and Female|2017
2.2|3.0|2.6|161|IIc Burkitt lymphoma|61805607|0-14|All Races|Male and Female|2017
6.2|7.5|6.8|418|IId Miscellaneous lymphoreticular neoplasms|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|IIe Unspecified lymphomas|61805607|0-14|All Races|Male and Female|2017
10.1|11.8|11.0|672|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61805607|0-14|All Races|Male and Female|2017
10.0|11.7|10.8|664|IVa Neuroblastoma and ganglioneuroblastoma|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|IVb Other peripheral nervous cell tumors|61805607|0-14|All Races|Male and Female|2017
9.9|11.5|10.7|660|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61805607|0-14|All Races|Male and Female|2017
4.4|5.6|5.0|308|IXa Rhabdomyosarcomas|61805607|0-14|All Races|Male and Female|2017
0.7|1.1|0.9|54|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|IXc Kaposi sarcoma|61805607|0-14|All Races|Male and Female|2017
2.8|3.7|3.2|198|IXd Other specified soft tissue sarcomas|61805607|0-14|All Races|Male and Female|2017
1.3|2.0|1.6|100|IXe Unspecified soft tissue sarcomas|61805607|0-14|All Races|Male and Female|2017
38.0|41.1|39.5|2446|Ia Lymphoid leukemias|61805607|0-14|All Races|Male and Female|2017
7.0|8.4|7.7|475|Ib Acute myeloid leukemias|61805607|0-14|All Races|Male and Female|2017
1.4|2.1|1.7|108|Ic Chronic myeloproliferative diseases|61805607|0-14|All Races|Male and Female|2017
1.1|1.7|1.3|82|Id Myelodysplastic syndrome and other myeloproliferative diseases|61805607|0-14|All Races|Male and Female|2017
0.8|1.4|1.1|66|Ie Unspecified and other specified leukemias|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|Not classified by ICCC|61805607|0-14|All Races|Male and Female|2017
3.6|4.7|4.1|252|V RETINOBLASTOMA|61805607|0-14|All Races|Male and Female|2017
7.7|9.2|8.5|521|VI RENAL TUMORS|61805607|0-14|All Races|Male and Female|2017
2.7|3.6|3.1|190|VII HEPATIC TUMORS|61805607|0-14|All Races|Male and Female|2017
6.7|8.0|7.3|458|VIII MALIGNANT BONE TUMORS|61805607|0-14|All Races|Male and Female|2017
3.8|4.9|4.3|269|VIIIa Osteosarcomas|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|VIIIb Chondrosarcomas|61805607|0-14|All Races|Male and Female|2017
2.0|2.8|2.3|146|VIIIc Ewing tumor and related sarcomas of bone|61805607|0-14|All Races|Male and Female|2017
0.2|0.5|0.3|21|VIIId Other specified malignant bone tumors|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|VIIIe Unspecified malignant bone tumors|61805607|0-14|All Races|Male and Female|2017
2.3|3.1|2.7|166|VIIa Hepatoblastoma and mesenchymal tumors of liver|61805607|0-14|All Races|Male and Female|2017
0.2|0.5|0.3|20|VIIb Hepatic carcinomas|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61805607|0-14|All Races|Male and Female|2017
7.3|8.7|8.0|492|VIa Nephroblastoma and other non-epithelial renal tumors|61805607|0-14|All Races|Male and Female|2017
0.3|0.6|0.4|27|VIb Renal carcinomas|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|VIc Unspecified malignant renal tumors|61805607|0-14|All Races|Male and Female|2017
5.5|6.8|6.1|380|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61805607|0-14|All Races|Male and Female|2017
8.2|9.7|8.9|557|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61805607|0-14|All Races|Male and Female|2017
0.9|1.4|1.1|68|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61805607|0-14|All Races|Male and Female|2017
0.5|0.9|0.7|43|XIIa Other specified malignant tumors|61805607|0-14|All Races|Male and Female|2017
0.3|0.6|0.4|25|XIIb Other unspecified malignant tumors|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|XIa Adrenocortical carcinomas|61805607|0-14|All Races|Male and Female|2017
2.8|3.7|3.2|200|XIb Thyroid carcinomas|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|XIc Nasopharyngeal carcinomas|61805607|0-14|All Races|Male and Female|2017
1.0|1.6|1.3|81|XId Malignant melanomas|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|XIe Skin carcinomas|61805607|0-14|All Races|Male and Female|2017
3.5|4.5|4.0|248|XIf Other and unspecified carcinomas|61805607|0-14|All Races|Male and Female|2017
1.6|2.3|1.9|117|Xa Intracranial and intraspinal germ cell tumors|61805607|0-14|All Races|Male and Female|2017
1.2|1.8|1.5|90|Xb Malignant extracranial and extragonadal germ cell tumors|61805607|0-14|All Races|Male and Female|2017
2.0|2.8|2.3|146|Xc Malignant gonadal germ cell tumors|61805607|0-14|All Races|Male and Female|2017
~|~|~|~|Xd Gonadal carcinomas|61805607|0-14|All Races|Male and Female|2017
0.2|0.5|0.4|22|Xe Other and unspecified malignant gonadal tumors|61805607|0-14|All Races|Male and Female|2017
170.3|176.9|173.6|10726|All ICCC Groups Combined|61793399|0-14|All Races|Male and Female|2018
51.6|55.3|53.4|3296|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61793399|0-14|All Races|Male and Female|2018
21.7|24.1|22.9|1423|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61793399|0-14|All Races|Male and Female|2018
31.9|34.8|33.3|2058|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61793399|0-14|All Races|Male and Female|2018
2.4|3.3|2.8|174|IIIa Ependymomas and choroid plexus tumor|61793399|0-14|All Races|Male and Female|2018
14.9|16.9|15.9|980|IIIb Astrocytomas|61793399|0-14|All Races|Male and Female|2018
6.1|7.4|6.7|411|IIIc Intracranial and intraspinal embryonal tumors|61793399|0-14|All Races|Male and Female|2018
6.2|7.5|6.8|420|IIId Other gliomas|61793399|0-14|All Races|Male and Female|2018
0.5|0.9|0.6|40|IIIe Other specified intracranial and intraspinal neoplasms|61793399|0-14|All Races|Male and Female|2018
0.4|0.8|0.5|33|IIIf Unspecified intracranial and intraspinal neoplasms|61793399|0-14|All Races|Male and Female|2018
5.3|6.5|5.9|369|IIa Hodgkin lymphomas|61793399|0-14|All Races|Male and Female|2018
8.1|9.6|8.8|549|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61793399|0-14|All Races|Male and Female|2018
1.9|2.6|2.2|137|IIc Burkitt lymphoma|61793399|0-14|All Races|Male and Female|2018
5.2|6.5|5.8|358|IId Miscellaneous lymphoreticular neoplasms|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|IIe Unspecified lymphomas|61793399|0-14|All Races|Male and Female|2018
11.0|12.8|11.9|722|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61793399|0-14|All Races|Male and Female|2018
10.8|12.6|11.7|710|IVa Neuroblastoma and ganglioneuroblastoma|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|IVb Other peripheral nervous cell tumors|61793399|0-14|All Races|Male and Female|2018
9.9|11.5|10.7|662|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61793399|0-14|All Races|Male and Female|2018
4.1|5.2|4.7|288|IXa Rhabdomyosarcomas|61793399|0-14|All Races|Male and Female|2018
0.9|1.4|1.1|70|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|IXc Kaposi sarcoma|61793399|0-14|All Races|Male and Female|2018
3.2|4.2|3.7|231|IXd Other specified soft tissue sarcomas|61793399|0-14|All Races|Male and Female|2018
0.9|1.4|1.1|71|IXe Unspecified soft tissue sarcomas|61793399|0-14|All Races|Male and Female|2018
40.0|43.2|41.6|2566|Ia Lymphoid leukemias|61793399|0-14|All Races|Male and Female|2018
7.2|8.6|7.9|486|Ib Acute myeloid leukemias|61793399|0-14|All Races|Male and Female|2018
1.0|1.6|1.3|82|Ic Chronic myeloproliferative diseases|61793399|0-14|All Races|Male and Female|2018
1.0|1.5|1.2|74|Id Myelodysplastic syndrome and other myeloproliferative diseases|61793399|0-14|All Races|Male and Female|2018
1.1|1.8|1.4|88|Ie Unspecified and other specified leukemias|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|Not classified by ICCC|61793399|0-14|All Races|Male and Female|2018
3.7|4.8|4.2|255|V RETINOBLASTOMA|61793399|0-14|All Races|Male and Female|2018
7.9|9.4|8.6|530|VI RENAL TUMORS|61793399|0-14|All Races|Male and Female|2018
2.9|3.8|3.4|205|VII HEPATIC TUMORS|61793399|0-14|All Races|Male and Female|2018
7.2|8.7|7.9|496|VIII MALIGNANT BONE TUMORS|61793399|0-14|All Races|Male and Female|2018
3.7|4.7|4.1|260|VIIIa Osteosarcomas|61793399|0-14|All Races|Male and Female|2018
0.2|0.4|0.3|17|VIIIb Chondrosarcomas|61793399|0-14|All Races|Male and Female|2018
2.5|3.4|2.9|181|VIIIc Ewing tumor and related sarcomas of bone|61793399|0-14|All Races|Male and Female|2018
0.2|0.6|0.4|23|VIIId Other specified malignant bone tumors|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|VIIIe Unspecified malignant bone tumors|61793399|0-14|All Races|Male and Female|2018
2.5|3.4|2.9|179|VIIa Hepatoblastoma and mesenchymal tumors of liver|61793399|0-14|All Races|Male and Female|2018
0.2|0.6|0.4|24|VIIb Hepatic carcinomas|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61793399|0-14|All Races|Male and Female|2018
7.4|8.9|8.1|499|VIa Nephroblastoma and other non-epithelial renal tumors|61793399|0-14|All Races|Male and Female|2018
0.3|0.6|0.4|27|VIb Renal carcinomas|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|VIc Unspecified malignant renal tumors|61793399|0-14|All Races|Male and Female|2018
5.1|6.3|5.7|355|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61793399|0-14|All Races|Male and Female|2018
9.6|11.3|10.4|657|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61793399|0-14|All Races|Male and Female|2018
0.6|1.1|0.9|53|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61793399|0-14|All Races|Male and Female|2018
0.3|0.7|0.5|28|XIIa Other specified malignant tumors|61793399|0-14|All Races|Male and Female|2018
0.3|0.6|0.4|25|XIIb Other unspecified malignant tumors|61793399|0-14|All Races|Male and Female|2018
0.2|0.5|0.4|22|XIa Adrenocortical carcinomas|61793399|0-14|All Races|Male and Female|2018
3.7|4.7|4.2|263|XIb Thyroid carcinomas|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|XIc Nasopharyngeal carcinomas|61793399|0-14|All Races|Male and Female|2018
1.4|2.0|1.7|105|XId Malignant melanomas|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|XIe Skin carcinomas|61793399|0-14|All Races|Male and Female|2018
3.5|4.5|4.0|252|XIf Other and unspecified carcinomas|61793399|0-14|All Races|Male and Female|2018
1.1|1.7|1.4|88|Xa Intracranial and intraspinal germ cell tumors|61793399|0-14|All Races|Male and Female|2018
1.1|1.8|1.4|86|Xb Malignant extracranial and extragonadal germ cell tumors|61793399|0-14|All Races|Male and Female|2018
2.2|3.0|2.5|159|Xc Malignant gonadal germ cell tumors|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|Xd Gonadal carcinomas|61793399|0-14|All Races|Male and Female|2018
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61793399|0-14|All Races|Male and Female|2018
165.2|171.7|168.4|10367|All ICCC Groups Combined|61640530|0-14|All Races|Male and Female|2019
49.4|53.0|51.2|3144|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61640530|0-14|All Races|Male and Female|2019
20.4|22.7|21.6|1336|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61640530|0-14|All Races|Male and Female|2019
30.8|33.6|32.2|1979|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61640530|0-14|All Races|Male and Female|2019
2.5|3.4|2.9|179|IIIa Ependymomas and choroid plexus tumor|61640530|0-14|All Races|Male and Female|2019
14.2|16.1|15.1|932|IIIb Astrocytomas|61640530|0-14|All Races|Male and Female|2019
5.6|6.8|6.2|378|IIIc Intracranial and intraspinal embryonal tumors|61640530|0-14|All Races|Male and Female|2019
6.3|7.6|6.9|428|IIId Other gliomas|61640530|0-14|All Races|Male and Female|2019
0.4|0.8|0.6|36|IIIe Other specified intracranial and intraspinal neoplasms|61640530|0-14|All Races|Male and Female|2019
0.3|0.6|0.4|26|IIIf Unspecified intracranial and intraspinal neoplasms|61640530|0-14|All Races|Male and Female|2019
4.9|6.1|5.5|347|IIa Hodgkin lymphomas|61640530|0-14|All Races|Male and Female|2019
7.4|8.8|8.1|501|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61640530|0-14|All Races|Male and Female|2019
1.9|2.7|2.3|143|IIc Burkitt lymphoma|61640530|0-14|All Races|Male and Female|2019
5.0|6.2|5.5|337|IId Miscellaneous lymphoreticular neoplasms|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|IIe Unspecified lymphomas|61640530|0-14|All Races|Male and Female|2019
11.2|13.0|12.1|731|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61640530|0-14|All Races|Male and Female|2019
11.1|12.9|12.0|723|IVa Neuroblastoma and ganglioneuroblastoma|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|IVb Other peripheral nervous cell tumors|61640530|0-14|All Races|Male and Female|2019
10.5|12.2|11.3|700|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61640530|0-14|All Races|Male and Female|2019
4.3|5.4|4.9|298|IXa Rhabdomyosarcomas|61640530|0-14|All Races|Male and Female|2019
0.8|1.4|1.1|67|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|IXc Kaposi sarcoma|61640530|0-14|All Races|Male and Female|2019
3.4|4.4|3.8|239|IXd Other specified soft tissue sarcomas|61640530|0-14|All Races|Male and Female|2019
1.3|1.9|1.6|96|IXe Unspecified soft tissue sarcomas|61640530|0-14|All Races|Male and Female|2019
38.0|41.2|39.6|2433|Ia Lymphoid leukemias|61640530|0-14|All Races|Male and Female|2019
7.2|8.6|7.9|484|Ib Acute myeloid leukemias|61640530|0-14|All Races|Male and Female|2019
1.0|1.6|1.3|78|Ic Chronic myeloproliferative diseases|61640530|0-14|All Races|Male and Female|2019
1.0|1.6|1.3|77|Id Myelodysplastic syndrome and other myeloproliferative diseases|61640530|0-14|All Races|Male and Female|2019
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|Not classified by ICCC|61640530|0-14|All Races|Male and Female|2019
3.6|4.6|4.0|243|V RETINOBLASTOMA|61640530|0-14|All Races|Male and Female|2019
7.3|8.8|8.0|490|VI RENAL TUMORS|61640530|0-14|All Races|Male and Female|2019
3.1|4.1|3.5|215|VII HEPATIC TUMORS|61640530|0-14|All Races|Male and Female|2019
7.0|8.4|7.7|483|VIII MALIGNANT BONE TUMORS|61640530|0-14|All Races|Male and Female|2019
3.9|5.0|4.4|279|VIIIa Osteosarcomas|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|VIIIb Chondrosarcomas|61640530|0-14|All Races|Male and Female|2019
2.0|2.8|2.4|151|VIIIc Ewing tumor and related sarcomas of bone|61640530|0-14|All Races|Male and Female|2019
0.2|0.6|0.4|24|VIIId Other specified malignant bone tumors|61640530|0-14|All Races|Male and Female|2019
0.2|0.5|0.3|21|VIIIe Unspecified malignant bone tumors|61640530|0-14|All Races|Male and Female|2019
2.6|3.5|3.0|184|VIIa Hepatoblastoma and mesenchymal tumors of liver|61640530|0-14|All Races|Male and Female|2019
0.3|0.6|0.4|27|VIIb Hepatic carcinomas|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61640530|0-14|All Races|Male and Female|2019
7.0|8.4|7.6|465|VIa Nephroblastoma and other non-epithelial renal tumors|61640530|0-14|All Races|Male and Female|2019
0.2|0.6|0.4|24|VIb Renal carcinomas|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|VIc Unspecified malignant renal tumors|61640530|0-14|All Races|Male and Female|2019
4.9|6.1|5.5|338|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61640530|0-14|All Races|Male and Female|2019
9.5|11.1|10.3|648|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61640530|0-14|All Races|Male and Female|2019
0.6|1.1|0.8|50|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61640530|0-14|All Races|Male and Female|2019
0.4|0.7|0.5|32|XIIa Other specified malignant tumors|61640530|0-14|All Races|Male and Female|2019
0.2|0.5|0.3|18|XIIb Other unspecified malignant tumors|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|XIa Adrenocortical carcinomas|61640530|0-14|All Races|Male and Female|2019
3.5|4.4|3.9|248|XIb Thyroid carcinomas|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|XIc Nasopharyngeal carcinomas|61640530|0-14|All Races|Male and Female|2019
1.4|2.0|1.7|103|XId Malignant melanomas|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|XIe Skin carcinomas|61640530|0-14|All Races|Male and Female|2019
3.8|4.9|4.3|274|XIf Other and unspecified carcinomas|61640530|0-14|All Races|Male and Female|2019
1.2|1.8|1.5|94|Xa Intracranial and intraspinal germ cell tumors|61640530|0-14|All Races|Male and Female|2019
1.1|1.7|1.3|79|Xb Malignant extracranial and extragonadal germ cell tumors|61640530|0-14|All Races|Male and Female|2019
1.9|2.7|2.3|142|Xc Malignant gonadal germ cell tumors|61640530|0-14|All Races|Male and Female|2019
~|~|~|~|Xd Gonadal carcinomas|61640530|0-14|All Races|Male and Female|2019
0.2|0.5|0.3|19|Xe Other and unspecified malignant gonadal tumors|61640530|0-14|All Races|Male and Female|2019
163.0|165.8|164.4|49727|All ICCC Groups Combined|303685675|0-14|All Races|Male and Female|2019-2023
50.9|52.5|51.7|15604|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|303685675|0-14|All Races|Male and Female|2019-2023
19.6|20.6|20.1|6142|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|303685675|0-14|All Races|Male and Female|2019-2023
29.6|30.8|30.2|9138|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|303685675|0-14|All Races|Male and Female|2019-2023
2.6|3.0|2.8|839|IIIa Ependymomas and choroid plexus tumor|303685675|0-14|All Races|Male and Female|2019-2023
11.5|12.2|11.8|3595|IIIb Astrocytomas|303685675|0-14|All Races|Male and Female|2019-2023
6.1|6.6|6.3|1908|IIIc Intracranial and intraspinal embryonal tumors|303685675|0-14|All Races|Male and Female|2019-2023
7.7|8.4|8.0|2444|IIId Other gliomas|303685675|0-14|All Races|Male and Female|2019-2023
0.5|0.7|0.6|179|IIIe Other specified intracranial and intraspinal neoplasms|303685675|0-14|All Races|Male and Female|2019-2023
0.5|0.7|0.6|173|IIIf Unspecified intracranial and intraspinal neoplasms|303685675|0-14|All Races|Male and Female|2019-2023
5.4|5.9|5.6|1746|IIa Hodgkin lymphomas|303685675|0-14|All Races|Male and Female|2019-2023
7.8|8.4|8.1|2482|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|303685675|0-14|All Races|Male and Female|2019-2023
2.8|3.2|3.0|899|IIc Burkitt lymphoma|303685675|0-14|All Races|Male and Female|2019-2023
3.0|3.5|3.2|970|IId Miscellaneous lymphoreticular neoplasms|303685675|0-14|All Races|Male and Female|2019-2023
0.1|0.2|0.1|45|IIe Unspecified lymphomas|303685675|0-14|All Races|Male and Female|2019-2023
11.3|12.1|11.7|3453|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|303685675|0-14|All Races|Male and Female|2019-2023
11.0|11.8|11.4|3350|IVa Neuroblastoma and ganglioneuroblastoma|303685675|0-14|All Races|Male and Female|2019-2023
0.3|0.4|0.3|103|IVb Other peripheral nervous cell tumors|303685675|0-14|All Races|Male and Female|2019-2023
10.6|11.3|11.0|3326|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|303685675|0-14|All Races|Male and Female|2019-2023
4.9|5.4|5.1|1545|IXa Rhabdomyosarcomas|303685675|0-14|All Races|Male and Female|2019-2023
0.8|1.0|0.9|260|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|303685675|0-14|All Races|Male and Female|2019-2023
~|~|~|~|IXc Kaposi sarcoma|303685675|0-14|All Races|Male and Female|2019-2023
3.3|3.7|3.5|1072|IXd Other specified soft tissue sarcomas|303685675|0-14|All Races|Male and Female|2019-2023
1.3|1.6|1.5|447|IXe Unspecified soft tissue sarcomas|303685675|0-14|All Races|Male and Female|2019-2023
40.0|41.4|40.7|12282|Ia Lymphoid leukemias|303685675|0-14|All Races|Male and Female|2019-2023
7.2|7.8|7.5|2272|Ib Acute myeloid leukemias|303685675|0-14|All Races|Male and Female|2019-2023
0.9|1.2|1.1|325|Ic Chronic myeloproliferative diseases|303685675|0-14|All Races|Male and Female|2019-2023
1.2|1.4|1.3|383|Id Myelodysplastic syndrome and other myeloproliferative diseases|303685675|0-14|All Races|Male and Female|2019-2023
1.0|1.3|1.1|342|Ie Unspecified and other specified leukemias|303685675|0-14|All Races|Male and Female|2019-2023
0.1|0.2|0.2|59|Not classified by ICCC|303685675|0-14|All Races|Male and Female|2019-2023
3.6|4.1|3.9|1127|V RETINOBLASTOMA|303685675|0-14|All Races|Male and Female|2019-2023
8.3|8.9|8.6|2565|VI RENAL TUMORS|303685675|0-14|All Races|Male and Female|2019-2023
3.5|3.9|3.7|1102|VII HEPATIC TUMORS|303685675|0-14|All Races|Male and Female|2019-2023
7.0|7.6|7.3|2265|VIII MALIGNANT BONE TUMORS|303685675|0-14|All Races|Male and Female|2019-2023
4.1|4.5|4.3|1335|VIIIa Osteosarcomas|303685675|0-14|All Races|Male and Female|2019-2023
0.1|0.2|0.2|49|VIIIb Chondrosarcomas|303685675|0-14|All Races|Male and Female|2019-2023
2.1|2.5|2.3|712|VIIIc Ewing tumor and related sarcomas of bone|303685675|0-14|All Races|Male and Female|2019-2023
0.3|0.4|0.3|107|VIIId Other specified malignant bone tumors|303685675|0-14|All Races|Male and Female|2019-2023
0.2|0.3|0.2|62|VIIIe Unspecified malignant bone tumors|303685675|0-14|All Races|Male and Female|2019-2023
3.0|3.4|3.2|936|VIIa Hepatoblastoma and mesenchymal tumors of liver|303685675|0-14|All Races|Male and Female|2019-2023
0.4|0.6|0.5|155|VIIb Hepatic carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
~|~|~|~|VIIc Unspecified malignant hepatic tumors|303685675|0-14|All Races|Male and Female|2019-2023
7.9|8.5|8.2|2434|VIa Nephroblastoma and other non-epithelial renal tumors|303685675|0-14|All Races|Male and Female|2019-2023
0.3|0.5|0.4|122|VIb Renal carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
~|~|~|~|VIc Unspecified malignant renal tumors|303685675|0-14|All Races|Male and Female|2019-2023
5.4|5.9|5.6|1715|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|303685675|0-14|All Races|Male and Female|2019-2023
9.1|9.8|9.5|2937|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|303685675|0-14|All Races|Male and Female|2019-2023
0.9|1.1|1.0|294|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|303685675|0-14|All Races|Male and Female|2019-2023
0.5|0.6|0.5|163|XIIa Other specified malignant tumors|303685675|0-14|All Races|Male and Female|2019-2023
0.4|0.5|0.4|131|XIIb Other unspecified malignant tumors|303685675|0-14|All Races|Male and Female|2019-2023
0.2|0.3|0.2|74|XIa Adrenocortical carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
2.9|3.3|3.1|970|XIb Thyroid carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
0.1|0.2|0.2|49|XIc Nasopharyngeal carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
1.3|1.6|1.4|436|XId Malignant melanomas|303685675|0-14|All Races|Male and Female|2019-2023
0.0|0.1|0.1|18|XIe Skin carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
4.2|4.7|4.5|1390|XIf Other and unspecified carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
1.4|1.6|1.5|460|Xa Intracranial and intraspinal germ cell tumors|303685675|0-14|All Races|Male and Female|2019-2023
1.3|1.5|1.4|409|Xb Malignant extracranial and extragonadal germ cell tumors|303685675|0-14|All Races|Male and Female|2019-2023
2.3|2.6|2.4|744|Xc Malignant gonadal germ cell tumors|303685675|0-14|All Races|Male and Female|2019-2023
0.1|0.1|0.1|27|Xd Gonadal carcinomas|303685675|0-14|All Races|Male and Female|2019-2023
0.2|0.3|0.2|75|Xe Other and unspecified malignant gonadal tumors|303685675|0-14|All Races|Male and Female|2019-2023
161.5|167.9|164.7|10063|All ICCC Groups Combined|61339195|0-14|All Races|Male and Female|2020
50.9|54.6|52.7|3215|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61339195|0-14|All Races|Male and Female|2020
19.6|21.9|20.8|1282|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61339195|0-14|All Races|Male and Female|2020
29.4|32.2|30.7|1878|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61339195|0-14|All Races|Male and Female|2020
2.2|3.0|2.6|157|IIIa Ependymomas and choroid plexus tumor|61339195|0-14|All Races|Male and Female|2020
12.4|14.2|13.3|812|IIIb Astrocytomas|61339195|0-14|All Races|Male and Female|2020
6.1|7.5|6.8|410|IIIc Intracranial and intraspinal embryonal tumors|61339195|0-14|All Races|Male and Female|2020
6.3|7.6|6.9|423|IIId Other gliomas|61339195|0-14|All Races|Male and Female|2020
0.4|0.8|0.6|37|IIIe Other specified intracranial and intraspinal neoplasms|61339195|0-14|All Races|Male and Female|2020
0.5|0.9|0.6|39|IIIf Unspecified intracranial and intraspinal neoplasms|61339195|0-14|All Races|Male and Female|2020
4.7|5.8|5.2|330|IIa Hodgkin lymphomas|61339195|0-14|All Races|Male and Female|2020
7.6|9.0|8.3|513|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61339195|0-14|All Races|Male and Female|2020
2.1|2.9|2.4|149|IIc Burkitt lymphoma|61339195|0-14|All Races|Male and Female|2020
4.1|5.2|4.6|281|IId Miscellaneous lymphoreticular neoplasms|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|IIe Unspecified lymphomas|61339195|0-14|All Races|Male and Female|2020
11.0|12.8|11.9|707|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61339195|0-14|All Races|Male and Female|2020
10.9|12.6|11.7|698|IVa Neuroblastoma and ganglioneuroblastoma|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|IVb Other peripheral nervous cell tumors|61339195|0-14|All Races|Male and Female|2020
9.9|11.6|10.7|657|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61339195|0-14|All Races|Male and Female|2020
4.5|5.7|5.1|311|IXa Rhabdomyosarcomas|61339195|0-14|All Races|Male and Female|2020
0.6|1.1|0.8|50|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|IXc Kaposi sarcoma|61339195|0-14|All Races|Male and Female|2020
2.8|3.7|3.3|203|IXd Other specified soft tissue sarcomas|61339195|0-14|All Races|Male and Female|2020
1.2|1.8|1.5|92|IXe Unspecified soft tissue sarcomas|61339195|0-14|All Races|Male and Female|2020
40.1|43.4|41.7|2544|Ia Lymphoid leukemias|61339195|0-14|All Races|Male and Female|2020
6.7|8.1|7.3|449|Ib Acute myeloid leukemias|61339195|0-14|All Races|Male and Female|2020
0.9|1.4|1.1|71|Ic Chronic myeloproliferative diseases|61339195|0-14|All Races|Male and Female|2020
1.0|1.6|1.2|75|Id Myelodysplastic syndrome and other myeloproliferative diseases|61339195|0-14|All Races|Male and Female|2020
1.0|1.6|1.3|76|Ie Unspecified and other specified leukemias|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|Not classified by ICCC|61339195|0-14|All Races|Male and Female|2020
3.5|4.5|4.0|235|V RETINOBLASTOMA|61339195|0-14|All Races|Male and Female|2020
8.3|9.8|9.0|545|VI RENAL TUMORS|61339195|0-14|All Races|Male and Female|2020
3.1|4.0|3.5|211|VII HEPATIC TUMORS|61339195|0-14|All Races|Male and Female|2020
5.8|7.1|6.4|401|VIII MALIGNANT BONE TUMORS|61339195|0-14|All Races|Male and Female|2020
3.4|4.4|3.8|241|VIIIa Osteosarcomas|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|VIIIb Chondrosarcomas|61339195|0-14|All Races|Male and Female|2020
1.9|2.6|2.2|137|VIIIc Ewing tumor and related sarcomas of bone|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|VIIId Other specified malignant bone tumors|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|VIIIe Unspecified malignant bone tumors|61339195|0-14|All Races|Male and Female|2020
2.6|3.5|3.0|181|VIIa Hepatoblastoma and mesenchymal tumors of liver|61339195|0-14|All Races|Male and Female|2020
0.3|0.7|0.5|29|VIIb Hepatic carcinomas|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61339195|0-14|All Races|Male and Female|2020
7.9|9.4|8.6|518|VIa Nephroblastoma and other non-epithelial renal tumors|61339195|0-14|All Races|Male and Female|2020
0.3|0.6|0.4|25|VIb Renal carcinomas|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|VIc Unspecified malignant renal tumors|61339195|0-14|All Races|Male and Female|2020
4.9|6.0|5.4|334|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61339195|0-14|All Races|Male and Female|2020
7.8|9.3|8.5|535|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61339195|0-14|All Races|Male and Female|2020
0.6|1.1|0.8|50|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61339195|0-14|All Races|Male and Female|2020
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|61339195|0-14|All Races|Male and Female|2020
0.3|0.6|0.4|25|XIIb Other unspecified malignant tumors|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|XIa Adrenocortical carcinomas|61339195|0-14|All Races|Male and Female|2020
2.5|3.3|2.9|181|XIb Thyroid carcinomas|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|XIc Nasopharyngeal carcinomas|61339195|0-14|All Races|Male and Female|2020
1.0|1.5|1.2|77|XId Malignant melanomas|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|XIe Skin carcinomas|61339195|0-14|All Races|Male and Female|2020
3.4|4.4|3.9|247|XIf Other and unspecified carcinomas|61339195|0-14|All Races|Male and Female|2020
1.1|1.7|1.4|85|Xa Intracranial and intraspinal germ cell tumors|61339195|0-14|All Races|Male and Female|2020
0.9|1.5|1.2|70|Xb Malignant extracranial and extragonadal germ cell tumors|61339195|0-14|All Races|Male and Female|2020
2.1|2.9|2.5|155|Xc Malignant gonadal germ cell tumors|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|Xd Gonadal carcinomas|61339195|0-14|All Races|Male and Female|2020
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61339195|0-14|All Races|Male and Female|2020
164.2|170.8|167.5|10098|All ICCC Groups Combined|60629813|0-14|All Races|Male and Female|2021
49.8|53.5|51.6|3108|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60629813|0-14|All Races|Male and Female|2021
18.2|20.5|19.3|1182|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60629813|0-14|All Races|Male and Female|2021
31.2|34.1|32.6|1970|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60629813|0-14|All Races|Male and Female|2021
2.2|3.0|2.6|155|IIIa Ependymomas and choroid plexus tumor|60629813|0-14|All Races|Male and Female|2021
13.2|15.2|14.2|858|IIIb Astrocytomas|60629813|0-14|All Races|Male and Female|2021
6.1|7.4|6.7|404|IIIc Intracranial and intraspinal embryonal tumors|60629813|0-14|All Races|Male and Female|2021
7.4|8.9|8.1|493|IIId Other gliomas|60629813|0-14|All Races|Male and Female|2021
0.3|0.6|0.4|27|IIIe Other specified intracranial and intraspinal neoplasms|60629813|0-14|All Races|Male and Female|2021
0.4|0.8|0.5|33|IIIf Unspecified intracranial and intraspinal neoplasms|60629813|0-14|All Races|Male and Female|2021
4.8|5.9|5.3|331|IIa Hodgkin lymphomas|60629813|0-14|All Races|Male and Female|2021
7.5|8.9|8.2|501|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60629813|0-14|All Races|Male and Female|2021
3.2|4.2|3.7|224|IIc Burkitt lymphoma|60629813|0-14|All Races|Male and Female|2021
1.7|2.4|2.0|119|IId Miscellaneous lymphoreticular neoplasms|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|IIe Unspecified lymphomas|60629813|0-14|All Races|Male and Female|2021
11.2|13.0|12.1|706|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60629813|0-14|All Races|Male and Female|2021
10.7|12.4|11.5|673|IVa Neuroblastoma and ganglioneuroblastoma|60629813|0-14|All Races|Male and Female|2021
0.4|0.8|0.5|33|IVb Other peripheral nervous cell tumors|60629813|0-14|All Races|Male and Female|2021
10.4|12.1|11.2|677|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60629813|0-14|All Races|Male and Female|2021
4.8|6.0|5.3|320|IXa Rhabdomyosarcomas|60629813|0-14|All Races|Male and Female|2021
0.7|1.2|0.9|52|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|IXc Kaposi sarcoma|60629813|0-14|All Races|Male and Female|2021
2.9|3.9|3.4|206|IXd Other specified soft tissue sarcomas|60629813|0-14|All Races|Male and Female|2021
1.3|2.0|1.6|99|IXe Unspecified soft tissue sarcomas|60629813|0-14|All Races|Male and Female|2021
39.1|42.4|40.7|2452|Ia Lymphoid leukemias|60629813|0-14|All Races|Male and Female|2021
6.6|7.9|7.2|435|Ib Acute myeloid leukemias|60629813|0-14|All Races|Male and Female|2021
0.8|1.4|1.1|65|Ic Chronic myeloproliferative diseases|60629813|0-14|All Races|Male and Female|2021
1.3|1.9|1.6|93|Id Myelodysplastic syndrome and other myeloproliferative diseases|60629813|0-14|All Races|Male and Female|2021
0.8|1.3|1.1|63|Ie Unspecified and other specified leukemias|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|Not classified by ICCC|60629813|0-14|All Races|Male and Female|2021
3.3|4.4|3.8|220|V RETINOBLASTOMA|60629813|0-14|All Races|Male and Female|2021
8.2|9.7|8.9|529|VI RENAL TUMORS|60629813|0-14|All Races|Male and Female|2021
3.4|4.4|3.9|226|VII HEPATIC TUMORS|60629813|0-14|All Races|Male and Female|2021
6.6|8.0|7.3|453|VIII MALIGNANT BONE TUMORS|60629813|0-14|All Races|Male and Female|2021
3.5|4.5|4.0|247|VIIIa Osteosarcomas|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|VIIIb Chondrosarcomas|60629813|0-14|All Races|Male and Female|2021
2.1|2.9|2.4|151|VIIIc Ewing tumor and related sarcomas of bone|60629813|0-14|All Races|Male and Female|2021
0.3|0.6|0.4|27|VIIId Other specified malignant bone tumors|60629813|0-14|All Races|Male and Female|2021
0.2|0.5|0.3|19|VIIIe Unspecified malignant bone tumors|60629813|0-14|All Races|Male and Female|2021
2.9|3.8|3.3|194|VIIa Hepatoblastoma and mesenchymal tumors of liver|60629813|0-14|All Races|Male and Female|2021
0.3|0.7|0.5|30|VIIb Hepatic carcinomas|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60629813|0-14|All Races|Male and Female|2021
7.8|9.3|8.5|504|VIa Nephroblastoma and other non-epithelial renal tumors|60629813|0-14|All Races|Male and Female|2021
0.2|0.6|0.4|23|VIb Renal carcinomas|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|VIc Unspecified malignant renal tumors|60629813|0-14|All Races|Male and Female|2021
5.3|6.5|5.9|353|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60629813|0-14|All Races|Male and Female|2021
8.9|10.5|9.7|601|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60629813|0-14|All Races|Male and Female|2021
0.8|1.3|1.0|59|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60629813|0-14|All Races|Male and Female|2021
0.4|0.8|0.5|33|XIIa Other specified malignant tumors|60629813|0-14|All Races|Male and Female|2021
0.3|0.6|0.4|26|XIIb Other unspecified malignant tumors|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|XIa Adrenocortical carcinomas|60629813|0-14|All Races|Male and Female|2021
2.5|3.4|2.9|184|XIb Thyroid carcinomas|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|XIc Nasopharyngeal carcinomas|60629813|0-14|All Races|Male and Female|2021
1.1|1.7|1.4|84|XId Malignant melanomas|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|XIe Skin carcinomas|60629813|0-14|All Races|Male and Female|2021
4.3|5.4|4.9|302|XIf Other and unspecified carcinomas|60629813|0-14|All Races|Male and Female|2021
1.3|1.9|1.6|97|Xa Intracranial and intraspinal germ cell tumors|60629813|0-14|All Races|Male and Female|2021
1.3|2.0|1.6|94|Xb Malignant extracranial and extragonadal germ cell tumors|60629813|0-14|All Races|Male and Female|2021
2.0|2.8|2.4|145|Xc Malignant gonadal germ cell tumors|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|Xd Gonadal carcinomas|60629813|0-14|All Races|Male and Female|2021
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60629813|0-14|All Races|Male and Female|2021
163.3|169.9|166.5|9983|All ICCC Groups Combined|60216026|0-14|All Races|Male and Female|2022
50.0|53.7|51.8|3092|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60216026|0-14|All Races|Male and Female|2022
18.7|21.0|19.8|1205|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60216026|0-14|All Races|Male and Female|2022
30.7|33.6|32.2|1928|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60216026|0-14|All Races|Male and Female|2022
2.6|3.4|3.0|176|IIIa Ependymomas and choroid plexus tumor|60216026|0-14|All Races|Male and Female|2022
11.4|13.2|12.3|739|IIIb Astrocytomas|60216026|0-14|All Races|Male and Female|2022
5.6|6.9|6.2|369|IIIc Intracranial and intraspinal embryonal tumors|60216026|0-14|All Races|Male and Female|2022
8.7|10.2|9.4|568|IIId Other gliomas|60216026|0-14|All Races|Male and Female|2022
0.3|0.7|0.5|31|IIIe Other specified intracranial and intraspinal neoplasms|60216026|0-14|All Races|Male and Female|2022
0.6|1.0|0.8|45|IIIf Unspecified intracranial and intraspinal neoplasms|60216026|0-14|All Races|Male and Female|2022
5.5|6.7|6.1|374|IIa Hodgkin lymphomas|60216026|0-14|All Races|Male and Female|2022
7.6|9.1|8.3|505|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60216026|0-14|All Races|Male and Female|2022
2.9|3.9|3.4|202|IIc Burkitt lymphoma|60216026|0-14|All Races|Male and Female|2022
1.6|2.3|1.9|112|IId Miscellaneous lymphoreticular neoplasms|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|IIe Unspecified lymphomas|60216026|0-14|All Races|Male and Female|2022
10.4|12.1|11.2|656|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60216026|0-14|All Races|Male and Female|2022
10.0|11.7|10.8|630|IVa Neuroblastoma and ganglioneuroblastoma|60216026|0-14|All Races|Male and Female|2022
0.3|0.6|0.4|26|IVb Other peripheral nervous cell tumors|60216026|0-14|All Races|Male and Female|2022
10.3|11.9|11.1|668|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60216026|0-14|All Races|Male and Female|2022
4.8|6.0|5.3|320|IXa Rhabdomyosarcomas|60216026|0-14|All Races|Male and Female|2022
0.4|0.9|0.6|38|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|IXc Kaposi sarcoma|60216026|0-14|All Races|Male and Female|2022
3.1|4.0|3.5|216|IXd Other specified soft tissue sarcomas|60216026|0-14|All Races|Male and Female|2022
1.2|1.9|1.5|93|IXe Unspecified soft tissue sarcomas|60216026|0-14|All Races|Male and Female|2022
39.7|43.0|41.4|2466|Ia Lymphoid leukemias|60216026|0-14|All Races|Male and Female|2022
6.7|8.1|7.4|441|Ib Acute myeloid leukemias|60216026|0-14|All Races|Male and Female|2022
0.7|1.3|1.0|59|Ic Chronic myeloproliferative diseases|60216026|0-14|All Races|Male and Female|2022
0.9|1.4|1.1|68|Id Myelodysplastic syndrome and other myeloproliferative diseases|60216026|0-14|All Races|Male and Female|2022
0.7|1.2|1.0|58|Ie Unspecified and other specified leukemias|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|Not classified by ICCC|60216026|0-14|All Races|Male and Female|2022
3.5|4.5|4.0|230|V RETINOBLASTOMA|60216026|0-14|All Races|Male and Female|2022
7.7|9.1|8.4|494|VI RENAL TUMORS|60216026|0-14|All Races|Male and Female|2022
3.3|4.3|3.8|223|VII HEPATIC TUMORS|60216026|0-14|All Races|Male and Female|2022
7.3|8.8|8.0|494|VIII MALIGNANT BONE TUMORS|60216026|0-14|All Races|Male and Female|2022
4.4|5.5|4.9|302|VIIIa Osteosarcomas|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|VIIIb Chondrosarcomas|60216026|0-14|All Races|Male and Female|2022
2.0|2.7|2.3|142|VIIIc Ewing tumor and related sarcomas of bone|60216026|0-14|All Races|Male and Female|2022
0.3|0.7|0.5|29|VIIId Other specified malignant bone tumors|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|VIIIe Unspecified malignant bone tumors|60216026|0-14|All Races|Male and Female|2022
2.8|3.7|3.2|189|VIIa Hepatoblastoma and mesenchymal tumors of liver|60216026|0-14|All Races|Male and Female|2022
0.4|0.8|0.5|33|VIIb Hepatic carcinomas|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60216026|0-14|All Races|Male and Female|2022
7.2|8.7|7.9|465|VIa Nephroblastoma and other non-epithelial renal tumors|60216026|0-14|All Races|Male and Female|2022
0.3|0.6|0.4|26|VIb Renal carcinomas|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|VIc Unspecified malignant renal tumors|60216026|0-14|All Races|Male and Female|2022
5.2|6.4|5.8|348|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60216026|0-14|All Races|Male and Female|2022
8.6|10.1|9.3|574|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60216026|0-14|All Races|Male and Female|2022
0.8|1.3|1.0|61|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60216026|0-14|All Races|Male and Female|2022
0.3|0.7|0.5|28|XIIa Other specified malignant tumors|60216026|0-14|All Races|Male and Female|2022
0.4|0.8|0.6|33|XIIb Other unspecified malignant tumors|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|XIa Adrenocortical carcinomas|60216026|0-14|All Races|Male and Female|2022
2.4|3.2|2.8|172|XIb Thyroid carcinomas|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|XIc Nasopharyngeal carcinomas|60216026|0-14|All Races|Male and Female|2022
1.2|1.8|1.5|90|XId Malignant melanomas|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|XIe Skin carcinomas|60216026|0-14|All Races|Male and Female|2022
4.2|5.3|4.7|290|XIf Other and unspecified carcinomas|60216026|0-14|All Races|Male and Female|2022
1.2|1.8|1.4|89|Xa Intracranial and intraspinal germ cell tumors|60216026|0-14|All Races|Male and Female|2022
1.0|1.6|1.3|76|Xb Malignant extracranial and extragonadal germ cell tumors|60216026|0-14|All Races|Male and Female|2022
2.2|3.1|2.6|160|Xc Malignant gonadal germ cell tumors|60216026|0-14|All Races|Male and Female|2022
~|~|~|~|Xd Gonadal carcinomas|60216026|0-14|All Races|Male and Female|2022
0.2|0.5|0.3|18|Xe Other and unspecified malignant gonadal tumors|60216026|0-14|All Races|Male and Female|2022
151.6|157.9|154.7|9216|All ICCC Groups Combined|59860111|0-14|All Races|Male and Female|2023
49.5|53.1|51.3|3045|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59860111|0-14|All Races|Male and Female|2023
17.8|20.0|18.8|1137|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59860111|0-14|All Races|Male and Female|2023
22.0|24.4|23.2|1383|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59860111|0-14|All Races|Male and Female|2023
2.5|3.4|2.9|172|IIIa Ependymomas and choroid plexus tumor|59860111|0-14|All Races|Male and Female|2023
3.8|4.8|4.3|254|IIIb Astrocytomas|59860111|0-14|All Races|Male and Female|2023
5.2|6.5|5.8|347|IIIc Intracranial and intraspinal embryonal tumors|59860111|0-14|All Races|Male and Female|2023
8.1|9.7|8.9|532|IIId Other gliomas|59860111|0-14|All Races|Male and Female|2023
0.6|1.1|0.8|48|IIIe Other specified intracranial and intraspinal neoplasms|59860111|0-14|All Races|Male and Female|2023
0.3|0.7|0.5|30|IIIf Unspecified intracranial and intraspinal neoplasms|59860111|0-14|All Races|Male and Female|2023
5.4|6.6|6.0|364|IIa Hodgkin lymphomas|59860111|0-14|All Races|Male and Female|2023
7.0|8.4|7.7|462|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59860111|0-14|All Races|Male and Female|2023
2.6|3.5|3.0|181|IIc Burkitt lymphoma|59860111|0-14|All Races|Male and Female|2023
1.7|2.5|2.1|121|IId Miscellaneous lymphoreticular neoplasms|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|IIe Unspecified lymphomas|59860111|0-14|All Races|Male and Female|2023
10.4|12.1|11.2|653|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59860111|0-14|All Races|Male and Female|2023
9.9|11.7|10.8|626|IVa Neuroblastoma and ganglioneuroblastoma|59860111|0-14|All Races|Male and Female|2023
0.3|0.6|0.4|27|IVb Other peripheral nervous cell tumors|59860111|0-14|All Races|Male and Female|2023
9.6|11.3|10.4|624|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59860111|0-14|All Races|Male and Female|2023
4.4|5.6|5.0|296|IXa Rhabdomyosarcomas|59860111|0-14|All Races|Male and Female|2023
0.7|1.2|0.9|53|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|IXc Kaposi sarcoma|59860111|0-14|All Races|Male and Female|2023
3.0|3.9|3.4|208|IXd Other specified soft tissue sarcomas|59860111|0-14|All Races|Male and Female|2023
0.9|1.4|1.1|67|IXe Unspecified soft tissue sarcomas|59860111|0-14|All Races|Male and Female|2023
38.6|41.9|40.2|2387|Ia Lymphoid leukemias|59860111|0-14|All Races|Male and Female|2023
7.1|8.5|7.8|463|Ib Acute myeloid leukemias|59860111|0-14|All Races|Male and Female|2023
0.6|1.1|0.9|52|Ic Chronic myeloproliferative diseases|59860111|0-14|All Races|Male and Female|2023
0.9|1.5|1.2|70|Id Myelodysplastic syndrome and other myeloproliferative diseases|59860111|0-14|All Races|Male and Female|2023
1.0|1.5|1.2|73|Ie Unspecified and other specified leukemias|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|Not classified by ICCC|59860111|0-14|All Races|Male and Female|2023
3.0|4.0|3.5|199|V RETINOBLASTOMA|59860111|0-14|All Races|Male and Female|2023
7.9|9.4|8.6|507|VI RENAL TUMORS|59860111|0-14|All Races|Male and Female|2023
3.4|4.4|3.9|227|VII HEPATIC TUMORS|59860111|0-14|All Races|Male and Female|2023
6.5|7.8|7.1|434|VIII MALIGNANT BONE TUMORS|59860111|0-14|All Races|Male and Female|2023
3.9|4.9|4.4|266|VIIIa Osteosarcomas|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|VIIIb Chondrosarcomas|59860111|0-14|All Races|Male and Female|2023
1.8|2.6|2.2|131|VIIIc Ewing tumor and related sarcomas of bone|59860111|0-14|All Races|Male and Female|2023
0.2|0.5|0.3|20|VIIId Other specified malignant bone tumors|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|VIIIe Unspecified malignant bone tumors|59860111|0-14|All Races|Male and Female|2023
2.8|3.7|3.2|188|VIIa Hepatoblastoma and mesenchymal tumors of liver|59860111|0-14|All Races|Male and Female|2023
0.4|0.8|0.6|36|VIIb Hepatic carcinomas|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59860111|0-14|All Races|Male and Female|2023
7.5|9.0|8.2|482|VIa Nephroblastoma and other non-epithelial renal tumors|59860111|0-14|All Races|Male and Female|2023
0.3|0.6|0.4|24|VIb Renal carcinomas|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|VIc Unspecified malignant renal tumors|59860111|0-14|All Races|Male and Female|2023
5.1|6.4|5.7|342|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59860111|0-14|All Races|Male and Female|2023
8.7|10.3|9.5|579|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59860111|0-14|All Races|Male and Female|2023
1.0|1.6|1.3|74|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59860111|0-14|All Races|Male and Female|2023
0.6|1.0|0.8|45|XIIa Other specified malignant tumors|59860111|0-14|All Races|Male and Female|2023
0.3|0.7|0.5|29|XIIb Other unspecified malignant tumors|59860111|0-14|All Races|Male and Female|2023
0.2|0.6|0.4|22|XIa Adrenocortical carcinomas|59860111|0-14|All Races|Male and Female|2023
2.6|3.5|3.0|185|XIb Thyroid carcinomas|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|XIc Nasopharyngeal carcinomas|59860111|0-14|All Races|Male and Female|2023
1.1|1.7|1.4|82|XId Malignant melanomas|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|XIe Skin carcinomas|59860111|0-14|All Races|Male and Female|2023
4.0|5.1|4.5|277|XIf Other and unspecified carcinomas|59860111|0-14|All Races|Male and Female|2023
1.3|1.9|1.6|95|Xa Intracranial and intraspinal germ cell tumors|59860111|0-14|All Races|Male and Female|2023
1.3|1.9|1.6|90|Xb Malignant extracranial and extragonadal germ cell tumors|59860111|0-14|All Races|Male and Female|2023
2.0|2.8|2.4|142|Xc Malignant gonadal germ cell tumors|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|Xd Gonadal carcinomas|59860111|0-14|All Races|Male and Female|2023
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59860111|0-14|All Races|Male and Female|2023
155.5|161.1|158.3|12472|All ICCC Groups Combined|78936986|0-19|All Races|Male and Female|1999
39.1|41.9|40.5|3193|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|78936986|0-19|All Races|Male and Female|1999
22.2|24.3|23.2|1829|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|78936986|0-19|All Races|Male and Female|1999
27.5|29.8|28.6|2261|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|78936986|0-19|All Races|Male and Female|1999
2.3|3.0|2.6|207|IIIa Ependymomas and choroid plexus tumor|78936986|0-19|All Races|Male and Female|1999
12.7|14.4|13.5|1069|IIIb Astrocytomas|78936986|0-19|All Races|Male and Female|1999
6.1|7.2|6.6|523|IIIc Intracranial and intraspinal embryonal tumors|78936986|0-19|All Races|Male and Female|1999
4.3|5.3|4.7|376|IIId Other gliomas|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|40|IIIe Other specified intracranial and intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999
0.4|0.8|0.6|46|IIIf Unspecified intracranial and intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999
11.1|12.7|11.9|934|IIa Hodgkin lymphomas|78936986|0-19|All Races|Male and Female|1999
7.0|8.3|7.6|601|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|78936986|0-19|All Races|Male and Female|1999
2.1|2.8|2.4|189|IIc Burkitt lymphoma|78936986|0-19|All Races|Male and Female|1999
0.5|0.9|0.7|56|IId Miscellaneous lymphoreticular neoplasms|78936986|0-19|All Races|Male and Female|1999
0.5|0.8|0.6|49|IIe Unspecified lymphomas|78936986|0-19|All Races|Male and Female|1999
7.7|8.9|8.3|649|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|78936986|0-19|All Races|Male and Female|1999
7.4|8.6|8.0|626|IVa Neuroblastoma and ganglioneuroblastoma|78936986|0-19|All Races|Male and Female|1999
0.2|0.4|0.3|23|IVb Other peripheral nervous cell tumors|78936986|0-19|All Races|Male and Female|1999
10.1|11.6|10.8|852|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|78936986|0-19|All Races|Male and Female|1999
3.9|4.9|4.4|347|IXa Rhabdomyosarcomas|78936986|0-19|All Races|Male and Female|1999
0.9|1.4|1.1|88|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|IXc Kaposi sarcoma|78936986|0-19|All Races|Male and Female|1999
3.6|4.5|4.0|315|IXd Other specified soft tissue sarcomas|78936986|0-19|All Races|Male and Female|1999
1.0|1.5|1.3|99|IXe Unspecified soft tissue sarcomas|78936986|0-19|All Races|Male and Female|1999
28.8|31.3|30.0|2370|Ia Lymphoid leukemias|78936986|0-19|All Races|Male and Female|1999
7.5|8.8|8.1|639|Ib Acute myeloid leukemias|78936986|0-19|All Races|Male and Female|1999
0.8|1.3|1.0|81|Ic Chronic myeloproliferative diseases|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|78936986|0-19|All Races|Male and Female|1999
0.9|1.4|1.2|92|Ie Unspecified and other specified leukemias|78936986|0-19|All Races|Male and Female|1999
0.3|0.6|0.4|33|Not classified by ICCC|78936986|0-19|All Races|Male and Female|1999
2.8|3.6|3.2|247|V RETINOBLASTOMA|78936986|0-19|All Races|Male and Female|1999
5.8|6.9|6.3|500|VI RENAL TUMORS|78936986|0-19|All Races|Male and Female|1999
1.8|2.4|2.1|164|VII HEPATIC TUMORS|78936986|0-19|All Races|Male and Female|1999
8.2|9.5|8.8|696|VIII MALIGNANT BONE TUMORS|78936986|0-19|All Races|Male and Female|1999
4.6|5.6|5.1|400|VIIIa Osteosarcomas|78936986|0-19|All Races|Male and Female|1999
0.3|0.5|0.4|30|VIIIb Chondrosarcomas|78936986|0-19|All Races|Male and Female|1999
2.4|3.1|2.7|214|VIIIc Ewing tumor and related sarcomas of bone|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|40|VIIId Other specified malignant bone tumors|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|VIIIe Unspecified malignant bone tumors|78936986|0-19|All Races|Male and Female|1999
1.2|1.7|1.4|112|VIIa Hepatoblastoma and mesenchymal tumors of liver|78936986|0-19|All Races|Male and Female|1999
0.5|0.9|0.6|51|VIIb Hepatic carcinomas|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|VIIc Unspecified malignant hepatic tumors|78936986|0-19|All Races|Male and Female|1999
5.3|6.3|5.8|456|VIa Nephroblastoma and other non-epithelial renal tumors|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|40|VIb Renal carcinomas|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|VIc Unspecified malignant renal tumors|78936986|0-19|All Races|Male and Female|1999
9.4|10.8|10.0|789|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|78936986|0-19|All Races|Male and Female|1999
14.3|16.1|15.2|1193|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|78936986|0-19|All Races|Male and Female|1999
0.6|1.1|0.8|66|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|78936986|0-19|All Races|Male and Female|1999
0.1|0.4|0.2|19|XIIa Other specified malignant tumors|78936986|0-19|All Races|Male and Female|1999
0.4|0.8|0.6|47|XIIb Other unspecified malignant tumors|78936986|0-19|All Races|Male and Female|1999
0.1|0.4|0.2|19|XIa Adrenocortical carcinomas|78936986|0-19|All Races|Male and Female|1999
5.4|6.4|5.9|463|XIb Thyroid carcinomas|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|42|XIc Nasopharyngeal carcinomas|78936986|0-19|All Races|Male and Female|1999
4.3|5.3|4.7|373|XId Malignant melanomas|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|XIe Skin carcinomas|78936986|0-19|All Races|Male and Female|1999
3.2|4.1|3.6|287|XIf Other and unspecified carcinomas|78936986|0-19|All Races|Male and Female|1999
1.2|1.7|1.4|111|Xa Intracranial and intraspinal germ cell tumors|78936986|0-19|All Races|Male and Female|1999
1.1|1.7|1.4|107|Xb Malignant extracranial and extragonadal germ cell tumors|78936986|0-19|All Races|Male and Female|1999
6.1|7.2|6.6|522|Xc Malignant gonadal germ cell tumors|78936986|0-19|All Races|Male and Female|1999
0.3|0.5|0.4|30|Xd Gonadal carcinomas|78936986|0-19|All Races|Male and Female|1999
0.1|0.4|0.2|19|Xe Other and unspecified malignant gonadal tumors|78936986|0-19|All Races|Male and Female|1999
160.6|166.2|163.4|12963|All ICCC Groups Combined|79474943|0-19|All Races|Male and Female|2000
39.8|42.7|41.3|3267|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|79474943|0-19|All Races|Male and Female|2000
23.8|26.0|24.9|1982|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|79474943|0-19|All Races|Male and Female|2000
28.6|31.0|29.7|2362|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|79474943|0-19|All Races|Male and Female|2000
2.0|2.7|2.3|184|IIIa Ependymomas and choroid plexus tumor|79474943|0-19|All Races|Male and Female|2000
14.6|16.3|15.4|1224|IIIb Astrocytomas|79474943|0-19|All Races|Male and Female|2000
5.8|6.9|6.4|505|IIIc Intracranial and intraspinal embryonal tumors|79474943|0-19|All Races|Male and Female|2000
4.1|5.0|4.5|361|IIId Other gliomas|79474943|0-19|All Races|Male and Female|2000
0.3|0.6|0.5|37|IIIe Other specified intracranial and intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000
0.5|0.8|0.6|51|IIIf Unspecified intracranial and intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000
11.6|13.2|12.4|984|IIa Hodgkin lymphomas|79474943|0-19|All Races|Male and Female|2000
7.6|8.8|8.2|652|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|79474943|0-19|All Races|Male and Female|2000
2.3|3.1|2.7|213|IIc Burkitt lymphoma|79474943|0-19|All Races|Male and Female|2000
0.8|1.3|1.0|81|IId Miscellaneous lymphoreticular neoplasms|79474943|0-19|All Races|Male and Female|2000
0.5|0.9|0.7|52|IIe Unspecified lymphomas|79474943|0-19|All Races|Male and Female|2000
7.1|8.3|7.7|608|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|79474943|0-19|All Races|Male and Female|2000
7.0|8.2|7.6|596|IVa Neuroblastoma and ganglioneuroblastoma|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|IVb Other peripheral nervous cell tumors|79474943|0-19|All Races|Male and Female|2000
11.2|12.7|11.9|947|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|79474943|0-19|All Races|Male and Female|2000
4.3|5.2|4.7|375|IXa Rhabdomyosarcomas|79474943|0-19|All Races|Male and Female|2000
1.0|1.5|1.2|95|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|IXc Kaposi sarcoma|79474943|0-19|All Races|Male and Female|2000
4.2|5.1|4.6|368|IXd Other specified soft tissue sarcomas|79474943|0-19|All Races|Male and Female|2000
1.1|1.6|1.3|104|IXe Unspecified soft tissue sarcomas|79474943|0-19|All Races|Male and Female|2000
30.5|33.0|31.7|2513|Ia Lymphoid leukemias|79474943|0-19|All Races|Male and Female|2000
6.8|8.0|7.3|582|Ib Acute myeloid leukemias|79474943|0-19|All Races|Male and Female|2000
0.7|1.1|0.9|71|Ic Chronic myeloproliferative diseases|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|79474943|0-19|All Races|Male and Female|2000
0.9|1.4|1.2|92|Ie Unspecified and other specified leukemias|79474943|0-19|All Races|Male and Female|2000
0.2|0.5|0.4|28|Not classified by ICCC|79474943|0-19|All Races|Male and Female|2000
2.9|3.7|3.3|258|V RETINOBLASTOMA|79474943|0-19|All Races|Male and Female|2000
6.3|7.5|6.9|541|VI RENAL TUMORS|79474943|0-19|All Races|Male and Female|2000
1.7|2.3|2.0|156|VII HEPATIC TUMORS|79474943|0-19|All Races|Male and Female|2000
7.7|9.0|8.4|667|VIII MALIGNANT BONE TUMORS|79474943|0-19|All Races|Male and Female|2000
4.2|5.2|4.7|374|VIIIa Osteosarcomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|VIIIb Chondrosarcomas|79474943|0-19|All Races|Male and Female|2000
2.7|3.4|3.0|241|VIIIc Ewing tumor and related sarcomas of bone|79474943|0-19|All Races|Male and Female|2000
0.2|0.4|0.3|20|VIIId Other specified malignant bone tumors|79474943|0-19|All Races|Male and Female|2000
0.1|0.3|0.2|17|VIIIe Unspecified malignant bone tumors|79474943|0-19|All Races|Male and Female|2000
1.3|1.9|1.6|124|VIIa Hepatoblastoma and mesenchymal tumors of liver|79474943|0-19|All Races|Male and Female|2000
0.3|0.5|0.4|30|VIIb Hepatic carcinomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|VIIc Unspecified malignant hepatic tumors|79474943|0-19|All Races|Male and Female|2000
5.8|6.9|6.3|500|VIa Nephroblastoma and other non-epithelial renal tumors|79474943|0-19|All Races|Male and Female|2000
0.3|0.7|0.5|39|VIb Renal carcinomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|VIc Unspecified malignant renal tumors|79474943|0-19|All Races|Male and Female|2000
10.1|11.5|10.8|857|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|79474943|0-19|All Races|Male and Female|2000
14.5|16.3|15.4|1225|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|79474943|0-19|All Races|Male and Female|2000
0.6|1.0|0.8|65|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|XIIa Other specified malignant tumors|79474943|0-19|All Races|Male and Female|2000
0.5|0.8|0.6|50|XIIb Other unspecified malignant tumors|79474943|0-19|All Races|Male and Female|2000
0.2|0.5|0.3|25|XIa Adrenocortical carcinomas|79474943|0-19|All Races|Male and Female|2000
5.2|6.2|5.7|452|XIb Thyroid carcinomas|79474943|0-19|All Races|Male and Female|2000
0.4|0.7|0.5|41|XIc Nasopharyngeal carcinomas|79474943|0-19|All Races|Male and Female|2000
4.7|5.7|5.2|413|XId Malignant melanomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|XIe Skin carcinomas|79474943|0-19|All Races|Male and Female|2000
3.2|4.1|3.6|288|XIf Other and unspecified carcinomas|79474943|0-19|All Races|Male and Female|2000
1.4|2.0|1.7|133|Xa Intracranial and intraspinal germ cell tumors|79474943|0-19|All Races|Male and Female|2000
1.1|1.6|1.4|108|Xb Malignant extracranial and extragonadal germ cell tumors|79474943|0-19|All Races|Male and Female|2000
6.5|7.7|7.1|561|Xc Malignant gonadal germ cell tumors|79474943|0-19|All Races|Male and Female|2000
0.3|0.6|0.5|37|Xd Gonadal carcinomas|79474943|0-19|All Races|Male and Female|2000
0.1|0.4|0.2|18|Xe Other and unspecified malignant gonadal tumors|79474943|0-19|All Races|Male and Female|2000
167.7|173.4|170.6|13651|All ICCC Groups Combined|80042731|0-19|All Races|Male and Female|2001
44.2|47.2|45.6|3635|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|80042731|0-19|All Races|Male and Female|2001
23.5|25.7|24.6|1977|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|80042731|0-19|All Races|Male and Female|2001
29.0|31.4|30.2|2408|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|80042731|0-19|All Races|Male and Female|2001
2.1|2.8|2.4|194|IIIa Ependymomas and choroid plexus tumor|80042731|0-19|All Races|Male and Female|2001
14.3|16.0|15.1|1207|IIIb Astrocytomas|80042731|0-19|All Races|Male and Female|2001
6.0|7.1|6.5|522|IIIc Intracranial and intraspinal embryonal tumors|80042731|0-19|All Races|Male and Female|2001
4.6|5.6|5.1|405|IIId Other gliomas|80042731|0-19|All Races|Male and Female|2001
0.5|0.8|0.6|49|IIIe Other specified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001
0.3|0.5|0.4|31|IIIf Unspecified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001
11.7|13.3|12.5|1007|IIa Hodgkin lymphomas|80042731|0-19|All Races|Male and Female|2001
8.0|9.3|8.6|694|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|0-19|All Races|Male and Female|2001
1.9|2.5|2.2|174|IIc Burkitt lymphoma|80042731|0-19|All Races|Male and Female|2001
0.6|1.0|0.8|64|IId Miscellaneous lymphoreticular neoplasms|80042731|0-19|All Races|Male and Female|2001
0.3|0.7|0.5|38|IIe Unspecified lymphomas|80042731|0-19|All Races|Male and Female|2001
8.2|9.6|8.9|710|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|80042731|0-19|All Races|Male and Female|2001
8.0|9.3|8.7|693|IVa Neuroblastoma and ganglioneuroblastoma|80042731|0-19|All Races|Male and Female|2001
0.1|0.3|0.2|17|IVb Other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001
11.0|12.6|11.8|945|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|80042731|0-19|All Races|Male and Female|2001
4.4|5.4|4.9|389|IXa Rhabdomyosarcomas|80042731|0-19|All Races|Male and Female|2001
1.2|1.7|1.4|115|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|IXc Kaposi sarcoma|80042731|0-19|All Races|Male and Female|2001
3.7|4.6|4.2|336|IXd Other specified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001
1.0|1.5|1.3|102|IXe Unspecified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001
31.6|34.1|32.8|2606|Ia Lymphoid leukemias|80042731|0-19|All Races|Male and Female|2001
7.2|8.4|7.8|625|Ib Acute myeloid leukemias|80042731|0-19|All Races|Male and Female|2001
2.0|2.7|2.3|188|Ic Chronic myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001
1.2|1.8|1.5|117|Id Myelodysplastic syndrome and other myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001
1.0|1.5|1.2|99|Ie Unspecified and other specified leukemias|80042731|0-19|All Races|Male and Female|2001
0.2|0.5|0.3|27|Not classified by ICCC|80042731|0-19|All Races|Male and Female|2001
2.9|3.7|3.3|263|V RETINOBLASTOMA|80042731|0-19|All Races|Male and Female|2001
6.2|7.4|6.8|539|VI RENAL TUMORS|80042731|0-19|All Races|Male and Female|2001
1.7|2.3|2.0|158|VII HEPATIC TUMORS|80042731|0-19|All Races|Male and Female|2001
8.9|10.3|9.6|771|VIII MALIGNANT BONE TUMORS|80042731|0-19|All Races|Male and Female|2001
4.7|5.7|5.2|420|VIIIa Osteosarcomas|80042731|0-19|All Races|Male and Female|2001
0.3|0.5|0.4|30|VIIIb Chondrosarcomas|80042731|0-19|All Races|Male and Female|2001
3.0|3.8|3.4|274|VIIIc Ewing tumor and related sarcomas of bone|80042731|0-19|All Races|Male and Female|2001
0.3|0.6|0.4|36|VIIId Other specified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|VIIIe Unspecified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001
1.2|1.7|1.4|114|VIIa Hepatoblastoma and mesenchymal tumors of liver|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|43|VIIb Hepatic carcinomas|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|VIIc Unspecified malignant hepatic tumors|80042731|0-19|All Races|Male and Female|2001
5.7|6.8|6.2|493|VIa Nephroblastoma and other non-epithelial renal tumors|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|43|VIb Renal carcinomas|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|VIc Unspecified malignant renal tumors|80042731|0-19|All Races|Male and Female|2001
9.6|11.1|10.3|833|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|80042731|0-19|All Races|Male and Female|2001
15.4|17.2|16.3|1311|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|80042731|0-19|All Races|Male and Female|2001
0.7|1.2|0.9|74|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|80042731|0-19|All Races|Male and Female|2001
0.3|0.6|0.4|32|XIIa Other specified malignant tumors|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|80042731|0-19|All Races|Male and Female|2001
0.1|0.4|0.2|18|XIa Adrenocortical carcinomas|80042731|0-19|All Races|Male and Female|2001
5.3|6.4|5.8|470|XIb Thyroid carcinomas|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|43|XIc Nasopharyngeal carcinomas|80042731|0-19|All Races|Male and Female|2001
5.2|6.3|5.8|463|XId Malignant melanomas|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|XIe Skin carcinomas|80042731|0-19|All Races|Male and Female|2001
3.4|4.3|3.8|310|XIf Other and unspecified carcinomas|80042731|0-19|All Races|Male and Female|2001
1.3|1.9|1.6|128|Xa Intracranial and intraspinal germ cell tumors|80042731|0-19|All Races|Male and Female|2001
1.3|1.9|1.6|128|Xb Malignant extracranial and extragonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001
6.0|7.1|6.5|526|Xc Malignant gonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001
0.2|0.5|0.3|27|Xd Gonadal carcinomas|80042731|0-19|All Races|Male and Female|2001
0.2|0.4|0.3|24|Xe Other and unspecified malignant gonadal tumors|80042731|0-19|All Races|Male and Female|2001
167.9|173.6|170.7|13724|All ICCC Groups Combined|80317363|0-19|All Races|Male and Female|2002
43.2|46.1|44.6|3569|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|80317363|0-19|All Races|Male and Female|2002
23.5|25.7|24.6|1991|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|80317363|0-19|All Races|Male and Female|2002
30.3|32.8|31.5|2523|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|80317363|0-19|All Races|Male and Female|2002
2.6|3.4|3.0|237|IIIa Ependymomas and choroid plexus tumor|80317363|0-19|All Races|Male and Female|2002
14.6|16.4|15.5|1241|IIIb Astrocytomas|80317363|0-19|All Races|Male and Female|2002
5.8|6.9|6.4|508|IIIc Intracranial and intraspinal embryonal tumors|80317363|0-19|All Races|Male and Female|2002
5.1|6.1|5.6|446|IIId Other gliomas|80317363|0-19|All Races|Male and Female|2002
0.5|0.9|0.7|58|IIIe Other specified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.4|33|IIIf Unspecified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002
11.6|13.1|12.4|1003|IIa Hodgkin lymphomas|80317363|0-19|All Races|Male and Female|2002
7.6|8.9|8.2|665|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|80317363|0-19|All Races|Male and Female|2002
2.4|3.1|2.8|221|IIc Burkitt lymphoma|80317363|0-19|All Races|Male and Female|2002
0.7|1.2|0.9|74|IId Miscellaneous lymphoreticular neoplasms|80317363|0-19|All Races|Male and Female|2002
0.2|0.5|0.3|28|IIe Unspecified lymphomas|80317363|0-19|All Races|Male and Female|2002
7.9|9.2|8.5|679|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|80317363|0-19|All Races|Male and Female|2002
7.6|8.9|8.3|661|IVa Neuroblastoma and ganglioneuroblastoma|80317363|0-19|All Races|Male and Female|2002
0.1|0.4|0.2|18|IVb Other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002
11.0|12.5|11.7|941|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|80317363|0-19|All Races|Male and Female|2002
4.3|5.2|4.7|378|IXa Rhabdomyosarcomas|80317363|0-19|All Races|Male and Female|2002
1.0|1.4|1.2|95|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|IXc Kaposi sarcoma|80317363|0-19|All Races|Male and Female|2002
4.3|5.3|4.8|389|IXd Other specified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002
0.8|1.2|1.0|79|IXe Unspecified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002
30.5|32.9|31.7|2526|Ia Lymphoid leukemias|80317363|0-19|All Races|Male and Female|2002
7.6|8.9|8.2|662|Ib Acute myeloid leukemias|80317363|0-19|All Races|Male and Female|2002
1.8|2.4|2.1|170|Ic Chronic myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002
1.3|1.8|1.5|122|Id Myelodysplastic syndrome and other myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002
0.9|1.4|1.1|89|Ie Unspecified and other specified leukemias|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.4|32|Not classified by ICCC|80317363|0-19|All Races|Male and Female|2002
2.5|3.2|2.8|225|V RETINOBLASTOMA|80317363|0-19|All Races|Male and Female|2002
6.0|7.1|6.5|518|VI RENAL TUMORS|80317363|0-19|All Races|Male and Female|2002
1.6|2.2|1.9|150|VII HEPATIC TUMORS|80317363|0-19|All Races|Male and Female|2002
8.5|9.9|9.2|743|VIII MALIGNANT BONE TUMORS|80317363|0-19|All Races|Male and Female|2002
4.4|5.4|4.9|399|VIIIa Osteosarcomas|80317363|0-19|All Races|Male and Female|2002
0.4|0.7|0.5|41|VIIIb Chondrosarcomas|80317363|0-19|All Races|Male and Female|2002
2.7|3.5|3.1|249|VIIIc Ewing tumor and related sarcomas of bone|80317363|0-19|All Races|Male and Female|2002
0.4|0.7|0.5|43|VIIId Other specified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|VIIIe Unspecified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002
1.1|1.6|1.3|107|VIIa Hepatoblastoma and mesenchymal tumors of liver|80317363|0-19|All Races|Male and Female|2002
0.4|0.7|0.5|42|VIIb Hepatic carcinomas|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|VIIc Unspecified malignant hepatic tumors|80317363|0-19|All Races|Male and Female|2002
5.5|6.6|6.0|480|VIa Nephroblastoma and other non-epithelial renal tumors|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.5|37|VIb Renal carcinomas|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|VIc Unspecified malignant renal tumors|80317363|0-19|All Races|Male and Female|2002
10.3|11.8|11.0|892|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|80317363|0-19|All Races|Male and Female|2002
16.2|18.0|17.1|1388|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|80317363|0-19|All Races|Male and Female|2002
0.7|1.1|0.9|73|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.5|38|XIIa Other specified malignant tumors|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.4|35|XIIb Other unspecified malignant tumors|80317363|0-19|All Races|Male and Female|2002
0.2|0.4|0.3|20|XIa Adrenocortical carcinomas|80317363|0-19|All Races|Male and Female|2002
5.4|6.5|5.9|479|XIb Thyroid carcinomas|80317363|0-19|All Races|Male and Female|2002
0.4|0.8|0.6|49|XIc Nasopharyngeal carcinomas|80317363|0-19|All Races|Male and Female|2002
5.9|7.0|6.5|524|XId Malignant melanomas|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|XIe Skin carcinomas|80317363|0-19|All Races|Male and Female|2002
3.4|4.2|3.8|307|XIf Other and unspecified carcinomas|80317363|0-19|All Races|Male and Female|2002
1.4|1.9|1.6|132|Xa Intracranial and intraspinal germ cell tumors|80317363|0-19|All Races|Male and Female|2002
1.3|1.9|1.6|127|Xb Malignant extracranial and extragonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002
6.6|7.8|7.2|582|Xc Malignant gonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002
0.2|0.5|0.3|28|Xd Gonadal carcinomas|80317363|0-19|All Races|Male and Female|2002
0.2|0.4|0.3|23|Xe Other and unspecified malignant gonadal tumors|80317363|0-19|All Races|Male and Female|2002
164.8|170.4|167.6|13685|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003
41.9|44.7|43.3|3511|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|81425816|0-19|All Races|Male and Female|2003
23.2|25.3|24.2|1989|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|81425816|0-19|All Races|Male and Female|2003
29.0|31.4|30.2|2447|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|81425816|0-19|All Races|Male and Female|2003
2.0|2.6|2.3|185|IIIa Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003
14.5|16.3|15.4|1250|IIIb Astrocytomas|81425816|0-19|All Races|Male and Female|2003
5.6|6.7|6.1|492|IIIc Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003
4.7|5.7|5.2|422|IIId Other gliomas|81425816|0-19|All Races|Male and Female|2003
0.7|1.1|0.8|68|IIIe Other specified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.4|30|IIIf Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003
11.7|13.2|12.4|1025|IIa Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003
7.5|8.7|8.1|659|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003
2.3|3.0|2.6|212|IIc Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003
0.7|1.2|0.9|76|IId Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003
0.1|0.3|0.2|17|IIe Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003
7.6|8.9|8.2|668|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|81425816|0-19|All Races|Male and Female|2003
7.4|8.7|8.0|653|IVa Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|IVb Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003
11.3|12.8|12.0|986|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|81425816|0-19|All Races|Male and Female|2003
4.2|5.1|4.6|376|IXa Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003
1.2|1.8|1.5|120|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|IXc Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003
4.2|5.1|4.7|383|IXd Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003
1.0|1.5|1.3|104|IXe Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003
29.3|31.7|30.5|2465|Ia Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003
7.3|8.5|7.8|642|Ib Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003
2.1|2.7|2.4|195|Ic Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003
1.4|2.0|1.7|136|Id Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003
0.7|1.1|0.9|73|Ie Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.3|28|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003
2.7|3.5|3.1|250|V RETINOBLASTOMA|81425816|0-19|All Races|Male and Female|2003
6.1|7.3|6.7|540|VI RENAL TUMORS|81425816|0-19|All Races|Male and Female|2003
2.0|2.6|2.3|187|VII HEPATIC TUMORS|81425816|0-19|All Races|Male and Female|2003
8.1|9.4|8.7|717|VIII MALIGNANT BONE TUMORS|81425816|0-19|All Races|Male and Female|2003
4.8|5.8|5.3|436|VIIIa Osteosarcomas|81425816|0-19|All Races|Male and Female|2003
0.2|0.4|0.3|25|VIIIb Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003
2.2|2.9|2.6|211|VIIIc Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.3|28|VIIId Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003
0.1|0.3|0.2|17|VIIIe Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003
1.4|2.0|1.7|138|VIIa Hepatoblastoma and mesenchymal tumors of liver|81425816|0-19|All Races|Male and Female|2003
0.4|0.8|0.6|49|VIIb Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|VIIc Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003
5.6|6.7|6.1|492|VIa Nephroblastoma and other non-epithelial renal tumors|81425816|0-19|All Races|Male and Female|2003
0.4|0.7|0.5|44|VIb Renal carcinomas|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|VIc Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003
9.6|11.0|10.3|848|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|81425816|0-19|All Races|Male and Female|2003
16.3|18.1|17.2|1421|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|81425816|0-19|All Races|Male and Female|2003
0.9|1.4|1.1|93|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|81425816|0-19|All Races|Male and Female|2003
0.4|0.7|0.5|45|XIIa Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003
0.4|0.8|0.6|48|XIIb Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003
0.1|0.4|0.2|20|XIa Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003
5.7|6.8|6.2|516|XIb Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003
0.5|0.9|0.7|54|XIc Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003
5.4|6.5|5.9|489|XId Malignant melanomas|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|XIe Skin carcinomas|81425816|0-19|All Races|Male and Female|2003
3.6|4.5|4.0|332|XIf Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003
1.1|1.6|1.3|111|Xa Intracranial and intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003
1.2|1.7|1.5|120|Xb Malignant extracranial and extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003
6.2|7.3|6.7|557|Xc Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.3|27|Xd Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003
0.3|0.6|0.4|33|Xe Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003
171.6|177.3|174.4|14332|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004
44.7|47.7|46.2|3764|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|81754354|0-19|All Races|Male and Female|2004
23.2|25.3|24.2|2004|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|81754354|0-19|All Races|Male and Female|2004
31.0|33.5|32.3|2625|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|81754354|0-19|All Races|Male and Female|2004
2.4|3.1|2.8|225|IIIa Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004
15.6|17.4|16.5|1344|IIIb Astrocytomas|81754354|0-19|All Races|Male and Female|2004
6.1|7.2|6.6|536|IIIc Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004
4.7|5.7|5.1|417|IIId Other gliomas|81754354|0-19|All Races|Male and Female|2004
0.6|0.9|0.7|60|IIIe Other specified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|43|IIIf Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004
11.2|12.7|11.9|992|IIa Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004
7.9|9.2|8.6|706|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004
2.0|2.7|2.3|191|IIc Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004
0.9|1.3|1.1|88|IId Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004
0.2|0.5|0.3|27|IIe Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004
7.9|9.2|8.5|698|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|81754354|0-19|All Races|Male and Female|2004
7.6|8.9|8.2|675|IVa Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004
0.2|0.4|0.3|23|IVb Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004
11.2|12.7|11.9|984|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|81754354|0-19|All Races|Male and Female|2004
3.8|4.7|4.2|343|IXa Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004
1.1|1.6|1.4|114|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|IXc Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004
4.6|5.6|5.1|425|IXd Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004
1.0|1.4|1.2|98|IXe Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004
31.9|34.4|33.1|2691|Ia Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004
7.7|8.9|8.3|681|Ib Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004
1.9|2.6|2.2|185|Ic Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004
1.1|1.6|1.4|112|Id Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004
0.9|1.4|1.2|95|Ie Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004
0.3|0.6|0.4|34|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004
2.8|3.6|3.2|265|V RETINOBLASTOMA|81754354|0-19|All Races|Male and Female|2004
5.9|7.1|6.5|528|VI RENAL TUMORS|81754354|0-19|All Races|Male and Female|2004
2.2|2.9|2.6|210|VII HEPATIC TUMORS|81754354|0-19|All Races|Male and Female|2004
8.4|9.7|9.1|750|VIII MALIGNANT BONE TUMORS|81754354|0-19|All Races|Male and Female|2004
4.6|5.6|5.1|424|VIIIa Osteosarcomas|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|43|VIIIb Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004
2.4|3.1|2.8|228|VIIIc Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|VIIIe Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004
1.6|2.3|1.9|158|VIIa Hepatoblastoma and mesenchymal tumors of liver|81754354|0-19|All Races|Male and Female|2004
0.4|0.8|0.6|48|VIIb Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|VIIc Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004
5.4|6.4|5.9|478|VIa Nephroblastoma and other non-epithelial renal tumors|81754354|0-19|All Races|Male and Female|2004
0.4|0.8|0.6|47|VIb Renal carcinomas|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|VIc Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004
10.4|11.9|11.1|929|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|81754354|0-19|All Races|Male and Female|2004
16.7|18.5|17.6|1466|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|81754354|0-19|All Races|Male and Female|2004
0.7|1.1|0.9|75|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|81754354|0-19|All Races|Male and Female|2004
0.3|0.6|0.4|34|XIIa Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|41|XIIb Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004
0.1|0.4|0.2|19|XIa Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004
6.3|7.4|6.8|570|XIb Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|46|XIc Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004
5.9|7.0|6.4|535|XId Malignant melanomas|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|XIe Skin carcinomas|81754354|0-19|All Races|Male and Female|2004
3.1|3.9|3.5|288|XIf Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004
1.5|2.1|1.8|149|Xa Intracranial and intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004
1.1|1.6|1.3|110|Xb Malignant extracranial and extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004
6.8|8.0|7.3|614|Xc Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004
0.2|0.5|0.4|30|Xd Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004
0.2|0.5|0.3|26|Xe Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004
169.9|175.6|172.7|14273|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005
43.0|45.9|44.4|3640|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82005260|0-19|All Races|Male and Female|2005
24.6|26.8|25.7|2146|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82005260|0-19|All Races|Male and Female|2005
29.2|31.6|30.4|2478|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82005260|0-19|All Races|Male and Female|2005
2.6|3.4|3.0|244|IIIa Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005
14.7|16.4|15.5|1271|IIIb Astrocytomas|82005260|0-19|All Races|Male and Female|2005
5.4|6.4|5.9|478|IIIc Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005
4.4|5.4|4.9|396|IIId Other gliomas|82005260|0-19|All Races|Male and Female|2005
0.5|0.8|0.6|52|IIIe Other specified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005
0.3|0.6|0.5|37|IIIf Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005
12.0|13.5|12.7|1070|IIa Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005
8.3|9.6|8.9|738|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005
2.2|2.9|2.5|205|IIc Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005
1.0|1.5|1.3|104|IId Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005
0.2|0.5|0.3|29|IIe Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005
8.5|9.8|9.1|750|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82005260|0-19|All Races|Male and Female|2005
8.3|9.6|8.9|731|IVa Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005
0.1|0.4|0.2|19|IVb Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005
11.5|13.0|12.2|1011|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82005260|0-19|All Races|Male and Female|2005
4.3|5.3|4.8|388|IXa Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005
1.2|1.7|1.4|118|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|IXc Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005
4.4|5.4|4.9|410|IXd Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005
0.9|1.4|1.1|91|IXe Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005
30.8|33.2|32.0|2608|Ia Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005
7.0|8.2|7.6|630|Ib Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005
1.8|2.4|2.1|172|Ic Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005
1.3|1.9|1.6|131|Id Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005
1.0|1.5|1.2|99|Ie Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005
0.3|0.6|0.4|35|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005
2.6|3.4|3.0|247|V RETINOBLASTOMA|82005260|0-19|All Races|Male and Female|2005
6.1|7.3|6.7|546|VI RENAL TUMORS|82005260|0-19|All Races|Male and Female|2005
1.8|2.5|2.2|178|VII HEPATIC TUMORS|82005260|0-19|All Races|Male and Female|2005
8.2|9.5|8.9|736|VIII MALIGNANT BONE TUMORS|82005260|0-19|All Races|Male and Female|2005
4.6|5.5|5.0|418|VIIIa Osteosarcomas|82005260|0-19|All Races|Male and Female|2005
0.2|0.4|0.3|24|VIIIb Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005
2.6|3.3|2.9|241|VIIIc Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005
0.3|0.6|0.4|37|VIIId Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005
0.1|0.3|0.2|16|VIIIe Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005
1.3|1.9|1.6|129|VIIa Hepatoblastoma and mesenchymal tumors of liver|82005260|0-19|All Races|Male and Female|2005
0.4|0.7|0.6|47|VIIb Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005
5.5|6.6|6.0|493|VIa Nephroblastoma and other non-epithelial renal tumors|82005260|0-19|All Races|Male and Female|2005
0.4|0.8|0.6|50|VIb Renal carcinomas|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|VIc Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005
10.7|12.2|11.5|965|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82005260|0-19|All Races|Male and Female|2005
16.4|18.2|17.3|1458|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82005260|0-19|All Races|Male and Female|2005
0.8|1.2|1.0|83|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82005260|0-19|All Races|Male and Female|2005
0.4|0.7|0.5|41|XIIa Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|XIa Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005
5.7|6.8|6.2|526|XIb Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005
0.3|0.5|0.4|33|XIc Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005
6.0|7.1|6.5|549|XId Malignant melanomas|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|XIe Skin carcinomas|82005260|0-19|All Races|Male and Female|2005
3.5|4.4|3.9|330|XIf Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005
1.3|1.9|1.6|133|Xa Intracranial and intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005
1.4|1.9|1.6|136|Xb Malignant extracranial and extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005
6.9|8.1|7.5|636|Xc Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005
0.3|0.5|0.4|32|Xd Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005
0.2|0.5|0.3|28|Xe Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005
170.8|176.4|173.6|14408|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006
45.4|48.4|46.9|3853|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82324418|0-19|All Races|Male and Female|2006
24.1|26.2|25.1|2109|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82324418|0-19|All Races|Male and Female|2006
30.3|32.8|31.5|2585|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82324418|0-19|All Races|Male and Female|2006
2.5|3.2|2.9|235|IIIa Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006
14.7|16.4|15.5|1276|IIIb Astrocytomas|82324418|0-19|All Races|Male and Female|2006
5.9|7.0|6.4|521|IIIc Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006
5.1|6.1|5.6|454|IIId Other gliomas|82324418|0-19|All Races|Male and Female|2006
0.4|0.8|0.6|48|IIIe Other specified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006
0.5|0.8|0.6|51|IIIf Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006
11.8|13.3|12.5|1059|IIa Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006
8.1|9.4|8.7|729|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006
2.1|2.8|2.4|199|IIc Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006
1.0|1.5|1.2|98|IId Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006
0.2|0.4|0.3|24|IIe Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006
7.4|8.6|7.9|655|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82324418|0-19|All Races|Male and Female|2006
7.2|8.4|7.7|638|IVa Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006
0.1|0.3|0.2|17|IVb Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006
10.8|12.3|11.5|958|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82324418|0-19|All Races|Male and Female|2006
3.9|4.9|4.4|360|IXa Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006
1.1|1.6|1.3|110|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|IXc Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006
4.1|5.0|4.5|379|IXd Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006
1.0|1.5|1.2|103|IXe Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006
32.0|34.5|33.2|2716|Ia Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006
7.7|9.0|8.4|695|Ib Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006
2.1|2.8|2.5|206|Ic Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006
1.4|2.0|1.7|139|Id Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006
1.0|1.4|1.2|97|Ie Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006
0.3|0.6|0.4|34|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006
2.7|3.5|3.1|254|V RETINOBLASTOMA|82324418|0-19|All Races|Male and Female|2006
6.2|7.3|6.7|549|VI RENAL TUMORS|82324418|0-19|All Races|Male and Female|2006
2.3|3.0|2.6|215|VII HEPATIC TUMORS|82324418|0-19|All Races|Male and Female|2006
8.7|10.0|9.3|777|VIII MALIGNANT BONE TUMORS|82324418|0-19|All Races|Male and Female|2006
4.9|5.9|5.4|450|VIIIa Osteosarcomas|82324418|0-19|All Races|Male and Female|2006
0.1|0.3|0.2|18|VIIIb Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006
2.7|3.4|3.0|251|VIIIc Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006
0.4|0.7|0.5|44|VIIId Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|VIIIe Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006
1.6|2.2|1.9|157|VIIa Hepatoblastoma and mesenchymal tumors of liver|82324418|0-19|All Races|Male and Female|2006
0.5|0.8|0.6|54|VIIb Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006
5.4|6.5|5.9|483|VIa Nephroblastoma and other non-epithelial renal tumors|82324418|0-19|All Races|Male and Female|2006
0.5|0.9|0.7|60|VIb Renal carcinomas|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|VIc Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006
9.6|11.0|10.3|876|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82324418|0-19|All Races|Male and Female|2006
16.4|18.1|17.2|1466|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82324418|0-19|All Races|Male and Female|2006
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82324418|0-19|All Races|Male and Female|2006
0.4|0.7|0.6|46|XIIa Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006
0.3|0.5|0.4|31|XIIb Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006
0.1|0.3|0.2|16|XIa Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006
6.3|7.4|6.8|581|XIb Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006
0.5|0.8|0.6|54|XIc Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006
4.9|5.9|5.4|461|XId Malignant melanomas|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|XIe Skin carcinomas|82324418|0-19|All Races|Male and Female|2006
3.7|4.5|4.1|346|XIf Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006
1.3|1.8|1.5|127|Xa Intracranial and intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006
1.3|1.8|1.5|130|Xb Malignant extracranial and extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006
5.9|7.0|6.4|548|Xc Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006
0.4|0.7|0.5|42|Xd Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006
0.2|0.5|0.3|29|Xe Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006
174.7|180.4|177.5|14836|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007
45.8|48.8|47.3|3910|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82749431|0-19|All Races|Male and Female|2007
24.0|26.1|25.0|2111|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82749431|0-19|All Races|Male and Female|2007
30.9|33.4|32.2|2647|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82749431|0-19|All Races|Male and Female|2007
2.2|2.9|2.5|210|IIIa Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007
15.5|17.2|16.3|1346|IIIb Astrocytomas|82749431|0-19|All Races|Male and Female|2007
5.9|7.0|6.4|527|IIIc Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007
5.2|6.3|5.7|470|IIId Other gliomas|82749431|0-19|All Races|Male and Female|2007
0.5|0.9|0.7|57|IIIe Other specified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.4|37|IIIf Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007
11.5|12.9|12.2|1041|IIa Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007
8.2|9.4|8.8|734|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007
2.3|3.0|2.6|213|IIc Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007
0.9|1.3|1.1|90|IId Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007
0.3|0.5|0.4|33|IIe Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007
8.4|9.7|9.1|758|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82749431|0-19|All Races|Male and Female|2007
8.2|9.5|8.8|739|IVa Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007
0.1|0.4|0.2|19|IVb Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007
11.8|13.3|12.5|1046|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82749431|0-19|All Races|Male and Female|2007
4.6|5.5|5.0|415|IXa Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007
1.1|1.7|1.4|117|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|IXc Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007
4.4|5.3|4.9|410|IXd Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007
1.0|1.4|1.2|100|IXe Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007
32.8|35.3|34.0|2798|Ia Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007
7.4|8.6|8.0|669|Ib Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007
2.3|3.0|2.6|225|Ic Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007
1.2|1.8|1.5|125|Id Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007
0.9|1.4|1.1|93|Ie Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007
0.2|0.5|0.3|27|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007
2.9|3.7|3.3|274|V RETINOBLASTOMA|82749431|0-19|All Races|Male and Female|2007
6.3|7.5|6.9|569|VI RENAL TUMORS|82749431|0-19|All Races|Male and Female|2007
2.1|2.8|2.5|206|VII HEPATIC TUMORS|82749431|0-19|All Races|Male and Female|2007
8.2|9.5|8.8|736|VIII MALIGNANT BONE TUMORS|82749431|0-19|All Races|Male and Female|2007
4.3|5.2|4.7|395|VIIIa Osteosarcomas|82749431|0-19|All Races|Male and Female|2007
0.3|0.5|0.4|32|VIIIb Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007
2.7|3.5|3.1|256|VIIIc Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.4|33|VIIId Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007
0.1|0.4|0.2|20|VIIIe Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007
1.6|2.2|1.9|155|VIIa Hepatoblastoma and mesenchymal tumors of liver|82749431|0-19|All Races|Male and Female|2007
0.4|0.8|0.6|51|VIIb Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007
5.7|6.8|6.2|512|VIa Nephroblastoma and other non-epithelial renal tumors|82749431|0-19|All Races|Male and Female|2007
0.5|0.9|0.7|55|VIb Renal carcinomas|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|VIc Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007
10.5|11.9|11.2|958|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82749431|0-19|All Races|Male and Female|2007
16.9|18.7|17.7|1525|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82749431|0-19|All Races|Male and Female|2007
0.6|1.0|0.8|69|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82749431|0-19|All Races|Male and Female|2007
0.3|0.5|0.4|31|XIIa Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.4|38|XIIb Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|XIa Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007
6.9|8.1|7.5|645|XIb Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007
0.5|0.8|0.6|52|XIc Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007
4.9|5.9|5.4|462|XId Malignant melanomas|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|XIe Skin carcinomas|82749431|0-19|All Races|Male and Female|2007
3.6|4.4|4.0|342|XIf Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007
1.3|1.9|1.6|131|Xa Intracranial and intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007
1.1|1.7|1.4|118|Xb Malignant extracranial and extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007
7.0|8.1|7.5|650|Xc Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007
0.3|0.5|0.4|33|Xd Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007
0.2|0.4|0.3|26|Xe Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007
176.5|182.3|179.4|15058|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008
47.4|50.4|48.9|4061|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83118264|0-19|All Races|Male and Female|2008
24.4|26.5|25.4|2152|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83118264|0-19|All Races|Male and Female|2008
31.4|33.8|32.6|2697|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83118264|0-19|All Races|Male and Female|2008
2.1|2.7|2.4|197|IIIa Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008
15.7|17.4|16.5|1369|IIIb Astrocytomas|83118264|0-19|All Races|Male and Female|2008
6.2|7.3|6.8|558|IIIc Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008
5.3|6.4|5.8|481|IIId Other gliomas|83118264|0-19|All Races|Male and Female|2008
0.5|0.9|0.7|60|IIIe Other specified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008
0.3|0.5|0.4|32|IIIf Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008
12.2|13.7|12.9|1104|IIa Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008
8.1|9.4|8.7|732|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008
2.2|2.9|2.6|212|IIc Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008
0.7|1.2|0.9|78|IId Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008
7.8|9.1|8.4|707|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83118264|0-19|All Races|Male and Female|2008
7.5|8.7|8.1|678|IVa Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008
0.2|0.5|0.3|29|IVb Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008
11.5|13.0|12.3|1030|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83118264|0-19|All Races|Male and Female|2008
4.5|5.5|5.0|414|IXa Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008
0.9|1.4|1.2|98|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|IXc Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008
4.2|5.1|4.6|391|IXd Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008
1.2|1.8|1.5|125|IXe Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008
33.7|36.2|34.9|2888|Ia Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008
7.8|9.1|8.4|707|Ib Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008
2.5|3.3|2.9|245|Ic Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008
1.3|1.9|1.6|134|Id Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008
0.8|1.3|1.0|87|Ie Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008
0.3|0.5|0.4|32|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008
2.8|3.6|3.2|268|V RETINOBLASTOMA|83118264|0-19|All Races|Male and Female|2008
6.6|7.8|7.2|600|VI RENAL TUMORS|83118264|0-19|All Races|Male and Female|2008
2.1|2.8|2.4|202|VII HEPATIC TUMORS|83118264|0-19|All Races|Male and Female|2008
8.2|9.5|8.8|740|VIII MALIGNANT BONE TUMORS|83118264|0-19|All Races|Male and Female|2008
4.5|5.5|5.0|415|VIIIa Osteosarcomas|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|36|VIIIb Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008
2.4|3.2|2.8|232|VIIIc Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|35|VIIId Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008
0.2|0.4|0.3|22|VIIIe Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008
1.6|2.2|1.9|156|VIIa Hepatoblastoma and mesenchymal tumors of liver|83118264|0-19|All Races|Male and Female|2008
0.4|0.7|0.5|45|VIIb Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008
5.9|7.0|6.5|536|VIa Nephroblastoma and other non-epithelial renal tumors|83118264|0-19|All Races|Male and Female|2008
0.6|0.9|0.7|62|VIb Renal carcinomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|VIc Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008
10.3|11.7|11.0|945|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83118264|0-19|All Races|Male and Female|2008
17.2|19.0|18.0|1555|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83118264|0-19|All Races|Male and Female|2008
0.6|1.0|0.8|69|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|36|XIIa Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008
0.3|0.5|0.4|33|XIIb Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008
0.1|0.4|0.2|20|XIa Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008
7.6|8.8|8.2|708|XIb Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008
0.4|0.7|0.5|46|XIc Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008
4.4|5.3|4.8|416|XId Malignant melanomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|XIe Skin carcinomas|83118264|0-19|All Races|Male and Female|2008
3.8|4.6|4.2|360|XIf Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008
1.5|2.0|1.7|146|Xa Intracranial and intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008
1.2|1.7|1.4|124|Xb Malignant extracranial and extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008
6.7|7.8|7.3|630|Xc Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008
0.2|0.5|0.3|30|Xd Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008
175.9|181.6|178.7|15015|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009
45.9|48.9|47.4|3949|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83280391|0-19|All Races|Male and Female|2009
24.4|26.5|25.4|2155|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83280391|0-19|All Races|Male and Female|2009
31.1|33.6|32.4|2683|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83280391|0-19|All Races|Male and Female|2009
2.1|2.8|2.4|204|IIIa Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009
15.6|17.3|16.4|1364|IIIb Astrocytomas|83280391|0-19|All Races|Male and Female|2009
5.8|6.9|6.4|526|IIIc Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009
5.6|6.7|6.1|506|IIId Other gliomas|83280391|0-19|All Races|Male and Female|2009
0.4|0.8|0.6|48|IIIe Other specified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009
0.3|0.6|0.4|35|IIIf Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009
11.9|13.5|12.7|1088|IIa Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009
8.2|9.5|8.8|742|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009
1.9|2.6|2.2|184|IIc Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009
1.1|1.7|1.4|115|IId Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009
7.7|9.0|8.3|694|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83280391|0-19|All Races|Male and Female|2009
7.4|8.7|8.0|669|IVa Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009
0.2|0.4|0.3|25|IVb Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009
11.4|12.9|12.1|1017|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83280391|0-19|All Races|Male and Female|2009
3.8|4.6|4.2|349|IXa Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009
1.3|1.9|1.6|136|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|IXc Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009
4.4|5.3|4.8|409|IXd Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009
1.1|1.7|1.4|116|IXe Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009
33.4|36.0|34.7|2880|Ia Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009
7.1|8.3|7.7|644|Ib Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009
2.1|2.8|2.4|205|Ic Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009
1.3|1.9|1.6|132|Id Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009
0.8|1.3|1.1|88|Ie Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009
0.3|0.5|0.4|32|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009
3.0|3.8|3.4|285|V RETINOBLASTOMA|83280391|0-19|All Races|Male and Female|2009
6.8|8.0|7.4|616|VI RENAL TUMORS|83280391|0-19|All Races|Male and Female|2009
1.8|2.5|2.1|180|VII HEPATIC TUMORS|83280391|0-19|All Races|Male and Female|2009
8.4|9.7|9.0|759|VIII MALIGNANT BONE TUMORS|83280391|0-19|All Races|Male and Female|2009
4.6|5.6|5.1|424|VIIIa Osteosarcomas|83280391|0-19|All Races|Male and Female|2009
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009
2.6|3.3|2.9|247|VIIIc Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009
0.1|0.3|0.2|17|VIIIe Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009
1.3|1.8|1.5|129|VIIa Hepatoblastoma and mesenchymal tumors of liver|83280391|0-19|All Races|Male and Female|2009
0.4|0.8|0.6|49|VIIb Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009
6.0|7.2|6.6|548|VIa Nephroblastoma and other non-epithelial renal tumors|83280391|0-19|All Races|Male and Female|2009
0.6|1.0|0.8|67|VIb Renal carcinomas|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|VIc Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009
10.9|12.3|11.6|995|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83280391|0-19|All Races|Male and Female|2009
17.3|19.1|18.2|1567|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83280391|0-19|All Races|Male and Female|2009
0.8|1.2|1.0|83|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83280391|0-19|All Races|Male and Female|2009
0.3|0.6|0.5|39|XIIa Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009
0.4|0.7|0.5|44|XIIb Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009
0.2|0.4|0.3|23|XIa Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009
7.8|9.0|8.4|724|XIb Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009
0.5|0.9|0.7|60|XIc Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009
3.9|4.8|4.4|377|XId Malignant melanomas|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|XIe Skin carcinomas|83280391|0-19|All Races|Male and Female|2009
3.9|4.8|4.3|372|XIf Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009
1.4|2.0|1.7|142|Xa Intracranial and intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009
1.1|1.6|1.4|116|Xb Malignant extracranial and extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009
7.0|8.2|7.6|658|Xc Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009
0.4|0.8|0.6|51|Xd Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009
0.2|0.5|0.3|28|Xe Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009
180.0|185.8|182.9|15320|All ICCC Groups Combined|83225072|0-19|All Races|Male and Female|2010
47.2|50.2|48.7|4054|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83225072|0-19|All Races|Male and Female|2010
27.0|29.3|28.2|2373|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83225072|0-19|All Races|Male and Female|2010
31.6|34.1|32.8|2720|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83225072|0-19|All Races|Male and Female|2010
2.5|3.2|2.9|238|IIIa Ependymomas and choroid plexus tumor|83225072|0-19|All Races|Male and Female|2010
16.4|18.2|17.3|1433|IIIb Astrocytomas|83225072|0-19|All Races|Male and Female|2010
5.6|6.6|6.1|503|IIIc Intracranial and intraspinal embryonal tumors|83225072|0-19|All Races|Male and Female|2010
5.2|6.2|5.7|469|IIId Other gliomas|83225072|0-19|All Races|Male and Female|2010
0.5|0.8|0.6|51|IIIe Other specified intracranial and intraspinal neoplasms|83225072|0-19|All Races|Male and Female|2010
0.2|0.5|0.3|26|IIIf Unspecified intracranial and intraspinal neoplasms|83225072|0-19|All Races|Male and Female|2010
11.4|12.9|12.1|1037|IIa Hodgkin lymphomas|83225072|0-19|All Races|Male and Female|2010
8.5|9.8|9.2|767|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83225072|0-19|All Races|Male and Female|2010
2.1|2.7|2.4|198|IIc Burkitt lymphoma|83225072|0-19|All Races|Male and Female|2010
3.7|4.6|4.1|340|IId Miscellaneous lymphoreticular neoplasms|83225072|0-19|All Races|Male and Female|2010
0.2|0.5|0.4|31|IIe Unspecified lymphomas|83225072|0-19|All Races|Male and Female|2010
8.0|9.3|8.6|717|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83225072|0-19|All Races|Male and Female|2010
7.8|9.1|8.4|698|IVa Neuroblastoma and ganglioneuroblastoma|83225072|0-19|All Races|Male and Female|2010
0.1|0.4|0.2|19|IVb Other peripheral nervous cell tumors|83225072|0-19|All Races|Male and Female|2010
11.7|13.2|12.4|1040|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83225072|0-19|All Races|Male and Female|2010
4.6|5.5|5.0|419|IXa Rhabdomyosarcomas|83225072|0-19|All Races|Male and Female|2010
0.8|1.3|1.1|89|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83225072|0-19|All Races|Male and Female|2010
~|~|~|~|IXc Kaposi sarcoma|83225072|0-19|All Races|Male and Female|2010
4.1|5.1|4.6|384|IXd Other specified soft tissue sarcomas|83225072|0-19|All Races|Male and Female|2010
1.4|2.0|1.7|144|IXe Unspecified soft tissue sarcomas|83225072|0-19|All Races|Male and Female|2010
33.4|36.0|34.7|2879|Ia Lymphoid leukemias|83225072|0-19|All Races|Male and Female|2010
7.9|9.2|8.5|713|Ib Acute myeloid leukemias|83225072|0-19|All Races|Male and Female|2010
2.4|3.1|2.7|230|Ic Chronic myeloproliferative diseases|83225072|0-19|All Races|Male and Female|2010
1.5|2.1|1.8|152|Id Myelodysplastic syndrome and other myeloproliferative diseases|83225072|0-19|All Races|Male and Female|2010
0.8|1.2|1.0|80|Ie Unspecified and other specified leukemias|83225072|0-19|All Races|Male and Female|2010
0.2|0.5|0.4|31|Not classified by ICCC|83225072|0-19|All Races|Male and Female|2010
3.0|3.8|3.4|282|V RETINOBLASTOMA|83225072|0-19|All Races|Male and Female|2010
6.1|7.2|6.6|553|VI RENAL TUMORS|83225072|0-19|All Races|Male and Female|2010
2.6|3.4|3.0|249|VII HEPATIC TUMORS|83225072|0-19|All Races|Male and Female|2010
7.8|9.1|8.4|704|VIII MALIGNANT BONE TUMORS|83225072|0-19|All Races|Male and Female|2010
4.3|5.2|4.7|397|VIIIa Osteosarcomas|83225072|0-19|All Races|Male and Female|2010
0.3|0.6|0.4|34|VIIIb Chondrosarcomas|83225072|0-19|All Races|Male and Female|2010
2.3|3.0|2.6|220|VIIIc Ewing tumor and related sarcomas of bone|83225072|0-19|All Races|Male and Female|2010
0.3|0.6|0.5|38|VIIId Other specified malignant bone tumors|83225072|0-19|All Races|Male and Female|2010
~|~|~|~|VIIIe Unspecified malignant bone tumors|83225072|0-19|All Races|Male and Female|2010
1.9|2.6|2.3|187|VIIa Hepatoblastoma and mesenchymal tumors of liver|83225072|0-19|All Races|Male and Female|2010
0.5|0.9|0.7|60|VIIb Hepatic carcinomas|83225072|0-19|All Races|Male and Female|2010
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83225072|0-19|All Races|Male and Female|2010
5.6|6.7|6.1|510|VIa Nephroblastoma and other non-epithelial renal tumors|83225072|0-19|All Races|Male and Female|2010
0.4|0.7|0.5|42|VIb Renal carcinomas|83225072|0-19|All Races|Male and Female|2010
~|~|~|~|VIc Unspecified malignant renal tumors|83225072|0-19|All Races|Male and Female|2010
10.9|12.3|11.6|987|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83225072|0-19|All Races|Male and Female|2010
17.1|18.9|18.0|1538|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83225072|0-19|All Races|Male and Female|2010
0.7|1.1|0.9|72|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83225072|0-19|All Races|Male and Female|2010
0.4|0.7|0.6|47|XIIa Other specified malignant tumors|83225072|0-19|All Races|Male and Female|2010
0.2|0.4|0.3|25|XIIb Other unspecified malignant tumors|83225072|0-19|All Races|Male and Female|2010
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|83225072|0-19|All Races|Male and Female|2010
8.1|9.3|8.7|746|XIb Thyroid carcinomas|83225072|0-19|All Races|Male and Female|2010
0.4|0.8|0.6|49|XIc Nasopharyngeal carcinomas|83225072|0-19|All Races|Male and Female|2010
3.6|4.5|4.0|346|XId Malignant melanomas|83225072|0-19|All Races|Male and Female|2010
~|~|~|~|XIe Skin carcinomas|83225072|0-19|All Races|Male and Female|2010
3.8|4.7|4.3|366|XIf Other and unspecified carcinomas|83225072|0-19|All Races|Male and Female|2010
1.7|2.3|2.0|167|Xa Intracranial and intraspinal germ cell tumors|83225072|0-19|All Races|Male and Female|2010
1.1|1.6|1.3|112|Xb Malignant extracranial and extragonadal germ cell tumors|83225072|0-19|All Races|Male and Female|2010
6.8|7.9|7.3|631|Xc Malignant gonadal germ cell tumors|83225072|0-19|All Races|Male and Female|2010
0.4|0.7|0.5|42|Xd Gonadal carcinomas|83225072|0-19|All Races|Male and Female|2010
0.3|0.6|0.4|35|Xe Other and unspecified malignant gonadal tumors|83225072|0-19|All Races|Male and Female|2010
181.7|187.5|184.6|15414|All ICCC Groups Combined|83042807|0-19|All Races|Male and Female|2011
47.3|50.4|48.8|4057|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83042807|0-19|All Races|Male and Female|2011
27.4|29.7|28.5|2395|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83042807|0-19|All Races|Male and Female|2011
32.4|34.9|33.6|2788|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83042807|0-19|All Races|Male and Female|2011
2.5|3.2|2.8|234|IIIa Ependymomas and choroid plexus tumor|83042807|0-19|All Races|Male and Female|2011
16.7|18.6|17.6|1463|IIIb Astrocytomas|83042807|0-19|All Races|Male and Female|2011
5.7|6.7|6.2|512|IIIc Intracranial and intraspinal embryonal tumors|83042807|0-19|All Races|Male and Female|2011
5.5|6.6|6.0|497|IIId Other gliomas|83042807|0-19|All Races|Male and Female|2011
0.4|0.8|0.6|50|IIIe Other specified intracranial and intraspinal neoplasms|83042807|0-19|All Races|Male and Female|2011
0.3|0.5|0.4|32|IIIf Unspecified intracranial and intraspinal neoplasms|83042807|0-19|All Races|Male and Female|2011
11.2|12.6|11.9|1008|IIa Hodgkin lymphomas|83042807|0-19|All Races|Male and Female|2011
8.3|9.6|8.9|749|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83042807|0-19|All Races|Male and Female|2011
2.2|2.9|2.5|208|IIc Burkitt lymphoma|83042807|0-19|All Races|Male and Female|2011
4.4|5.4|4.9|402|IId Miscellaneous lymphoreticular neoplasms|83042807|0-19|All Races|Male and Female|2011
0.2|0.5|0.3|28|IIe Unspecified lymphomas|83042807|0-19|All Races|Male and Female|2011
8.1|9.3|8.7|719|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83042807|0-19|All Races|Male and Female|2011
7.8|9.1|8.4|697|IVa Neuroblastoma and ganglioneuroblastoma|83042807|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|22|IVb Other peripheral nervous cell tumors|83042807|0-19|All Races|Male and Female|2011
11.1|12.6|11.9|990|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83042807|0-19|All Races|Male and Female|2011
4.0|5.0|4.5|373|IXa Rhabdomyosarcomas|83042807|0-19|All Races|Male and Female|2011
1.1|1.6|1.3|111|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83042807|0-19|All Races|Male and Female|2011
~|~|~|~|IXc Kaposi sarcoma|83042807|0-19|All Races|Male and Female|2011
4.2|5.2|4.7|393|IXd Other specified soft tissue sarcomas|83042807|0-19|All Races|Male and Female|2011
1.0|1.5|1.3|106|IXe Unspecified soft tissue sarcomas|83042807|0-19|All Races|Male and Female|2011
34.5|37.1|35.8|2966|Ia Lymphoid leukemias|83042807|0-19|All Races|Male and Female|2011
7.8|9.1|8.4|705|Ib Acute myeloid leukemias|83042807|0-19|All Races|Male and Female|2011
2.2|2.9|2.5|211|Ic Chronic myeloproliferative diseases|83042807|0-19|All Races|Male and Female|2011
1.0|1.5|1.3|106|Id Myelodysplastic syndrome and other myeloproliferative diseases|83042807|0-19|All Races|Male and Female|2011
0.6|1.1|0.8|69|Ie Unspecified and other specified leukemias|83042807|0-19|All Races|Male and Female|2011
0.3|0.5|0.4|33|Not classified by ICCC|83042807|0-19|All Races|Male and Female|2011
2.8|3.5|3.1|260|V RETINOBLASTOMA|83042807|0-19|All Races|Male and Female|2011
6.6|7.8|7.2|596|VI RENAL TUMORS|83042807|0-19|All Races|Male and Female|2011
2.5|3.3|2.9|238|VII HEPATIC TUMORS|83042807|0-19|All Races|Male and Female|2011
8.3|9.6|8.9|746|VIII MALIGNANT BONE TUMORS|83042807|0-19|All Races|Male and Female|2011
4.6|5.6|5.1|422|VIIIa Osteosarcomas|83042807|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|24|VIIIb Chondrosarcomas|83042807|0-19|All Races|Male and Female|2011
2.8|3.5|3.1|260|VIIIc Ewing tumor and related sarcomas of bone|83042807|0-19|All Races|Male and Female|2011
0.2|0.5|0.3|27|VIIId Other specified malignant bone tumors|83042807|0-19|All Races|Male and Female|2011
~|~|~|~|VIIIe Unspecified malignant bone tumors|83042807|0-19|All Races|Male and Female|2011
2.0|2.7|2.3|191|VIIa Hepatoblastoma and mesenchymal tumors of liver|83042807|0-19|All Races|Male and Female|2011
0.4|0.7|0.5|44|VIIb Hepatic carcinomas|83042807|0-19|All Races|Male and Female|2011
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83042807|0-19|All Races|Male and Female|2011
6.0|7.1|6.5|539|VIa Nephroblastoma and other non-epithelial renal tumors|83042807|0-19|All Races|Male and Female|2011
0.5|0.9|0.7|56|VIb Renal carcinomas|83042807|0-19|All Races|Male and Female|2011
~|~|~|~|VIc Unspecified malignant renal tumors|83042807|0-19|All Races|Male and Female|2011
10.1|11.5|10.8|917|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83042807|0-19|All Races|Male and Female|2011
18.0|19.9|19.0|1611|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83042807|0-19|All Races|Male and Female|2011
0.6|1.0|0.8|64|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83042807|0-19|All Races|Male and Female|2011
0.3|0.6|0.4|34|XIIa Other specified malignant tumors|83042807|0-19|All Races|Male and Female|2011
0.2|0.5|0.4|30|XIIb Other unspecified malignant tumors|83042807|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|22|XIa Adrenocortical carcinomas|83042807|0-19|All Races|Male and Female|2011
8.8|10.1|9.4|804|XIb Thyroid carcinomas|83042807|0-19|All Races|Male and Female|2011
0.5|0.8|0.6|52|XIc Nasopharyngeal carcinomas|83042807|0-19|All Races|Male and Female|2011
3.8|4.7|4.3|361|XId Malignant melanomas|83042807|0-19|All Races|Male and Female|2011
~|~|~|~|XIe Skin carcinomas|83042807|0-19|All Races|Male and Female|2011
3.8|4.7|4.3|362|XIf Other and unspecified carcinomas|83042807|0-19|All Races|Male and Female|2011
1.4|2.0|1.7|139|Xa Intracranial and intraspinal germ cell tumors|83042807|0-19|All Races|Male and Female|2011
1.2|1.7|1.4|117|Xb Malignant extracranial and extragonadal germ cell tumors|83042807|0-19|All Races|Male and Female|2011
6.6|7.8|7.2|615|Xc Malignant gonadal germ cell tumors|83042807|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|24|Xd Gonadal carcinomas|83042807|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|22|Xe Other and unspecified malignant gonadal tumors|83042807|0-19|All Races|Male and Female|2011
182.7|188.5|185.6|15444|All ICCC Groups Combined|82869473|0-19|All Races|Male and Female|2012
45.8|48.7|47.2|3915|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82869473|0-19|All Races|Male and Female|2012
29.2|31.6|30.4|2541|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82869473|0-19|All Races|Male and Female|2012
31.5|33.9|32.7|2703|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82869473|0-19|All Races|Male and Female|2012
2.4|3.1|2.7|225|IIIa Ependymomas and choroid plexus tumor|82869473|0-19|All Races|Male and Female|2012
16.8|18.6|17.7|1461|IIIb Astrocytomas|82869473|0-19|All Races|Male and Female|2012
5.3|6.4|5.8|480|IIIc Intracranial and intraspinal embryonal tumors|82869473|0-19|All Races|Male and Female|2012
4.8|5.8|5.3|440|IIId Other gliomas|82869473|0-19|All Races|Male and Female|2012
0.4|0.8|0.6|47|IIIe Other specified intracranial and intraspinal neoplasms|82869473|0-19|All Races|Male and Female|2012
0.4|0.8|0.6|50|IIIf Unspecified intracranial and intraspinal neoplasms|82869473|0-19|All Races|Male and Female|2012
11.7|13.2|12.5|1049|IIa Hodgkin lymphomas|82869473|0-19|All Races|Male and Female|2012
9.7|11.0|10.3|862|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82869473|0-19|All Races|Male and Female|2012
2.0|2.7|2.3|191|IIc Burkitt lymphoma|82869473|0-19|All Races|Male and Female|2012
4.4|5.4|4.9|401|IId Miscellaneous lymphoreticular neoplasms|82869473|0-19|All Races|Male and Female|2012
0.3|0.6|0.5|38|IIe Unspecified lymphomas|82869473|0-19|All Races|Male and Female|2012
8.1|9.4|8.8|723|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82869473|0-19|All Races|Male and Female|2012
7.9|9.2|8.5|702|IVa Neuroblastoma and ganglioneuroblastoma|82869473|0-19|All Races|Male and Female|2012
0.2|0.4|0.3|21|IVb Other peripheral nervous cell tumors|82869473|0-19|All Races|Male and Female|2012
11.0|12.4|11.7|970|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82869473|0-19|All Races|Male and Female|2012
4.0|4.9|4.5|369|IXa Rhabdomyosarcomas|82869473|0-19|All Races|Male and Female|2012
1.0|1.5|1.2|102|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82869473|0-19|All Races|Male and Female|2012
~|~|~|~|IXc Kaposi sarcoma|82869473|0-19|All Races|Male and Female|2012
4.0|5.0|4.5|374|IXd Other specified soft tissue sarcomas|82869473|0-19|All Races|Male and Female|2012
1.2|1.7|1.4|120|IXe Unspecified soft tissue sarcomas|82869473|0-19|All Races|Male and Female|2012
32.9|35.4|34.1|2825|Ia Lymphoid leukemias|82869473|0-19|All Races|Male and Female|2012
7.3|8.5|7.9|654|Ib Acute myeloid leukemias|82869473|0-19|All Races|Male and Female|2012
2.3|3.0|2.6|221|Ic Chronic myeloproliferative diseases|82869473|0-19|All Races|Male and Female|2012
1.2|1.8|1.5|124|Id Myelodysplastic syndrome and other myeloproliferative diseases|82869473|0-19|All Races|Male and Female|2012
0.9|1.3|1.1|91|Ie Unspecified and other specified leukemias|82869473|0-19|All Races|Male and Female|2012
0.3|0.6|0.5|40|Not classified by ICCC|82869473|0-19|All Races|Male and Female|2012
2.9|3.7|3.3|271|V RETINOBLASTOMA|82869473|0-19|All Races|Male and Female|2012
6.5|7.6|7.0|580|VI RENAL TUMORS|82869473|0-19|All Races|Male and Female|2012
2.6|3.3|2.9|244|VII HEPATIC TUMORS|82869473|0-19|All Races|Male and Female|2012
8.4|9.7|9.1|754|VIII MALIGNANT BONE TUMORS|82869473|0-19|All Races|Male and Female|2012
4.7|5.7|5.2|432|VIIIa Osteosarcomas|82869473|0-19|All Races|Male and Female|2012
0.2|0.5|0.4|30|VIIIb Chondrosarcomas|82869473|0-19|All Races|Male and Female|2012
2.5|3.2|2.8|237|VIIIc Ewing tumor and related sarcomas of bone|82869473|0-19|All Races|Male and Female|2012
0.3|0.6|0.4|37|VIIId Other specified malignant bone tumors|82869473|0-19|All Races|Male and Female|2012
0.1|0.3|0.2|18|VIIIe Unspecified malignant bone tumors|82869473|0-19|All Races|Male and Female|2012
2.0|2.7|2.3|190|VIIa Hepatoblastoma and mesenchymal tumors of liver|82869473|0-19|All Races|Male and Female|2012
0.5|0.8|0.6|52|VIIb Hepatic carcinomas|82869473|0-19|All Races|Male and Female|2012
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82869473|0-19|All Races|Male and Female|2012
5.7|6.8|6.3|517|VIa Nephroblastoma and other non-epithelial renal tumors|82869473|0-19|All Races|Male and Female|2012
0.5|0.9|0.7|58|VIb Renal carcinomas|82869473|0-19|All Races|Male and Female|2012
~|~|~|~|VIc Unspecified malignant renal tumors|82869473|0-19|All Races|Male and Female|2012
11.0|12.4|11.7|985|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82869473|0-19|All Races|Male and Female|2012
18.4|20.3|19.4|1635|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82869473|0-19|All Races|Male and Female|2012
0.8|1.2|1.0|83|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82869473|0-19|All Races|Male and Female|2012
0.3|0.7|0.5|40|XIIa Other specified malignant tumors|82869473|0-19|All Races|Male and Female|2012
0.4|0.7|0.5|43|XIIb Other unspecified malignant tumors|82869473|0-19|All Races|Male and Female|2012
0.2|0.4|0.3|22|XIa Adrenocortical carcinomas|82869473|0-19|All Races|Male and Female|2012
9.0|10.4|9.7|820|XIb Thyroid carcinomas|82869473|0-19|All Races|Male and Female|2012
0.3|0.6|0.5|38|XIc Nasopharyngeal carcinomas|82869473|0-19|All Races|Male and Female|2012
3.8|4.7|4.2|354|XId Malignant melanomas|82869473|0-19|All Races|Male and Female|2012
~|~|~|~|XIe Skin carcinomas|82869473|0-19|All Races|Male and Female|2012
4.2|5.1|4.6|392|XIf Other and unspecified carcinomas|82869473|0-19|All Races|Male and Female|2012
1.3|1.9|1.6|130|Xa Intracranial and intraspinal germ cell tumors|82869473|0-19|All Races|Male and Female|2012
1.4|2.0|1.7|143|Xb Malignant extracranial and extragonadal germ cell tumors|82869473|0-19|All Races|Male and Female|2012
7.1|8.3|7.7|649|Xc Malignant gonadal germ cell tumors|82869473|0-19|All Races|Male and Female|2012
0.3|0.6|0.4|36|Xd Gonadal carcinomas|82869473|0-19|All Races|Male and Female|2012
0.2|0.5|0.3|27|Xe Other and unspecified malignant gonadal tumors|82869473|0-19|All Races|Male and Female|2012
181.8|187.6|184.7|15326|All ICCC Groups Combined|82802400|0-19|All Races|Male and Female|2013
45.0|47.9|46.4|3839|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82802400|0-19|All Races|Male and Female|2013
27.7|30.0|28.8|2402|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82802400|0-19|All Races|Male and Female|2013
32.2|34.7|33.5|2765|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82802400|0-19|All Races|Male and Female|2013
2.3|3.1|2.7|221|IIIa Ependymomas and choroid plexus tumor|82802400|0-19|All Races|Male and Female|2013
17.1|19.0|18.0|1490|IIIb Astrocytomas|82802400|0-19|All Races|Male and Female|2013
5.2|6.3|5.7|473|IIIc Intracranial and intraspinal embryonal tumors|82802400|0-19|All Races|Male and Female|2013
5.3|6.3|5.8|477|IIId Other gliomas|82802400|0-19|All Races|Male and Female|2013
0.6|0.9|0.7|61|IIIe Other specified intracranial and intraspinal neoplasms|82802400|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|43|IIIf Unspecified intracranial and intraspinal neoplasms|82802400|0-19|All Races|Male and Female|2013
10.8|12.3|11.5|967|IIa Hodgkin lymphomas|82802400|0-19|All Races|Male and Female|2013
8.9|10.2|9.6|795|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82802400|0-19|All Races|Male and Female|2013
2.0|2.7|2.3|192|IIc Burkitt lymphoma|82802400|0-19|All Races|Male and Female|2013
4.6|5.6|5.1|419|IId Miscellaneous lymphoreticular neoplasms|82802400|0-19|All Races|Male and Female|2013
0.2|0.5|0.3|29|IIe Unspecified lymphomas|82802400|0-19|All Races|Male and Female|2013
8.7|10.1|9.4|772|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82802400|0-19|All Races|Male and Female|2013
8.4|9.7|9.1|745|IVa Neuroblastoma and ganglioneuroblastoma|82802400|0-19|All Races|Male and Female|2013
0.2|0.5|0.3|27|IVb Other peripheral nervous cell tumors|82802400|0-19|All Races|Male and Female|2013
11.0|12.5|11.7|971|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82802400|0-19|All Races|Male and Female|2013
4.2|5.1|4.7|385|IXa Rhabdomyosarcomas|82802400|0-19|All Races|Male and Female|2013
1.0|1.5|1.3|105|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82802400|0-19|All Races|Male and Female|2013
~|~|~|~|IXc Kaposi sarcoma|82802400|0-19|All Races|Male and Female|2013
4.1|5.0|4.5|377|IXd Other specified soft tissue sarcomas|82802400|0-19|All Races|Male and Female|2013
1.0|1.5|1.2|103|IXe Unspecified soft tissue sarcomas|82802400|0-19|All Races|Male and Female|2013
31.4|33.9|32.7|2696|Ia Lymphoid leukemias|82802400|0-19|All Races|Male and Female|2013
7.8|9.0|8.4|696|Ib Acute myeloid leukemias|82802400|0-19|All Races|Male and Female|2013
2.2|2.8|2.5|207|Ic Chronic myeloproliferative diseases|82802400|0-19|All Races|Male and Female|2013
1.4|2.0|1.7|139|Id Myelodysplastic syndrome and other myeloproliferative diseases|82802400|0-19|All Races|Male and Female|2013
1.0|1.5|1.2|101|Ie Unspecified and other specified leukemias|82802400|0-19|All Races|Male and Female|2013
0.3|0.6|0.4|33|Not classified by ICCC|82802400|0-19|All Races|Male and Female|2013
2.9|3.7|3.2|266|V RETINOBLASTOMA|82802400|0-19|All Races|Male and Female|2013
6.7|7.9|7.3|603|VI RENAL TUMORS|82802400|0-19|All Races|Male and Female|2013
2.3|3.0|2.6|214|VII HEPATIC TUMORS|82802400|0-19|All Races|Male and Female|2013
8.5|9.9|9.2|764|VIII MALIGNANT BONE TUMORS|82802400|0-19|All Races|Male and Female|2013
4.5|5.5|5.0|414|VIIIa Osteosarcomas|82802400|0-19|All Races|Male and Female|2013
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|82802400|0-19|All Races|Male and Female|2013
2.8|3.6|3.2|262|VIIIc Ewing tumor and related sarcomas of bone|82802400|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|45|VIIId Other specified malignant bone tumors|82802400|0-19|All Races|Male and Female|2013
~|~|~|~|VIIIe Unspecified malignant bone tumors|82802400|0-19|All Races|Male and Female|2013
1.6|2.3|1.9|159|VIIa Hepatoblastoma and mesenchymal tumors of liver|82802400|0-19|All Races|Male and Female|2013
0.5|0.8|0.6|53|VIIb Hepatic carcinomas|82802400|0-19|All Races|Male and Female|2013
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82802400|0-19|All Races|Male and Female|2013
5.9|7.0|6.4|529|VIa Nephroblastoma and other non-epithelial renal tumors|82802400|0-19|All Races|Male and Female|2013
0.7|1.1|0.8|71|VIb Renal carcinomas|82802400|0-19|All Races|Male and Female|2013
~|~|~|~|VIc Unspecified malignant renal tumors|82802400|0-19|All Races|Male and Female|2013
11.1|12.6|11.8|990|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82802400|0-19|All Races|Male and Female|2013
18.5|20.4|19.4|1630|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82802400|0-19|All Races|Male and Female|2013
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82802400|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|43|XIIa Other specified malignant tumors|82802400|0-19|All Races|Male and Female|2013
0.3|0.6|0.4|34|XIIb Other unspecified malignant tumors|82802400|0-19|All Races|Male and Female|2013
~|~|~|~|XIa Adrenocortical carcinomas|82802400|0-19|All Races|Male and Female|2013
8.8|10.1|9.4|791|XIb Thyroid carcinomas|82802400|0-19|All Races|Male and Female|2013
0.5|0.8|0.6|52|XIc Nasopharyngeal carcinomas|82802400|0-19|All Races|Male and Female|2013
3.8|4.7|4.2|356|XId Malignant melanomas|82802400|0-19|All Races|Male and Female|2013
~|~|~|~|XIe Skin carcinomas|82802400|0-19|All Races|Male and Female|2013
4.5|5.4|4.9|415|XIf Other and unspecified carcinomas|82802400|0-19|All Races|Male and Female|2013
1.7|2.3|1.9|161|Xa Intracranial and intraspinal germ cell tumors|82802400|0-19|All Races|Male and Female|2013
1.1|1.6|1.4|113|Xb Malignant extracranial and extragonadal germ cell tumors|82802400|0-19|All Races|Male and Female|2013
7.0|8.1|7.5|635|Xc Malignant gonadal germ cell tumors|82802400|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|45|Xd Gonadal carcinomas|82802400|0-19|All Races|Male and Female|2013
0.3|0.6|0.4|36|Xe Other and unspecified malignant gonadal tumors|82802400|0-19|All Races|Male and Female|2013
187.5|193.4|190.4|15810|All ICCC Groups Combined|82834118|0-19|All Races|Male and Female|2014
46.2|49.2|47.7|3943|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82834118|0-19|All Races|Male and Female|2014
30.4|32.8|31.6|2634|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82834118|0-19|All Races|Male and Female|2014
32.4|34.9|33.7|2783|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82834118|0-19|All Races|Male and Female|2014
2.5|3.2|2.8|234|IIIa Ependymomas and choroid plexus tumor|82834118|0-19|All Races|Male and Female|2014
17.0|18.9|17.9|1485|IIIb Astrocytomas|82834118|0-19|All Races|Male and Female|2014
5.6|6.7|6.1|503|IIIc Intracranial and intraspinal embryonal tumors|82834118|0-19|All Races|Male and Female|2014
4.9|5.9|5.4|448|IIId Other gliomas|82834118|0-19|All Races|Male and Female|2014
0.6|1.1|0.8|69|IIIe Other specified intracranial and intraspinal neoplasms|82834118|0-19|All Races|Male and Female|2014
0.4|0.7|0.5|44|IIIf Unspecified intracranial and intraspinal neoplasms|82834118|0-19|All Races|Male and Female|2014
11.1|12.6|11.8|992|IIa Hodgkin lymphomas|82834118|0-19|All Races|Male and Female|2014
10.5|12.0|11.2|935|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82834118|0-19|All Races|Male and Female|2014
2.3|3.0|2.6|219|IIc Burkitt lymphoma|82834118|0-19|All Races|Male and Female|2014
5.0|6.0|5.5|454|IId Miscellaneous lymphoreticular neoplasms|82834118|0-19|All Races|Male and Female|2014
0.3|0.6|0.4|34|IIe Unspecified lymphomas|82834118|0-19|All Races|Male and Female|2014
8.7|10.0|9.4|770|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82834118|0-19|All Races|Male and Female|2014
8.3|9.6|9.0|738|IVa Neuroblastoma and ganglioneuroblastoma|82834118|0-19|All Races|Male and Female|2014
0.3|0.5|0.4|32|IVb Other peripheral nervous cell tumors|82834118|0-19|All Races|Male and Female|2014
11.4|12.9|12.1|1007|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82834118|0-19|All Races|Male and Female|2014
3.8|4.7|4.2|346|IXa Rhabdomyosarcomas|82834118|0-19|All Races|Male and Female|2014
1.3|1.8|1.6|129|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82834118|0-19|All Races|Male and Female|2014
~|~|~|~|IXc Kaposi sarcoma|82834118|0-19|All Races|Male and Female|2014
4.5|5.4|4.9|412|IXd Other specified soft tissue sarcomas|82834118|0-19|All Races|Male and Female|2014
1.1|1.7|1.4|115|IXe Unspecified soft tissue sarcomas|82834118|0-19|All Races|Male and Female|2014
32.4|34.9|33.6|2774|Ia Lymphoid leukemias|82834118|0-19|All Races|Male and Female|2014
8.0|9.3|8.6|717|Ib Acute myeloid leukemias|82834118|0-19|All Races|Male and Female|2014
2.3|3.0|2.6|219|Ic Chronic myeloproliferative diseases|82834118|0-19|All Races|Male and Female|2014
1.3|1.9|1.6|129|Id Myelodysplastic syndrome and other myeloproliferative diseases|82834118|0-19|All Races|Male and Female|2014
1.0|1.5|1.3|104|Ie Unspecified and other specified leukemias|82834118|0-19|All Races|Male and Female|2014
0.3|0.6|0.5|39|Not classified by ICCC|82834118|0-19|All Races|Male and Female|2014
2.8|3.5|3.1|258|V RETINOBLASTOMA|82834118|0-19|All Races|Male and Female|2014
6.7|7.9|7.3|599|VI RENAL TUMORS|82834118|0-19|All Races|Male and Female|2014
2.4|3.1|2.7|225|VII HEPATIC TUMORS|82834118|0-19|All Races|Male and Female|2014
8.7|10.0|9.3|774|VIII MALIGNANT BONE TUMORS|82834118|0-19|All Races|Male and Female|2014
4.6|5.6|5.1|426|VIIIa Osteosarcomas|82834118|0-19|All Races|Male and Female|2014
0.2|0.5|0.4|30|VIIIb Chondrosarcomas|82834118|0-19|All Races|Male and Female|2014
2.7|3.4|3.0|251|VIIIc Ewing tumor and related sarcomas of bone|82834118|0-19|All Races|Male and Female|2014
0.4|0.7|0.6|46|VIIId Other specified malignant bone tumors|82834118|0-19|All Races|Male and Female|2014
0.2|0.4|0.3|21|VIIIe Unspecified malignant bone tumors|82834118|0-19|All Races|Male and Female|2014
1.9|2.5|2.2|179|VIIa Hepatoblastoma and mesenchymal tumors of liver|82834118|0-19|All Races|Male and Female|2014
0.4|0.7|0.5|45|VIIb Hepatic carcinomas|82834118|0-19|All Races|Male and Female|2014
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82834118|0-19|All Races|Male and Female|2014
6.1|7.2|6.6|544|VIa Nephroblastoma and other non-epithelial renal tumors|82834118|0-19|All Races|Male and Female|2014
0.5|0.8|0.6|53|VIb Renal carcinomas|82834118|0-19|All Races|Male and Female|2014
~|~|~|~|VIc Unspecified malignant renal tumors|82834118|0-19|All Races|Male and Female|2014
10.5|11.9|11.2|935|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82834118|0-19|All Races|Male and Female|2014
20.2|22.2|21.2|1780|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82834118|0-19|All Races|Male and Female|2014
0.6|1.0|0.8|63|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82834118|0-19|All Races|Male and Female|2014
0.3|0.6|0.4|36|XIIa Other specified malignant tumors|82834118|0-19|All Races|Male and Female|2014
0.2|0.5|0.3|27|XIIb Other unspecified malignant tumors|82834118|0-19|All Races|Male and Female|2014
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|82834118|0-19|All Races|Male and Female|2014
10.1|11.5|10.7|903|XIb Thyroid carcinomas|82834118|0-19|All Races|Male and Female|2014
0.2|0.5|0.4|30|XIc Nasopharyngeal carcinomas|82834118|0-19|All Races|Male and Female|2014
3.7|4.6|4.1|344|XId Malignant melanomas|82834118|0-19|All Races|Male and Female|2014
~|~|~|~|XIe Skin carcinomas|82834118|0-19|All Races|Male and Female|2014
5.1|6.2|5.6|474|XIf Other and unspecified carcinomas|82834118|0-19|All Races|Male and Female|2014
1.4|1.9|1.6|137|Xa Intracranial and intraspinal germ cell tumors|82834118|0-19|All Races|Male and Female|2014
1.4|2.0|1.7|138|Xb Malignant extracranial and extragonadal germ cell tumors|82834118|0-19|All Races|Male and Female|2014
6.4|7.6|7.0|586|Xc Malignant gonadal germ cell tumors|82834118|0-19|All Races|Male and Female|2014
0.3|0.6|0.5|40|Xd Gonadal carcinomas|82834118|0-19|All Races|Male and Female|2014
0.3|0.6|0.4|34|Xe Other and unspecified malignant gonadal tumors|82834118|0-19|All Races|Male and Female|2014
192.8|198.8|195.8|16292|All ICCC Groups Combined|82981714|0-19|All Races|Male and Female|2015
48.3|51.4|49.8|4129|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82981714|0-19|All Races|Male and Female|2015
30.2|32.7|31.4|2625|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82981714|0-19|All Races|Male and Female|2015
31.7|34.1|32.9|2722|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82981714|0-19|All Races|Male and Female|2015
2.4|3.1|2.7|227|IIIa Ependymomas and choroid plexus tumor|82981714|0-19|All Races|Male and Female|2015
15.9|17.6|16.7|1384|IIIb Astrocytomas|82981714|0-19|All Races|Male and Female|2015
5.6|6.7|6.1|505|IIIc Intracranial and intraspinal embryonal tumors|82981714|0-19|All Races|Male and Female|2015
5.5|6.6|6.0|501|IIId Other gliomas|82981714|0-19|All Races|Male and Female|2015
0.6|1.0|0.8|68|IIIe Other specified intracranial and intraspinal neoplasms|82981714|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|37|IIIf Unspecified intracranial and intraspinal neoplasms|82981714|0-19|All Races|Male and Female|2015
11.5|13.0|12.2|1030|IIa Hodgkin lymphomas|82981714|0-19|All Races|Male and Female|2015
9.9|11.3|10.5|880|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82981714|0-19|All Races|Male and Female|2015
2.1|2.8|2.5|205|IIc Burkitt lymphoma|82981714|0-19|All Races|Male and Female|2015
5.2|6.3|5.8|475|IId Miscellaneous lymphoreticular neoplasms|82981714|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|35|IIe Unspecified lymphomas|82981714|0-19|All Races|Male and Female|2015
8.9|10.2|9.6|789|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82981714|0-19|All Races|Male and Female|2015
8.6|9.9|9.2|762|IVa Neuroblastoma and ganglioneuroblastoma|82981714|0-19|All Races|Male and Female|2015
0.2|0.5|0.3|27|IVb Other peripheral nervous cell tumors|82981714|0-19|All Races|Male and Female|2015
11.4|12.9|12.1|1009|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82981714|0-19|All Races|Male and Female|2015
4.1|5.0|4.5|377|IXa Rhabdomyosarcomas|82981714|0-19|All Races|Male and Female|2015
1.1|1.7|1.4|116|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82981714|0-19|All Races|Male and Female|2015
~|~|~|~|IXc Kaposi sarcoma|82981714|0-19|All Races|Male and Female|2015
4.2|5.1|4.6|388|IXd Other specified soft tissue sarcomas|82981714|0-19|All Races|Male and Female|2015
1.2|1.8|1.5|124|IXe Unspecified soft tissue sarcomas|82981714|0-19|All Races|Male and Female|2015
34.6|37.2|35.9|2968|Ia Lymphoid leukemias|82981714|0-19|All Races|Male and Female|2015
7.9|9.1|8.5|705|Ib Acute myeloid leukemias|82981714|0-19|All Races|Male and Female|2015
2.5|3.2|2.8|236|Ic Chronic myeloproliferative diseases|82981714|0-19|All Races|Male and Female|2015
1.3|1.8|1.5|127|Id Myelodysplastic syndrome and other myeloproliferative diseases|82981714|0-19|All Races|Male and Female|2015
0.9|1.4|1.1|93|Ie Unspecified and other specified leukemias|82981714|0-19|All Races|Male and Female|2015
0.2|0.5|0.4|30|Not classified by ICCC|82981714|0-19|All Races|Male and Female|2015
3.3|4.1|3.7|305|V RETINOBLASTOMA|82981714|0-19|All Races|Male and Female|2015
7.3|8.5|7.9|651|VI RENAL TUMORS|82981714|0-19|All Races|Male and Female|2015
2.7|3.5|3.1|256|VII HEPATIC TUMORS|82981714|0-19|All Races|Male and Female|2015
8.5|9.8|9.1|762|VIII MALIGNANT BONE TUMORS|82981714|0-19|All Races|Male and Female|2015
4.4|5.3|4.8|405|VIIIa Osteosarcomas|82981714|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|33|VIIIb Chondrosarcomas|82981714|0-19|All Races|Male and Female|2015
2.7|3.5|3.1|259|VIIIc Ewing tumor and related sarcomas of bone|82981714|0-19|All Races|Male and Female|2015
0.4|0.7|0.6|46|VIIId Other specified malignant bone tumors|82981714|0-19|All Races|Male and Female|2015
0.1|0.4|0.2|19|VIIIe Unspecified malignant bone tumors|82981714|0-19|All Races|Male and Female|2015
2.1|2.8|2.4|198|VIIa Hepatoblastoma and mesenchymal tumors of liver|82981714|0-19|All Races|Male and Female|2015
0.5|0.9|0.7|56|VIIb Hepatic carcinomas|82981714|0-19|All Races|Male and Female|2015
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82981714|0-19|All Races|Male and Female|2015
6.5|7.7|7.1|582|VIa Nephroblastoma and other non-epithelial renal tumors|82981714|0-19|All Races|Male and Female|2015
0.6|1.0|0.8|67|VIb Renal carcinomas|82981714|0-19|All Races|Male and Female|2015
~|~|~|~|VIc Unspecified malignant renal tumors|82981714|0-19|All Races|Male and Female|2015
10.9|12.3|11.6|975|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82981714|0-19|All Races|Male and Female|2015
22.3|24.3|23.3|1962|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82981714|0-19|All Races|Male and Female|2015
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82981714|0-19|All Races|Male and Female|2015
0.5|0.8|0.6|52|XIIa Other specified malignant tumors|82981714|0-19|All Races|Male and Female|2015
0.2|0.4|0.3|25|XIIb Other unspecified malignant tumors|82981714|0-19|All Races|Male and Female|2015
~|~|~|~|XIa Adrenocortical carcinomas|82981714|0-19|All Races|Male and Female|2015
10.2|11.6|10.8|916|XIb Thyroid carcinomas|82981714|0-19|All Races|Male and Female|2015
0.4|0.8|0.6|51|XIc Nasopharyngeal carcinomas|82981714|0-19|All Races|Male and Female|2015
3.5|4.3|3.9|325|XId Malignant melanomas|82981714|0-19|All Races|Male and Female|2015
~|~|~|~|XIe Skin carcinomas|82981714|0-19|All Races|Male and Female|2015
7.2|8.4|7.7|652|XIf Other and unspecified carcinomas|82981714|0-19|All Races|Male and Female|2015
1.5|2.1|1.8|152|Xa Intracranial and intraspinal germ cell tumors|82981714|0-19|All Races|Male and Female|2015
1.2|1.7|1.4|116|Xb Malignant extracranial and extragonadal germ cell tumors|82981714|0-19|All Races|Male and Female|2015
7.0|8.2|7.6|639|Xc Malignant gonadal germ cell tumors|82981714|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|38|Xd Gonadal carcinomas|82981714|0-19|All Races|Male and Female|2015
0.2|0.5|0.4|30|Xe Other and unspecified malignant gonadal tumors|82981714|0-19|All Races|Male and Female|2015
190.9|196.9|193.9|16181|All ICCC Groups Combined|83193069|0-19|All Races|Male and Female|2016
48.3|51.4|49.8|4137|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83193069|0-19|All Races|Male and Female|2016
29.5|31.8|30.6|2568|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83193069|0-19|All Races|Male and Female|2016
30.9|33.3|32.1|2659|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83193069|0-19|All Races|Male and Female|2016
2.2|2.9|2.5|209|IIIa Ependymomas and choroid plexus tumor|83193069|0-19|All Races|Male and Female|2016
15.2|17.0|16.1|1336|IIIb Astrocytomas|83193069|0-19|All Races|Male and Female|2016
5.1|6.1|5.6|459|IIIc Intracranial and intraspinal embryonal tumors|83193069|0-19|All Races|Male and Female|2016
5.9|7.0|6.4|531|IIId Other gliomas|83193069|0-19|All Races|Male and Female|2016
0.7|1.2|0.9|78|IIIe Other specified intracranial and intraspinal neoplasms|83193069|0-19|All Races|Male and Female|2016
0.4|0.7|0.6|46|IIIf Unspecified intracranial and intraspinal neoplasms|83193069|0-19|All Races|Male and Female|2016
11.6|13.1|12.3|1044|IIa Hodgkin lymphomas|83193069|0-19|All Races|Male and Female|2016
10.1|11.5|10.8|903|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83193069|0-19|All Races|Male and Female|2016
2.1|2.8|2.5|204|IIc Burkitt lymphoma|83193069|0-19|All Races|Male and Female|2016
4.2|5.1|4.6|383|IId Miscellaneous lymphoreticular neoplasms|83193069|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|34|IIe Unspecified lymphomas|83193069|0-19|All Races|Male and Female|2016
8.2|9.5|8.9|731|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83193069|0-19|All Races|Male and Female|2016
8.1|9.4|8.7|717|IVa Neuroblastoma and ganglioneuroblastoma|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|IVb Other peripheral nervous cell tumors|83193069|0-19|All Races|Male and Female|2016
11.5|13.0|12.2|1023|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83193069|0-19|All Races|Male and Female|2016
4.5|5.5|5.0|411|IXa Rhabdomyosarcomas|83193069|0-19|All Races|Male and Female|2016
0.9|1.4|1.1|92|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|IXc Kaposi sarcoma|83193069|0-19|All Races|Male and Female|2016
4.3|5.2|4.7|396|IXd Other specified soft tissue sarcomas|83193069|0-19|All Races|Male and Female|2016
1.2|1.7|1.5|122|IXe Unspecified soft tissue sarcomas|83193069|0-19|All Races|Male and Female|2016
34.5|37.1|35.8|2965|Ia Lymphoid leukemias|83193069|0-19|All Races|Male and Female|2016
8.0|9.3|8.6|718|Ib Acute myeloid leukemias|83193069|0-19|All Races|Male and Female|2016
2.5|3.3|2.9|241|Ic Chronic myeloproliferative diseases|83193069|0-19|All Races|Male and Female|2016
1.2|1.7|1.5|122|Id Myelodysplastic syndrome and other myeloproliferative diseases|83193069|0-19|All Races|Male and Female|2016
0.9|1.3|1.1|91|Ie Unspecified and other specified leukemias|83193069|0-19|All Races|Male and Female|2016
0.2|0.4|0.3|25|Not classified by ICCC|83193069|0-19|All Races|Male and Female|2016
2.8|3.6|3.2|261|V RETINOBLASTOMA|83193069|0-19|All Races|Male and Female|2016
6.4|7.5|6.9|571|VI RENAL TUMORS|83193069|0-19|All Races|Male and Female|2016
2.5|3.3|2.9|239|VII HEPATIC TUMORS|83193069|0-19|All Races|Male and Female|2016
9.2|10.5|9.8|822|VIII MALIGNANT BONE TUMORS|83193069|0-19|All Races|Male and Female|2016
4.7|5.7|5.2|435|VIIIa Osteosarcomas|83193069|0-19|All Races|Male and Female|2016
0.2|0.4|0.3|25|VIIIb Chondrosarcomas|83193069|0-19|All Races|Male and Female|2016
3.1|4.0|3.5|295|VIIIc Ewing tumor and related sarcomas of bone|83193069|0-19|All Races|Male and Female|2016
0.5|0.9|0.7|55|VIIId Other specified malignant bone tumors|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|VIIIe Unspecified malignant bone tumors|83193069|0-19|All Races|Male and Female|2016
2.1|2.8|2.4|199|VIIa Hepatoblastoma and mesenchymal tumors of liver|83193069|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|37|VIIb Hepatic carcinomas|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83193069|0-19|All Races|Male and Female|2016
5.6|6.6|6.1|501|VIa Nephroblastoma and other non-epithelial renal tumors|83193069|0-19|All Races|Male and Female|2016
0.6|1.0|0.8|67|VIb Renal carcinomas|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|VIc Unspecified malignant renal tumors|83193069|0-19|All Races|Male and Female|2016
10.6|12.0|11.3|951|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83193069|0-19|All Races|Male and Female|2016
23.7|25.8|24.7|2092|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83193069|0-19|All Races|Male and Female|2016
1.0|1.5|1.2|102|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83193069|0-19|All Races|Male and Female|2016
0.5|0.9|0.7|59|XIIa Other specified malignant tumors|83193069|0-19|All Races|Male and Female|2016
0.4|0.7|0.5|43|XIIb Other unspecified malignant tumors|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|XIa Adrenocortical carcinomas|83193069|0-19|All Races|Male and Female|2016
10.5|11.9|11.2|950|XIb Thyroid carcinomas|83193069|0-19|All Races|Male and Female|2016
0.2|0.5|0.3|28|XIc Nasopharyngeal carcinomas|83193069|0-19|All Races|Male and Female|2016
3.4|4.3|3.8|324|XId Malignant melanomas|83193069|0-19|All Races|Male and Female|2016
~|~|~|~|XIe Skin carcinomas|83193069|0-19|All Races|Male and Female|2016
8.4|9.7|9.0|763|XIf Other and unspecified carcinomas|83193069|0-19|All Races|Male and Female|2016
1.7|2.4|2.0|169|Xa Intracranial and intraspinal germ cell tumors|83193069|0-19|All Races|Male and Female|2016
1.1|1.6|1.3|109|Xb Malignant extracranial and extragonadal germ cell tumors|83193069|0-19|All Races|Male and Female|2016
6.5|7.7|7.1|600|Xc Malignant gonadal germ cell tumors|83193069|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|36|Xd Gonadal carcinomas|83193069|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|37|Xe Other and unspecified malignant gonadal tumors|83193069|0-19|All Races|Male and Female|2016
186.1|192.0|189.0|15793|All ICCC Groups Combined|83318260|0-19|All Races|Male and Female|2017
45.4|48.3|46.8|3892|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83318260|0-19|All Races|Male and Female|2017
29.4|31.8|30.6|2568|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83318260|0-19|All Races|Male and Female|2017
32.9|35.5|34.2|2840|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83318260|0-19|All Races|Male and Female|2017
2.5|3.3|2.9|241|IIIa Ependymomas and choroid plexus tumor|83318260|0-19|All Races|Male and Female|2017
16.9|18.7|17.8|1482|IIIb Astrocytomas|83318260|0-19|All Races|Male and Female|2017
5.2|6.3|5.7|474|IIIc Intracranial and intraspinal embryonal tumors|83318260|0-19|All Races|Male and Female|2017
6.0|7.1|6.6|546|IIId Other gliomas|83318260|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|49|IIIe Other specified intracranial and intraspinal neoplasms|83318260|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|48|IIIf Unspecified intracranial and intraspinal neoplasms|83318260|0-19|All Races|Male and Female|2017
11.3|12.8|12.0|1018|IIa Hodgkin lymphomas|83318260|0-19|All Races|Male and Female|2017
9.5|10.9|10.2|857|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83318260|0-19|All Races|Male and Female|2017
2.1|2.8|2.5|206|IIc Burkitt lymphoma|83318260|0-19|All Races|Male and Female|2017
5.1|6.1|5.6|461|IId Miscellaneous lymphoreticular neoplasms|83318260|0-19|All Races|Male and Female|2017
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83318260|0-19|All Races|Male and Female|2017
7.9|9.2|8.5|702|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83318260|0-19|All Races|Male and Female|2017
7.7|9.0|8.4|686|IVa Neuroblastoma and ganglioneuroblastoma|83318260|0-19|All Races|Male and Female|2017
0.1|0.3|0.2|16|IVb Other peripheral nervous cell tumors|83318260|0-19|All Races|Male and Female|2017
11.6|13.1|12.3|1031|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83318260|0-19|All Races|Male and Female|2017
4.4|5.3|4.8|403|IXa Rhabdomyosarcomas|83318260|0-19|All Races|Male and Female|2017
0.9|1.3|1.1|91|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83318260|0-19|All Races|Male and Female|2017
~|~|~|~|IXc Kaposi sarcoma|83318260|0-19|All Races|Male and Female|2017
4.1|5.0|4.5|380|IXd Other specified soft tissue sarcomas|83318260|0-19|All Races|Male and Female|2017
1.6|2.2|1.9|155|IXe Unspecified soft tissue sarcomas|83318260|0-19|All Races|Male and Female|2017
32.6|35.1|33.8|2808|Ia Lymphoid leukemias|83318260|0-19|All Races|Male and Female|2017
7.4|8.6|8.0|666|Ib Acute myeloid leukemias|83318260|0-19|All Races|Male and Female|2017
2.4|3.1|2.7|228|Ic Chronic myeloproliferative diseases|83318260|0-19|All Races|Male and Female|2017
1.0|1.5|1.2|99|Id Myelodysplastic syndrome and other myeloproliferative diseases|83318260|0-19|All Races|Male and Female|2017
0.9|1.3|1.1|91|Ie Unspecified and other specified leukemias|83318260|0-19|All Races|Male and Female|2017
0.2|0.5|0.4|31|Not classified by ICCC|83318260|0-19|All Races|Male and Female|2017
2.7|3.5|3.1|253|V RETINOBLASTOMA|83318260|0-19|All Races|Male and Female|2017
6.2|7.3|6.7|556|VI RENAL TUMORS|83318260|0-19|All Races|Male and Female|2017
2.3|3.0|2.7|221|VII HEPATIC TUMORS|83318260|0-19|All Races|Male and Female|2017
8.7|10.0|9.3|787|VIII MALIGNANT BONE TUMORS|83318260|0-19|All Races|Male and Female|2017
4.9|5.9|5.3|450|VIIIa Osteosarcomas|83318260|0-19|All Races|Male and Female|2017
0.2|0.5|0.4|30|VIIIb Chondrosarcomas|83318260|0-19|All Races|Male and Female|2017
2.5|3.3|2.9|242|VIIIc Ewing tumor and related sarcomas of bone|83318260|0-19|All Races|Male and Female|2017
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|83318260|0-19|All Races|Male and Female|2017
0.2|0.4|0.3|23|VIIIe Unspecified malignant bone tumors|83318260|0-19|All Races|Male and Female|2017
1.7|2.4|2.0|168|VIIa Hepatoblastoma and mesenchymal tumors of liver|83318260|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|49|VIIb Hepatic carcinomas|83318260|0-19|All Races|Male and Female|2017
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83318260|0-19|All Races|Male and Female|2017
5.5|6.6|6.0|498|VIa Nephroblastoma and other non-epithelial renal tumors|83318260|0-19|All Races|Male and Female|2017
0.5|0.9|0.7|56|VIb Renal carcinomas|83318260|0-19|All Races|Male and Female|2017
~|~|~|~|VIc Unspecified malignant renal tumors|83318260|0-19|All Races|Male and Female|2017
10.5|11.9|11.2|944|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83318260|0-19|All Races|Male and Female|2017
21.1|23.1|22.0|1873|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83318260|0-19|All Races|Male and Female|2017
0.9|1.4|1.1|95|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83318260|0-19|All Races|Male and Female|2017
0.5|0.9|0.7|55|XIIa Other specified malignant tumors|83318260|0-19|All Races|Male and Female|2017
0.3|0.7|0.5|40|XIIb Other unspecified malignant tumors|83318260|0-19|All Races|Male and Female|2017
~|~|~|~|XIa Adrenocortical carcinomas|83318260|0-19|All Races|Male and Female|2017
9.5|10.9|10.2|864|XIb Thyroid carcinomas|83318260|0-19|All Races|Male and Female|2017
0.3|0.7|0.5|41|XIc Nasopharyngeal carcinomas|83318260|0-19|All Races|Male and Female|2017
2.6|3.3|2.9|249|XId Malignant melanomas|83318260|0-19|All Races|Male and Female|2017
~|~|~|~|XIe Skin carcinomas|83318260|0-19|All Races|Male and Female|2017
7.6|8.8|8.2|693|XIf Other and unspecified carcinomas|83318260|0-19|All Races|Male and Female|2017
1.8|2.5|2.1|178|Xa Intracranial and intraspinal germ cell tumors|83318260|0-19|All Races|Male and Female|2017
1.1|1.6|1.3|109|Xb Malignant extracranial and extragonadal germ cell tumors|83318260|0-19|All Races|Male and Female|2017
6.3|7.4|6.8|578|Xc Malignant gonadal germ cell tumors|83318260|0-19|All Races|Male and Female|2017
0.2|0.5|0.4|30|Xd Gonadal carcinomas|83318260|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|49|Xe Other and unspecified malignant gonadal tumors|83318260|0-19|All Races|Male and Female|2017
188.0|193.9|190.9|15949|All ICCC Groups Combined|83333434|0-19|All Races|Male and Female|2018
47.9|50.9|49.4|4099|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83333434|0-19|All Races|Male and Female|2018
28.9|31.2|30.0|2525|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83333434|0-19|All Races|Male and Female|2018
29.5|31.9|30.7|2546|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83333434|0-19|All Races|Male and Female|2018
2.1|2.8|2.5|203|IIIa Ependymomas and choroid plexus tumor|83333434|0-19|All Races|Male and Female|2018
14.4|16.1|15.2|1269|IIIb Astrocytomas|83333434|0-19|All Races|Male and Female|2018
4.9|5.9|5.4|442|IIIc Intracranial and intraspinal embryonal tumors|83333434|0-19|All Races|Male and Female|2018
5.8|6.9|6.4|530|IIId Other gliomas|83333434|0-19|All Races|Male and Female|2018
0.5|0.9|0.7|58|IIIe Other specified intracranial and intraspinal neoplasms|83333434|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|44|IIIf Unspecified intracranial and intraspinal neoplasms|83333434|0-19|All Races|Male and Female|2018
11.5|13.0|12.3|1042|IIa Hodgkin lymphomas|83333434|0-19|All Races|Male and Female|2018
9.9|11.3|10.6|888|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83333434|0-19|All Races|Male and Female|2018
1.9|2.5|2.2|181|IIc Burkitt lymphoma|83333434|0-19|All Races|Male and Female|2018
4.3|5.2|4.7|388|IId Miscellaneous lymphoreticular neoplasms|83333434|0-19|All Races|Male and Female|2018
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83333434|0-19|All Races|Male and Female|2018
8.5|9.8|9.1|742|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83333434|0-19|All Races|Male and Female|2018
8.2|9.5|8.8|720|IVa Neuroblastoma and ganglioneuroblastoma|83333434|0-19|All Races|Male and Female|2018
0.2|0.4|0.3|22|IVb Other peripheral nervous cell tumors|83333434|0-19|All Races|Male and Female|2018
10.9|12.4|11.7|976|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83333434|0-19|All Races|Male and Female|2018
3.9|4.8|4.3|359|IXa Rhabdomyosarcomas|83333434|0-19|All Races|Male and Female|2018
1.0|1.5|1.2|100|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83333434|0-19|All Races|Male and Female|2018
~|~|~|~|IXc Kaposi sarcoma|83333434|0-19|All Races|Male and Female|2018
4.3|5.2|4.7|398|IXd Other specified soft tissue sarcomas|83333434|0-19|All Races|Male and Female|2018
1.1|1.6|1.4|115|IXe Unspecified soft tissue sarcomas|83333434|0-19|All Races|Male and Female|2018
35.0|37.7|36.3|3011|Ia Lymphoid leukemias|83333434|0-19|All Races|Male and Female|2018
7.5|8.7|8.1|674|Ib Acute myeloid leukemias|83333434|0-19|All Races|Male and Female|2018
2.1|2.8|2.4|204|Ic Chronic myeloproliferative diseases|83333434|0-19|All Races|Male and Female|2018
0.9|1.4|1.2|95|Id Myelodysplastic syndrome and other myeloproliferative diseases|83333434|0-19|All Races|Male and Female|2018
1.1|1.7|1.4|115|Ie Unspecified and other specified leukemias|83333434|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|42|Not classified by ICCC|83333434|0-19|All Races|Male and Female|2018
2.8|3.6|3.1|255|V RETINOBLASTOMA|83333434|0-19|All Races|Male and Female|2018
6.4|7.6|7.0|574|VI RENAL TUMORS|83333434|0-19|All Races|Male and Female|2018
2.6|3.3|2.9|239|VII HEPATIC TUMORS|83333434|0-19|All Races|Male and Female|2018
9.1|10.4|9.7|821|VIII MALIGNANT BONE TUMORS|83333434|0-19|All Races|Male and Female|2018
4.8|5.8|5.3|448|VIIIa Osteosarcomas|83333434|0-19|All Races|Male and Female|2018
0.3|0.6|0.4|34|VIIIb Chondrosarcomas|83333434|0-19|All Races|Male and Female|2018
2.9|3.7|3.3|276|VIIIc Ewing tumor and related sarcomas of bone|83333434|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|83333434|0-19|All Races|Male and Female|2018
0.2|0.4|0.3|21|VIIIe Unspecified malignant bone tumors|83333434|0-19|All Races|Male and Female|2018
1.9|2.6|2.2|180|VIIa Hepatoblastoma and mesenchymal tumors of liver|83333434|0-19|All Races|Male and Female|2018
0.5|0.8|0.7|55|VIIb Hepatic carcinomas|83333434|0-19|All Races|Male and Female|2018
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83333434|0-19|All Races|Male and Female|2018
5.7|6.8|6.2|509|VIa Nephroblastoma and other non-epithelial renal tumors|83333434|0-19|All Races|Male and Female|2018
0.5|0.9|0.7|60|VIb Renal carcinomas|83333434|0-19|All Races|Male and Female|2018
~|~|~|~|VIc Unspecified malignant renal tumors|83333434|0-19|All Races|Male and Female|2018
9.8|11.2|10.5|889|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83333434|0-19|All Races|Male and Female|2018
24.2|26.3|25.3|2151|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83333434|0-19|All Races|Male and Female|2018
0.9|1.3|1.1|90|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83333434|0-19|All Races|Male and Female|2018
0.4|0.8|0.6|48|XIIa Other specified malignant tumors|83333434|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|83333434|0-19|All Races|Male and Female|2018
0.2|0.5|0.4|30|XIa Adrenocortical carcinomas|83333434|0-19|All Races|Male and Female|2018
11.4|12.9|12.2|1037|XIb Thyroid carcinomas|83333434|0-19|All Races|Male and Female|2018
0.3|0.6|0.4|35|XIc Nasopharyngeal carcinomas|83333434|0-19|All Races|Male and Female|2018
3.0|3.7|3.3|283|XId Malignant melanomas|83333434|0-19|All Races|Male and Female|2018
~|~|~|~|XIe Skin carcinomas|83333434|0-19|All Races|Male and Female|2018
8.3|9.5|8.9|757|XIf Other and unspecified carcinomas|83333434|0-19|All Races|Male and Female|2018
1.3|1.9|1.6|131|Xa Intracranial and intraspinal germ cell tumors|83333434|0-19|All Races|Male and Female|2018
1.2|1.7|1.4|117|Xb Malignant extracranial and extragonadal germ cell tumors|83333434|0-19|All Races|Male and Female|2018
6.1|7.2|6.7|568|Xc Malignant gonadal germ cell tumors|83333434|0-19|All Races|Male and Female|2018
0.3|0.6|0.5|40|Xd Gonadal carcinomas|83333434|0-19|All Races|Male and Female|2018
0.3|0.5|0.4|33|Xe Other and unspecified malignant gonadal tumors|83333434|0-19|All Races|Male and Female|2018
184.7|190.6|187.6|15649|All ICCC Groups Combined|83226688|0-19|All Races|Male and Female|2019
45.7|48.6|47.1|3903|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83226688|0-19|All Races|Male and Female|2019
28.7|31.0|29.8|2510|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83226688|0-19|All Races|Male and Female|2019
28.2|30.6|29.4|2432|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83226688|0-19|All Races|Male and Female|2019
2.2|2.9|2.5|210|IIIa Ependymomas and choroid plexus tumor|83226688|0-19|All Races|Male and Female|2019
13.5|15.2|14.3|1192|IIIb Astrocytomas|83226688|0-19|All Races|Male and Female|2019
4.5|5.5|5.0|410|IIIc Intracranial and intraspinal embryonal tumors|83226688|0-19|All Races|Male and Female|2019
6.0|7.1|6.5|539|IIId Other gliomas|83226688|0-19|All Races|Male and Female|2019
0.4|0.7|0.6|46|IIIe Other specified intracranial and intraspinal neoplasms|83226688|0-19|All Races|Male and Female|2019
0.3|0.6|0.4|35|IIIf Unspecified intracranial and intraspinal neoplasms|83226688|0-19|All Races|Male and Female|2019
11.7|13.2|12.4|1056|IIa Hodgkin lymphomas|83226688|0-19|All Races|Male and Female|2019
9.7|11.0|10.3|869|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83226688|0-19|All Races|Male and Female|2019
1.9|2.5|2.2|182|IIc Burkitt lymphoma|83226688|0-19|All Races|Male and Female|2019
4.2|5.2|4.7|385|IId Miscellaneous lymphoreticular neoplasms|83226688|0-19|All Races|Male and Female|2019
0.1|0.3|0.2|18|IIe Unspecified lymphomas|83226688|0-19|All Races|Male and Female|2019
8.8|10.1|9.4|763|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83226688|0-19|All Races|Male and Female|2019
8.5|9.8|9.1|738|IVa Neuroblastoma and ganglioneuroblastoma|83226688|0-19|All Races|Male and Female|2019
0.2|0.4|0.3|25|IVb Other peripheral nervous cell tumors|83226688|0-19|All Races|Male and Female|2019
12.3|13.8|13.0|1088|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83226688|0-19|All Races|Male and Female|2019
4.0|4.9|4.5|369|IXa Rhabdomyosarcomas|83226688|0-19|All Races|Male and Female|2019
1.1|1.6|1.3|109|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83226688|0-19|All Races|Male and Female|2019
~|~|~|~|IXc Kaposi sarcoma|83226688|0-19|All Races|Male and Female|2019
4.8|5.8|5.3|449|IXd Other specified soft tissue sarcomas|83226688|0-19|All Races|Male and Female|2019
1.6|2.2|1.9|156|IXe Unspecified soft tissue sarcomas|83226688|0-19|All Races|Male and Female|2019
33.0|35.5|34.3|2830|Ia Lymphoid leukemias|83226688|0-19|All Races|Male and Female|2019
7.5|8.7|8.1|673|Ib Acute myeloid leukemias|83226688|0-19|All Races|Male and Female|2019
2.0|2.7|2.3|196|Ic Chronic myeloproliferative diseases|83226688|0-19|All Races|Male and Female|2019
1.0|1.5|1.3|103|Id Myelodysplastic syndrome and other myeloproliferative diseases|83226688|0-19|All Races|Male and Female|2019
1.0|1.5|1.2|101|Ie Unspecified and other specified leukemias|83226688|0-19|All Races|Male and Female|2019
0.3|0.6|0.4|38|Not classified by ICCC|83226688|0-19|All Races|Male and Female|2019
2.7|3.4|3.0|244|V RETINOBLASTOMA|83226688|0-19|All Races|Male and Female|2019
6.1|7.2|6.6|540|VI RENAL TUMORS|83226688|0-19|All Races|Male and Female|2019
2.6|3.4|3.0|244|VII HEPATIC TUMORS|83226688|0-19|All Races|Male and Female|2019
8.6|10.0|9.3|784|VIII MALIGNANT BONE TUMORS|83226688|0-19|All Races|Male and Female|2019
4.7|5.7|5.2|440|VIIIa Osteosarcomas|83226688|0-19|All Races|Male and Female|2019
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|83226688|0-19|All Races|Male and Female|2019
2.6|3.3|2.9|246|VIIIc Ewing tumor and related sarcomas of bone|83226688|0-19|All Races|Male and Female|2019
0.3|0.7|0.5|41|VIIId Other specified malignant bone tumors|83226688|0-19|All Races|Male and Female|2019
0.2|0.5|0.3|28|VIIIe Unspecified malignant bone tumors|83226688|0-19|All Races|Male and Female|2019
2.0|2.6|2.3|185|VIIa Hepatoblastoma and mesenchymal tumors of liver|83226688|0-19|All Races|Male and Female|2019
0.5|0.8|0.6|54|VIIb Hepatic carcinomas|83226688|0-19|All Races|Male and Female|2019
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83226688|0-19|All Races|Male and Female|2019
5.2|6.3|5.8|468|VIa Nephroblastoma and other non-epithelial renal tumors|83226688|0-19|All Races|Male and Female|2019
0.6|1.0|0.8|70|VIb Renal carcinomas|83226688|0-19|All Races|Male and Female|2019
~|~|~|~|VIc Unspecified malignant renal tumors|83226688|0-19|All Races|Male and Female|2019
10.2|11.6|10.9|917|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83226688|0-19|All Races|Male and Female|2019
23.7|25.9|24.8|2115|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83226688|0-19|All Races|Male and Female|2019
0.7|1.1|0.9|71|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83226688|0-19|All Races|Male and Female|2019
0.3|0.6|0.5|39|XIIa Other specified malignant tumors|83226688|0-19|All Races|Male and Female|2019
0.3|0.5|0.4|32|XIIb Other unspecified malignant tumors|83226688|0-19|All Races|Male and Female|2019
0.1|0.3|0.2|16|XIa Adrenocortical carcinomas|83226688|0-19|All Races|Male and Female|2019
11.0|12.5|11.7|1004|XIb Thyroid carcinomas|83226688|0-19|All Races|Male and Female|2019
0.3|0.6|0.5|41|XIc Nasopharyngeal carcinomas|83226688|0-19|All Races|Male and Female|2019
2.8|3.6|3.2|268|XId Malignant melanomas|83226688|0-19|All Races|Male and Female|2019
~|~|~|~|XIe Skin carcinomas|83226688|0-19|All Races|Male and Female|2019
8.5|9.8|9.1|779|XIf Other and unspecified carcinomas|83226688|0-19|All Races|Male and Female|2019
1.6|2.2|1.9|159|Xa Intracranial and intraspinal germ cell tumors|83226688|0-19|All Races|Male and Female|2019
1.2|1.7|1.5|119|Xb Malignant extracranial and extragonadal germ cell tumors|83226688|0-19|All Races|Male and Female|2019
6.1|7.3|6.7|569|Xc Malignant gonadal germ cell tumors|83226688|0-19|All Races|Male and Female|2019
0.3|0.6|0.4|35|Xd Gonadal carcinomas|83226688|0-19|All Races|Male and Female|2019
0.3|0.6|0.4|35|Xe Other and unspecified malignant gonadal tumors|83226688|0-19|All Races|Male and Female|2019
182.5|185.1|183.8|75997|All ICCC Groups Combined|412527765|0-19|All Races|Male and Female|2019-2023
47.1|48.4|47.7|19507|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|412527765|0-19|All Races|Male and Female|2019-2023
27.8|28.8|28.3|11883|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|412527765|0-19|All Races|Male and Female|2019-2023
27.4|28.4|27.9|11418|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|412527765|0-19|All Races|Male and Female|2019-2023
2.3|2.6|2.4|978|IIIa Ependymomas and choroid plexus tumor|412527765|0-19|All Races|Male and Female|2019-2023
11.0|11.7|11.3|4665|IIIb Astrocytomas|412527765|0-19|All Races|Male and Female|2019-2023
5.0|5.4|5.2|2107|IIIc Intracranial and intraspinal embryonal tumors|412527765|0-19|All Races|Male and Female|2019-2023
7.4|7.9|7.6|3137|IIId Other gliomas|412527765|0-19|All Races|Male and Female|2019-2023
0.6|0.8|0.7|299|IIIe Other specified intracranial and intraspinal neoplasms|412527765|0-19|All Races|Male and Female|2019-2023
0.5|0.6|0.6|232|IIIf Unspecified intracranial and intraspinal neoplasms|412527765|0-19|All Races|Male and Female|2019-2023
11.9|12.6|12.2|5216|IIa Hodgkin lymphomas|412527765|0-19|All Races|Male and Female|2019-2023
10.0|10.6|10.3|4317|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|412527765|0-19|All Races|Male and Female|2019-2023
2.7|3.0|2.8|1159|IIc Burkitt lymphoma|412527765|0-19|All Races|Male and Female|2019-2023
2.5|2.9|2.7|1083|IId Miscellaneous lymphoreticular neoplasms|412527765|0-19|All Races|Male and Female|2019-2023
0.2|0.3|0.3|108|IIe Unspecified lymphomas|412527765|0-19|All Races|Male and Female|2019-2023
8.9|9.5|9.2|3633|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|412527765|0-19|All Races|Male and Female|2019-2023
8.4|9.0|8.7|3418|IVa Neuroblastoma and ganglioneuroblastoma|412527765|0-19|All Races|Male and Female|2019-2023
0.4|0.6|0.5|215|IVb Other peripheral nervous cell tumors|412527765|0-19|All Races|Male and Female|2019-2023
11.9|12.6|12.3|5091|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|412527765|0-19|All Races|Male and Female|2019-2023
4.6|5.1|4.8|1985|IXa Rhabdomyosarcomas|412527765|0-19|All Races|Male and Female|2019-2023
0.9|1.1|1.0|420|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|412527765|0-19|All Races|Male and Female|2019-2023
0.0|0.1|0.0|20|IXc Kaposi sarcoma|412527765|0-19|All Races|Male and Female|2019-2023
4.5|4.9|4.7|1972|IXd Other specified soft tissue sarcomas|412527765|0-19|All Races|Male and Female|2019-2023
1.5|1.8|1.7|694|IXe Unspecified soft tissue sarcomas|412527765|0-19|All Races|Male and Female|2019-2023
34.7|35.9|35.3|14363|Ia Lymphoid leukemias|412527765|0-19|All Races|Male and Female|2019-2023
7.7|8.3|8.0|3290|Ib Acute myeloid leukemias|412527765|0-19|All Races|Male and Female|2019-2023
1.9|2.2|2.1|873|Ic Chronic myeloproliferative diseases|412527765|0-19|All Races|Male and Female|2019-2023
1.1|1.4|1.3|509|Id Myelodysplastic syndrome and other myeloproliferative diseases|412527765|0-19|All Races|Male and Female|2019-2023
1.0|1.3|1.1|472|Ie Unspecified and other specified leukemias|412527765|0-19|All Races|Male and Female|2019-2023
0.4|0.6|0.5|217|Not classified by ICCC|412527765|0-19|All Races|Male and Female|2019-2023
2.7|3.1|2.9|1129|V RETINOBLASTOMA|412527765|0-19|All Races|Male and Female|2019-2023
6.8|7.3|7.0|2829|VI RENAL TUMORS|412527765|0-19|All Races|Male and Female|2019-2023
3.0|3.3|3.1|1261|VII HEPATIC TUMORS|412527765|0-19|All Races|Male and Female|2019-2023
9.0|9.6|9.3|3909|VIII MALIGNANT BONE TUMORS|412527765|0-19|All Races|Male and Female|2019-2023
5.1|5.5|5.3|2235|VIIIa Osteosarcomas|412527765|0-19|All Races|Male and Female|2019-2023
0.3|0.4|0.4|162|VIIIb Chondrosarcomas|412527765|0-19|All Races|Male and Female|2019-2023
2.7|3.0|2.8|1187|VIIIc Ewing tumor and related sarcomas of bone|412527765|0-19|All Races|Male and Female|2019-2023
0.4|0.6|0.5|216|VIIId Other specified malignant bone tumors|412527765|0-19|All Races|Male and Female|2019-2023
0.2|0.3|0.3|109|VIIIe Unspecified malignant bone tumors|412527765|0-19|All Races|Male and Female|2019-2023
2.2|2.6|2.4|945|VIIa Hepatoblastoma and mesenchymal tumors of liver|412527765|0-19|All Races|Male and Female|2019-2023
0.6|0.8|0.7|303|VIIb Hepatic carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
~|~|~|~|VIIc Unspecified malignant hepatic tumors|412527765|0-19|All Races|Male and Female|2019-2023
5.9|6.4|6.2|2465|VIa Nephroblastoma and other non-epithelial renal tumors|412527765|0-19|All Races|Male and Female|2019-2023
0.7|0.9|0.8|349|VIb Renal carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
~|~|~|~|VIc Unspecified malignant renal tumors|412527765|0-19|All Races|Male and Female|2019-2023
11.0|11.7|11.4|4803|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|412527765|0-19|All Races|Male and Female|2019-2023
22.7|23.6|23.1|9881|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|412527765|0-19|All Races|Male and Female|2019-2023
1.0|1.2|1.1|436|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|412527765|0-19|All Races|Male and Female|2019-2023
0.5|0.6|0.6|231|XIIa Other specified malignant tumors|412527765|0-19|All Races|Male and Female|2019-2023
0.4|0.6|0.5|205|XIIb Other unspecified malignant tumors|412527765|0-19|All Races|Male and Female|2019-2023
0.2|0.3|0.3|105|XIa Adrenocortical carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
10.0|10.6|10.3|4402|XIb Thyroid carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
0.3|0.4|0.4|164|XIc Nasopharyngeal carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
2.8|3.1|2.9|1240|XId Malignant melanomas|412527765|0-19|All Races|Male and Female|2019-2023
0.1|0.1|0.1|33|XIe Skin carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
8.9|9.5|9.2|3937|XIf Other and unspecified carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
1.7|1.9|1.8|753|Xa Intracranial and intraspinal germ cell tumors|412527765|0-19|All Races|Male and Female|2019-2023
1.3|1.5|1.4|563|Xb Malignant extracranial and extragonadal germ cell tumors|412527765|0-19|All Races|Male and Female|2019-2023
7.0|7.5|7.2|3079|Xc Malignant gonadal germ cell tumors|412527765|0-19|All Races|Male and Female|2019-2023
0.4|0.6|0.5|212|Xd Gonadal carcinomas|412527765|0-19|All Races|Male and Female|2019-2023
0.4|0.5|0.5|196|Xe Other and unspecified malignant gonadal tumors|412527765|0-19|All Races|Male and Female|2019-2023
178.6|184.4|181.5|15053|All ICCC Groups Combined|82886629|0-19|All Races|Male and Female|2020
46.6|49.6|48.1|3951|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82886629|0-19|All Races|Male and Female|2020
27.3|29.6|28.5|2388|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82886629|0-19|All Races|Male and Female|2020
27.5|29.8|28.6|2358|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82886629|0-19|All Races|Male and Female|2020
1.9|2.6|2.3|185|IIIa Ependymomas and choroid plexus tumor|82886629|0-19|All Races|Male and Female|2020
12.1|13.6|12.8|1063|IIIb Astrocytomas|82886629|0-19|All Races|Male and Female|2020
5.1|6.1|5.6|454|IIIc Intracranial and intraspinal embryonal tumors|82886629|0-19|All Races|Male and Female|2020
6.1|7.2|6.6|547|IIId Other gliomas|82886629|0-19|All Races|Male and Female|2020
0.5|0.9|0.7|56|IIIe Other specified intracranial and intraspinal neoplasms|82886629|0-19|All Races|Male and Female|2020
0.5|0.8|0.6|53|IIIf Unspecified intracranial and intraspinal neoplasms|82886629|0-19|All Races|Male and Female|2020
10.9|12.4|11.6|989|IIa Hodgkin lymphomas|82886629|0-19|All Races|Male and Female|2020
9.7|11.1|10.4|870|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82886629|0-19|All Races|Male and Female|2020
2.1|2.7|2.4|197|IIc Burkitt lymphoma|82886629|0-19|All Races|Male and Female|2020
3.4|4.3|3.8|310|IId Miscellaneous lymphoreticular neoplasms|82886629|0-19|All Races|Male and Female|2020
0.2|0.4|0.3|22|IIe Unspecified lymphomas|82886629|0-19|All Races|Male and Female|2020
8.5|9.9|9.2|731|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82886629|0-19|All Races|Male and Female|2020
8.3|9.7|9.0|715|IVa Neuroblastoma and ganglioneuroblastoma|82886629|0-19|All Races|Male and Female|2020
0.1|0.3|0.2|16|IVb Other peripheral nervous cell tumors|82886629|0-19|All Races|Male and Female|2020
11.3|12.8|12.1|1005|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82886629|0-19|All Races|Male and Female|2020
4.4|5.3|4.8|397|IXa Rhabdomyosarcomas|82886629|0-19|All Races|Male and Female|2020
0.8|1.2|1.0|81|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82886629|0-19|All Races|Male and Female|2020
~|~|~|~|IXc Kaposi sarcoma|82886629|0-19|All Races|Male and Female|2020
4.1|5.0|4.6|384|IXd Other specified soft tissue sarcomas|82886629|0-19|All Races|Male and Female|2020
1.4|2.0|1.7|138|IXe Unspecified soft tissue sarcomas|82886629|0-19|All Races|Male and Female|2020
34.4|37.0|35.7|2929|Ia Lymphoid leukemias|82886629|0-19|All Races|Male and Female|2020
7.2|8.4|7.8|644|Ib Acute myeloid leukemias|82886629|0-19|All Races|Male and Female|2020
1.9|2.5|2.2|185|Ic Chronic myeloproliferative diseases|82886629|0-19|All Races|Male and Female|2020
1.0|1.5|1.2|101|Id Myelodysplastic syndrome and other myeloproliferative diseases|82886629|0-19|All Races|Male and Female|2020
0.9|1.4|1.1|92|Ie Unspecified and other specified leukemias|82886629|0-19|All Races|Male and Female|2020
0.4|0.7|0.5|42|Not classified by ICCC|82886629|0-19|All Races|Male and Female|2020
2.6|3.4|3.0|235|V RETINOBLASTOMA|82886629|0-19|All Races|Male and Female|2020
6.7|7.9|7.3|590|VI RENAL TUMORS|82886629|0-19|All Races|Male and Female|2020
2.6|3.4|3.0|242|VII HEPATIC TUMORS|82886629|0-19|All Races|Male and Female|2020
8.0|9.3|8.7|732|VIII MALIGNANT BONE TUMORS|82886629|0-19|All Races|Male and Female|2020
4.5|5.5|5.0|421|VIIIa Osteosarcomas|82886629|0-19|All Races|Male and Female|2020
0.2|0.5|0.4|30|VIIIb Chondrosarcomas|82886629|0-19|All Races|Male and Female|2020
2.4|3.2|2.8|233|VIIIc Ewing tumor and related sarcomas of bone|82886629|0-19|All Races|Male and Female|2020
0.2|0.5|0.3|27|VIIId Other specified malignant bone tumors|82886629|0-19|All Races|Male and Female|2020
0.2|0.4|0.2|21|VIIIe Unspecified malignant bone tumors|82886629|0-19|All Races|Male and Female|2020
2.0|2.7|2.3|185|VIIa Hepatoblastoma and mesenchymal tumors of liver|82886629|0-19|All Races|Male and Female|2020
0.5|0.9|0.7|56|VIIb Hepatic carcinomas|82886629|0-19|All Races|Male and Female|2020
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82886629|0-19|All Races|Male and Female|2020
6.0|7.1|6.5|523|VIa Nephroblastoma and other non-epithelial renal tumors|82886629|0-19|All Races|Male and Female|2020
0.6|1.0|0.8|65|VIb Renal carcinomas|82886629|0-19|All Races|Male and Female|2020
~|~|~|~|VIc Unspecified malignant renal tumors|82886629|0-19|All Races|Male and Female|2020
10.3|11.8|11.0|930|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82886629|0-19|All Races|Male and Female|2020
19.8|21.8|20.8|1772|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82886629|0-19|All Races|Male and Female|2020
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82886629|0-19|All Races|Male and Female|2020
0.3|0.6|0.5|38|XIIa Other specified malignant tumors|82886629|0-19|All Races|Male and Female|2020
0.3|0.6|0.5|39|XIIb Other unspecified malignant tumors|82886629|0-19|All Races|Male and Female|2020
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|82886629|0-19|All Races|Male and Female|2020
8.5|9.8|9.1|780|XIb Thyroid carcinomas|82886629|0-19|All Races|Male and Female|2020
0.2|0.4|0.3|24|XIc Nasopharyngeal carcinomas|82886629|0-19|All Races|Male and Female|2020
2.3|3.0|2.7|226|XId Malignant melanomas|82886629|0-19|All Races|Male and Female|2020
~|~|~|~|XIe Skin carcinomas|82886629|0-19|All Races|Male and Female|2020
7.8|9.0|8.4|714|XIf Other and unspecified carcinomas|82886629|0-19|All Races|Male and Female|2020
1.5|2.1|1.8|151|Xa Intracranial and intraspinal germ cell tumors|82886629|0-19|All Races|Male and Female|2020
0.9|1.4|1.1|92|Xb Malignant extracranial and extragonadal germ cell tumors|82886629|0-19|All Races|Male and Female|2020
6.7|7.8|7.2|614|Xc Malignant gonadal germ cell tumors|82886629|0-19|All Races|Male and Female|2020
0.3|0.6|0.4|37|Xd Gonadal carcinomas|82886629|0-19|All Races|Male and Female|2020
0.3|0.6|0.4|36|Xe Other and unspecified malignant gonadal tumors|82886629|0-19|All Races|Male and Female|2020
182.6|188.5|185.5|15260|All ICCC Groups Combined|82212844|0-19|All Races|Male and Female|2021
46.1|49.1|47.6|3875|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82212844|0-19|All Races|Male and Female|2021
26.4|28.7|27.5|2303|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82212844|0-19|All Races|Male and Female|2021
28.7|31.1|29.9|2438|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82212844|0-19|All Races|Male and Female|2021
1.9|2.5|2.2|178|IIIa Ependymomas and choroid plexus tumor|82212844|0-19|All Races|Male and Female|2021
12.4|14.0|13.2|1081|IIIb Astrocytomas|82212844|0-19|All Races|Male and Female|2021
5.0|6.0|5.5|442|IIIc Intracranial and intraspinal embryonal tumors|82212844|0-19|All Races|Male and Female|2021
7.3|8.5|7.8|644|IIId Other gliomas|82212844|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|44|IIIe Other specified intracranial and intraspinal neoplasms|82212844|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|49|IIIf Unspecified intracranial and intraspinal neoplasms|82212844|0-19|All Races|Male and Female|2021
11.3|12.8|12.0|1023|IIa Hodgkin lymphomas|82212844|0-19|All Races|Male and Female|2021
9.5|10.9|10.2|847|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82212844|0-19|All Races|Male and Female|2021
3.1|3.9|3.5|285|IIc Burkitt lymphoma|82212844|0-19|All Races|Male and Female|2021
1.4|1.9|1.6|129|IId Miscellaneous lymphoreticular neoplasms|82212844|0-19|All Races|Male and Female|2021
0.1|0.4|0.2|19|IIe Unspecified lymphomas|82212844|0-19|All Races|Male and Female|2021
8.8|10.1|9.4|740|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82212844|0-19|All Races|Male and Female|2021
8.1|9.4|8.7|680|IVa Neuroblastoma and ganglioneuroblastoma|82212844|0-19|All Races|Male and Female|2021
0.5|0.9|0.7|60|IVb Other peripheral nervous cell tumors|82212844|0-19|All Races|Male and Female|2021
11.3|12.8|12.1|991|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82212844|0-19|All Races|Male and Female|2021
4.4|5.4|4.9|398|IXa Rhabdomyosarcomas|82212844|0-19|All Races|Male and Female|2021
0.8|1.2|1.0|80|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82212844|0-19|All Races|Male and Female|2021
~|~|~|~|IXc Kaposi sarcoma|82212844|0-19|All Races|Male and Female|2021
3.9|4.8|4.3|363|IXd Other specified soft tissue sarcomas|82212844|0-19|All Races|Male and Female|2021
1.5|2.1|1.8|146|IXe Unspecified soft tissue sarcomas|82212844|0-19|All Races|Male and Female|2021
33.9|36.5|35.2|2856|Ia Lymphoid leukemias|82212844|0-19|All Races|Male and Female|2021
7.1|8.4|7.7|635|Ib Acute myeloid leukemias|82212844|0-19|All Races|Male and Female|2021
1.8|2.5|2.1|179|Ic Chronic myeloproliferative diseases|82212844|0-19|All Races|Male and Female|2021
1.2|1.7|1.5|118|Id Myelodysplastic syndrome and other myeloproliferative diseases|82212844|0-19|All Races|Male and Female|2021
0.9|1.3|1.1|87|Ie Unspecified and other specified leukemias|82212844|0-19|All Races|Male and Female|2021
0.4|0.7|0.6|47|Not classified by ICCC|82212844|0-19|All Races|Male and Female|2021
2.5|3.3|2.9|220|V RETINOBLASTOMA|82212844|0-19|All Races|Male and Female|2021
6.6|7.8|7.2|574|VI RENAL TUMORS|82212844|0-19|All Races|Male and Female|2021
2.9|3.7|3.2|257|VII HEPATIC TUMORS|82212844|0-19|All Races|Male and Female|2021
8.7|10.0|9.4|787|VIII MALIGNANT BONE TUMORS|82212844|0-19|All Races|Male and Female|2021
4.6|5.6|5.1|429|VIIIa Osteosarcomas|82212844|0-19|All Races|Male and Female|2021
0.2|0.5|0.3|27|VIIIb Chondrosarcomas|82212844|0-19|All Races|Male and Female|2021
2.7|3.4|3.0|255|VIIIc Ewing tumor and related sarcomas of bone|82212844|0-19|All Races|Male and Female|2021
0.5|0.8|0.6|51|VIIId Other specified malignant bone tumors|82212844|0-19|All Races|Male and Female|2021
0.2|0.4|0.3|25|VIIIe Unspecified malignant bone tumors|82212844|0-19|All Races|Male and Female|2021
2.2|2.9|2.5|195|VIIa Hepatoblastoma and mesenchymal tumors of liver|82212844|0-19|All Races|Male and Female|2021
0.5|0.9|0.7|59|VIIb Hepatic carcinomas|82212844|0-19|All Races|Male and Female|2021
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82212844|0-19|All Races|Male and Female|2021
5.9|7.1|6.5|513|VIa Nephroblastoma and other non-epithelial renal tumors|82212844|0-19|All Races|Male and Female|2021
0.5|0.9|0.7|57|VIb Renal carcinomas|82212844|0-19|All Races|Male and Female|2021
~|~|~|~|VIc Unspecified malignant renal tumors|82212844|0-19|All Races|Male and Female|2021
10.8|12.2|11.5|962|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82212844|0-19|All Races|Male and Female|2021
22.2|24.3|23.3|1975|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82212844|0-19|All Races|Male and Female|2021
0.9|1.4|1.1|91|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82212844|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|43|XIIa Other specified malignant tumors|82212844|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|48|XIIb Other unspecified malignant tumors|82212844|0-19|All Races|Male and Female|2021
0.2|0.4|0.2|20|XIa Adrenocortical carcinomas|82212844|0-19|All Races|Male and Female|2021
9.5|10.8|10.1|866|XIb Thyroid carcinomas|82212844|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|43|XIc Nasopharyngeal carcinomas|82212844|0-19|All Races|Male and Female|2021
2.5|3.2|2.8|237|XId Malignant melanomas|82212844|0-19|All Races|Male and Female|2021
~|~|~|~|XIe Skin carcinomas|82212844|0-19|All Races|Male and Female|2021
8.8|10.2|9.5|804|XIf Other and unspecified carcinomas|82212844|0-19|All Races|Male and Female|2021
1.6|2.2|1.8|154|Xa Intracranial and intraspinal germ cell tumors|82212844|0-19|All Races|Male and Female|2021
1.3|1.8|1.5|120|Xb Malignant extracranial and extragonadal germ cell tumors|82212844|0-19|All Races|Male and Female|2021
6.5|7.6|7.0|596|Xc Malignant gonadal germ cell tumors|82212844|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|51|Xd Gonadal carcinomas|82212844|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|41|Xe Other and unspecified malignant gonadal tumors|82212844|0-19|All Races|Male and Female|2021
184.7|190.7|187.7|15470|All ICCC Groups Combined|82113420|0-19|All Races|Male and Female|2022
46.7|49.8|48.2|3915|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82113420|0-19|All Races|Male and Female|2022
27.2|29.5|28.4|2383|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82113420|0-19|All Races|Male and Female|2022
28.2|30.6|29.4|2393|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82113420|0-19|All Races|Male and Female|2022
2.2|2.9|2.6|206|IIIa Ependymomas and choroid plexus tumor|82113420|0-19|All Races|Male and Female|2022
11.0|12.5|11.7|959|IIIb Astrocytomas|82113420|0-19|All Races|Male and Female|2022
4.5|5.5|5.0|397|IIIc Intracranial and intraspinal embryonal tumors|82113420|0-19|All Races|Male and Female|2022
8.3|9.6|8.9|728|IIId Other gliomas|82113420|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|48|IIIe Other specified intracranial and intraspinal neoplasms|82113420|0-19|All Races|Male and Female|2022
0.5|0.9|0.7|55|IIIf Unspecified intracranial and intraspinal neoplasms|82113420|0-19|All Races|Male and Female|2022
12.0|13.5|12.8|1090|IIa Hodgkin lymphomas|82113420|0-19|All Races|Male and Female|2022
10.0|11.5|10.7|898|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82113420|0-19|All Races|Male and Female|2022
2.7|3.5|3.1|251|IIc Burkitt lymphoma|82113420|0-19|All Races|Male and Female|2022
1.3|1.8|1.5|121|IId Miscellaneous lymphoreticular neoplasms|82113420|0-19|All Races|Male and Female|2022
0.2|0.4|0.3|23|IIe Unspecified lymphomas|82113420|0-19|All Races|Male and Female|2022
8.1|9.5|8.8|690|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82113420|0-19|All Races|Male and Female|2022
7.6|8.8|8.2|638|IVa Neuroblastoma and ganglioneuroblastoma|82113420|0-19|All Races|Male and Female|2022
0.5|0.8|0.6|52|IVb Other peripheral nervous cell tumors|82113420|0-19|All Races|Male and Female|2022
11.6|13.2|12.4|1023|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82113420|0-19|All Races|Male and Female|2022
4.6|5.6|5.1|413|IXa Rhabdomyosarcomas|82113420|0-19|All Races|Male and Female|2022
0.6|1.1|0.8|69|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82113420|0-19|All Races|Male and Female|2022
~|~|~|~|IXc Kaposi sarcoma|82113420|0-19|All Races|Male and Female|2022
4.2|5.1|4.6|387|IXd Other specified soft tissue sarcomas|82113420|0-19|All Races|Male and Female|2022
1.5|2.1|1.8|150|IXe Unspecified soft tissue sarcomas|82113420|0-19|All Races|Male and Female|2022
34.8|37.4|36.1|2913|Ia Lymphoid leukemias|82113420|0-19|All Races|Male and Female|2022
7.4|8.7|8.0|661|Ib Acute myeloid leukemias|82113420|0-19|All Races|Male and Female|2022
1.6|2.2|1.9|161|Ic Chronic myeloproliferative diseases|82113420|0-19|All Races|Male and Female|2022
0.9|1.4|1.1|90|Id Myelodysplastic syndrome and other myeloproliferative diseases|82113420|0-19|All Races|Male and Female|2022
0.9|1.3|1.1|90|Ie Unspecified and other specified leukemias|82113420|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|50|Not classified by ICCC|82113420|0-19|All Races|Male and Female|2022
2.6|3.4|3.0|231|V RETINOBLASTOMA|82113420|0-19|All Races|Male and Female|2022
6.5|7.7|7.1|564|VI RENAL TUMORS|82113420|0-19|All Races|Male and Female|2022
2.9|3.7|3.3|260|VII HEPATIC TUMORS|82113420|0-19|All Races|Male and Female|2022
9.4|10.8|10.1|849|VIII MALIGNANT BONE TUMORS|82113420|0-19|All Races|Male and Female|2022
5.5|6.6|6.0|508|VIIIa Osteosarcomas|82113420|0-19|All Races|Male and Female|2022
0.3|0.6|0.4|35|VIIIb Chondrosarcomas|82113420|0-19|All Races|Male and Female|2022
2.4|3.2|2.8|232|VIIIc Ewing tumor and related sarcomas of bone|82113420|0-19|All Races|Male and Female|2022
0.5|0.8|0.7|55|VIIId Other specified malignant bone tumors|82113420|0-19|All Races|Male and Female|2022
0.1|0.4|0.2|19|VIIIe Unspecified malignant bone tumors|82113420|0-19|All Races|Male and Female|2022
2.1|2.8|2.4|190|VIIa Hepatoblastoma and mesenchymal tumors of liver|82113420|0-19|All Races|Male and Female|2022
0.6|1.0|0.8|69|VIIb Hepatic carcinomas|82113420|0-19|All Races|Male and Female|2022
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82113420|0-19|All Races|Male and Female|2022
5.4|6.5|6.0|470|VIa Nephroblastoma and other non-epithelial renal tumors|82113420|0-19|All Races|Male and Female|2022
0.8|1.3|1.1|90|VIb Renal carcinomas|82113420|0-19|All Races|Male and Female|2022
~|~|~|~|VIc Unspecified malignant renal tumors|82113420|0-19|All Races|Male and Female|2022
11.1|12.6|11.8|1004|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82113420|0-19|All Races|Male and Female|2022
22.5|24.6|23.6|2016|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82113420|0-19|All Races|Male and Female|2022
0.9|1.4|1.1|92|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82113420|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|48|XIIa Other specified malignant tumors|82113420|0-19|All Races|Male and Female|2022
0.4|0.7|0.5|44|XIIb Other unspecified malignant tumors|82113420|0-19|All Races|Male and Female|2022
0.1|0.3|0.2|18|XIa Adrenocortical carcinomas|82113420|0-19|All Races|Male and Female|2022
9.5|10.9|10.2|878|XIb Thyroid carcinomas|82113420|0-19|All Races|Male and Female|2022
0.2|0.4|0.3|25|XIc Nasopharyngeal carcinomas|82113420|0-19|All Races|Male and Female|2022
2.7|3.4|3.0|258|XId Malignant melanomas|82113420|0-19|All Races|Male and Female|2022
~|~|~|~|XIe Skin carcinomas|82113420|0-19|All Races|Male and Female|2022
9.1|10.4|9.7|831|XIf Other and unspecified carcinomas|82113420|0-19|All Races|Male and Female|2022
1.3|1.9|1.6|131|Xa Intracranial and intraspinal germ cell tumors|82113420|0-19|All Races|Male and Female|2022
1.1|1.6|1.3|103|Xb Malignant extracranial and extragonadal germ cell tumors|82113420|0-19|All Races|Male and Female|2022
7.4|8.6|7.9|680|Xc Malignant gonadal germ cell tumors|82113420|0-19|All Races|Male and Female|2022
0.3|0.6|0.5|40|Xd Gonadal carcinomas|82113420|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|50|Xe Other and unspecified malignant gonadal tumors|82113420|0-19|All Races|Male and Female|2022
173.5|179.2|176.4|14565|All ICCC Groups Combined|82088184|0-19|All Races|Male and Female|2023
46.2|49.2|47.6|3863|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82088184|0-19|All Races|Male and Female|2023
26.1|28.4|27.2|2299|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82088184|0-19|All Races|Male and Female|2023
21.0|23.1|22.0|1797|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82088184|0-19|All Races|Male and Female|2023
2.2|2.9|2.5|199|IIIa Ependymomas and choroid plexus tumor|82088184|0-19|All Races|Male and Female|2023
4.1|5.0|4.5|370|IIIb Astrocytomas|82088184|0-19|All Races|Male and Female|2023
4.5|5.5|5.0|404|IIIc Intracranial and intraspinal embryonal tumors|82088184|0-19|All Races|Male and Female|2023
7.7|9.0|8.3|679|IIId Other gliomas|82088184|0-19|All Races|Male and Female|2023
1.0|1.5|1.2|105|IIIe Other specified intracranial and intraspinal neoplasms|82088184|0-19|All Races|Male and Female|2023
0.3|0.7|0.5|40|IIIf Unspecified intracranial and intraspinal neoplasms|82088184|0-19|All Races|Male and Female|2023
11.6|13.1|12.3|1058|IIa Hodgkin lymphomas|82088184|0-19|All Races|Male and Female|2023
9.3|10.6|9.9|833|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82088184|0-19|All Races|Male and Female|2023
2.6|3.4|3.0|244|IIc Burkitt lymphoma|82088184|0-19|All Races|Male and Female|2023
1.5|2.0|1.7|138|IId Miscellaneous lymphoreticular neoplasms|82088184|0-19|All Races|Male and Female|2023
0.2|0.4|0.3|26|IIe Unspecified lymphomas|82088184|0-19|All Races|Male and Female|2023
8.4|9.7|9.0|709|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82088184|0-19|All Races|Male and Female|2023
7.7|9.0|8.3|647|IVa Neuroblastoma and ganglioneuroblastoma|82088184|0-19|All Races|Male and Female|2023
0.6|0.9|0.7|62|IVb Other peripheral nervous cell tumors|82088184|0-19|All Races|Male and Female|2023
11.1|12.6|11.9|984|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82088184|0-19|All Races|Male and Female|2023
4.5|5.5|5.0|408|IXa Rhabdomyosarcomas|82088184|0-19|All Races|Male and Female|2023
0.8|1.2|1.0|81|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82088184|0-19|All Races|Male and Female|2023
~|~|~|~|IXc Kaposi sarcoma|82088184|0-19|All Races|Male and Female|2023
4.2|5.1|4.6|389|IXd Other specified soft tissue sarcomas|82088184|0-19|All Races|Male and Female|2023
1.0|1.5|1.3|104|IXe Unspecified soft tissue sarcomas|82088184|0-19|All Races|Male and Female|2023
33.9|36.5|35.2|2835|Ia Lymphoid leukemias|82088184|0-19|All Races|Male and Female|2023
7.7|8.9|8.3|677|Ib Acute myeloid leukemias|82088184|0-19|All Races|Male and Female|2023
1.5|2.1|1.8|152|Ic Chronic myeloproliferative diseases|82088184|0-19|All Races|Male and Female|2023
1.0|1.5|1.2|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|82088184|0-19|All Races|Male and Female|2023
1.0|1.5|1.2|102|Ie Unspecified and other specified leukemias|82088184|0-19|All Races|Male and Female|2023
0.3|0.6|0.5|40|Not classified by ICCC|82088184|0-19|All Races|Male and Female|2023
2.2|3.0|2.6|199|V RETINOBLASTOMA|82088184|0-19|All Races|Male and Female|2023
6.5|7.7|7.1|561|VI RENAL TUMORS|82088184|0-19|All Races|Male and Female|2023
2.9|3.7|3.3|258|VII HEPATIC TUMORS|82088184|0-19|All Races|Male and Female|2023
8.4|9.7|9.0|757|VIII MALIGNANT BONE TUMORS|82088184|0-19|All Races|Male and Female|2023
4.7|5.7|5.2|437|VIIIa Osteosarcomas|82088184|0-19|All Races|Male and Female|2023
0.3|0.6|0.5|41|VIIIb Chondrosarcomas|82088184|0-19|All Races|Male and Female|2023
2.3|3.0|2.6|221|VIIIc Ewing tumor and related sarcomas of bone|82088184|0-19|All Races|Male and Female|2023
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|82088184|0-19|All Races|Male and Female|2023
0.1|0.3|0.2|16|VIIIe Unspecified malignant bone tumors|82088184|0-19|All Races|Male and Female|2023
2.1|2.8|2.4|190|VIIa Hepatoblastoma and mesenchymal tumors of liver|82088184|0-19|All Races|Male and Female|2023
0.6|1.0|0.8|65|VIIb Hepatic carcinomas|82088184|0-19|All Races|Male and Female|2023
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82088184|0-19|All Races|Male and Female|2023
5.7|6.8|6.3|491|VIa Nephroblastoma and other non-epithelial renal tumors|82088184|0-19|All Races|Male and Female|2023
0.6|1.0|0.8|67|VIb Renal carcinomas|82088184|0-19|All Races|Male and Female|2023
~|~|~|~|VIc Unspecified malignant renal tumors|82088184|0-19|All Races|Male and Female|2023
10.9|12.4|11.6|990|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82088184|0-19|All Races|Male and Female|2023
22.2|24.3|23.2|2003|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82088184|0-19|All Races|Male and Female|2023
1.1|1.6|1.3|105|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82088184|0-19|All Races|Male and Female|2023
0.6|1.0|0.8|63|XIIa Other specified malignant tumors|82088184|0-19|All Races|Male and Female|2023
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|82088184|0-19|All Races|Male and Female|2023
0.2|0.5|0.4|30|XIa Adrenocortical carcinomas|82088184|0-19|All Races|Male and Female|2023
9.4|10.7|10.1|874|XIb Thyroid carcinomas|82088184|0-19|All Races|Male and Female|2023
0.2|0.5|0.4|31|XIc Nasopharyngeal carcinomas|82088184|0-19|All Races|Male and Female|2023
2.6|3.3|2.9|251|XId Malignant melanomas|82088184|0-19|All Races|Male and Female|2023
~|~|~|~|XIe Skin carcinomas|82088184|0-19|All Races|Male and Female|2023
8.8|10.1|9.4|809|XIf Other and unspecified carcinomas|82088184|0-19|All Races|Male and Female|2023
1.6|2.2|1.9|158|Xa Intracranial and intraspinal germ cell tumors|82088184|0-19|All Races|Male and Female|2023
1.3|1.9|1.6|129|Xb Malignant extracranial and extragonadal germ cell tumors|82088184|0-19|All Races|Male and Female|2023
6.6|7.8|7.2|620|Xc Malignant gonadal germ cell tumors|82088184|0-19|All Races|Male and Female|2023
0.4|0.7|0.6|49|Xd Gonadal carcinomas|82088184|0-19|All Races|Male and Female|2023
0.3|0.6|0.4|34|Xe Other and unspecified malignant gonadal tumors|82088184|0-19|All Races|Male and Female|2023
